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Emerging infectious diseases are mostly zoonotic in origin and defined as “infections that have newly emerged 
in a population or have existed but are rapidly increasing in incidence or geographic range". Zoonotic viruses 
are directly (e.g. bite from a rabid bat) or indirectly (via an intermediate host or vector) transmitted from 
animals to humans. Bats have received increasing attention as potential hosts for zoonotic diseases. Bats belong 
to the order Chiroptera, which consists of two suborders: Yinpterochiroptera and Yangochiroptera. More than 
1 300 species have been described globally, occurring on almost all continents excluding Antarctica. Specific 
physiological and ecological characteristics make bats extraordinary evolutionary vessels to carry numerous 
infectious agents including pathogens.  
Astroviruses (AstVs) are amongst the vast array of viruses that have been detected in bats. AstVs are single 
stranded, positive sense, RNA viruses that are transmitted via the faecal-oral route. Infection with AstVs causes 
acute diarrhoea, however, more serious clinical presentations such as neurological deficits, stunted growth and 
encephalitis have also been documented. Bats on the other hand, seem to be asymptomatically infected with 
AstVs. Little attention has been given to the evolution, phylogenetic relationship, ecology and diversity of 
AstVs in South African bats. In 2013 the first study in South Africa screening for a variety of viruses in small 
mammals, including SAn bats, found that bats were frequently co-infected with AstVs and coronaviruses.  
The overall aims of the current study were to describe the prevalence, diversity and ecology of AstVs in South 
African bats, to determine the potential threat to environmental and animal health at wastewater treatment 
works (WWTW) through testing water and bat samples for the presence of AstVs, to monitor AstV and CoV 
co-infection in a Neoromicia capensis colony over time and to isolate and propagate a bat AstV in vitro. The 
results will be used to determine the potential One Health implications of AstVs in a South African setting.  
Sample collection was done via non-invasive capture and release methods by collaborating zoologists. 
Morphological and ecological data of each bat were recorded. Bat faecal samples (n=500) were screened for 
AstVs using the hemi-nested screening assay that targets the RNA-dependent RNA polymerase (RdRP) gene 
of the virus. Plasmid positive controls were generated to ensure an optimal AstV screening PCR assay. 
The One Health concept emphasizes the interlinkage between human, animal and environmental health. To 
determine the impact that potential exposure to human AstVs at WWTW might have on animal and 
environmental health, water samples upstream and downstream of two WWTW were also collected and 
screened for AstVs. 
The overall detection rate of AstVs across bat species was 13%, but it differed significantly between species 
(Miniopterus natalensis, 55%; Rhinolophus capensis, 39%; and R. clivosus, 17%). Positive samples were 
further analysed to try and amplify the capsid protein gene (ORF2), which is highly variable and only one 
ORF2 gene fragment was obtained. 
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Twenty-five novel AstV RdRp sequences and one ORF2 sequence were identified, bringing the total RdRp 
sequences available for South African bat AstVs to forty-four. Maximum likelihood analyses of the RdRp gene 
fragments suggest that South African bat AstVs are not restricted by host species identity or geographical 
location. Interestingly, the maximum likelihood analyses of the ORF2 sequence suggest that the South African 
bat AstVs might be more similar to human AstVs from Japan compared to any bat AstVs.  
The water samples collected from the WWTW tested negative for the presence of AstVs and only one bat 
sample collected at the WWTW tested positive for AstV.  
Two real-time PCR assays were designed to monitor AstVs and coronaviruses in a N. capensis colony over 
time, as these two viruses regularly co-infect bats. The results indicated that both these viruses had a single 
amplification peak that was associated with colony formation after migration. Interestingly the peak in viral 
loads did not correlate with the pupping season of the bats, as was found by another study conducted on these 
two viruses in Germany.  
Statistical analyses of ecological and individual bat factors suggest that being a sexually active adult male bat, 
species identity and occurrence in the Succulent Karoo biome could contribute to AstV positivity. 
The current study was the first ever to successfully isolate and propagate a Miniopterus bat derived AstV in 
vitro. During the isolation attempts three different cell lines were used, human adenocarcinoma, Neoromicia 
capensis kidney and baby hamster kidney cells. Isolation and propagation was only successful in the baby 
hamster kidney cells. The refined protocol for isolation and propagation of bat AstVs in cell culture will enable 
future studies to successfully isolate bat AstVs as well as enable genomic and functional studies. The results 
also gave insight into the potential zoonotic risk of bat AstVs.  
The findings of the current study indicated that bat AstVs are diverse and relatively prevalent in South African 
bats. Phylogenetic analyses of the 24 novel RdRp and one ORF2 genes from this study indicated that the virus 
was not limited by species identity or host geographical range. Furthermore, the phylogenetic analyses of the 
bat AstV ORF2 gene would suggest that the bat AstV is more similar to human AstVs, which could imply that 
South African bat AstVs have zoonotic potential. The results of current study gave some potential insights into 





Opkomende aansteeklike siektes word gedefinieer as “infeksies wat onlangs verskyn het in ŉ populasie of wat 
al lank reeds teenwoordig was in ŉ populasie maar vinnig toeneem in insidensie of geografiese verspreiding”. 
Die meerderheid van opkomende aansteeklike siektes is zoonoties in oorsprong, wat beteken dat hul 
oorspronklik in diere voorgekom het, maar nou na mense oorgedra kan word. Zoonotiese virusse kan direk 
oorgedra word na die mens bv. deur gebyt te raak deur ŉ hond met hondsdolheid of indirek deur ŉ tussenganger 
gasheer of vektor. Met die soeke na wilde diere wat dien as gashere van moontlike zoonotiese siektes was 
vlermuise geïdentifiseer as belangrike gashere vir verskeie potensiële zoonotiese siektes. Vlermuise behoort 
aan die orde Chiroptera wat verder in twee subordes verdeel word, naamlik Yinpterochiroptera en 
Yangochiroptera. Die orde Chiroptera is baie divers met meer as 1300 spesies wat globaal beskryf is en 
voorkom op alle vastelande, uitsluitend Antarktika. Daar is verskeie eienskappe (fisiologies en ekologies) wat 
vlermuise besonderse evolusionêre vaartuie maak om as draers te dien vir verskeie patogene. 
Astrovirusse (AstVs) is een groep van verskeie virusse wat in vlermuise voorkom. AstVs is enkelstring, 
positiewe sense, RNA virusse wat via die fekale-orale roete versprei word. Infeksie met AstVs veroorsaak 
gewoonlik akute diarree, maar meer ernstige simptome soos neurologiese afwykings, vertraagde groei asook 
enkefalitis is al waargeneem. Dit wil voorkom of vlermuise asimptomaties geïnfekteer word deur die virus. 
Baie min aandag is geskenk aan die evolusie, filogenetiese verwantskappe, ekologie en diversiteit van AstVs 
wat in Suid Afrikaanse (SA) vlermuise voorkom. Die enigste bestaande studie wat AstVs bestudeer het in SA 
vlermuise was uitgevoer deur Dr Ithete tydens haar doktorale studie. Die studie deur Ithete (2013) was 
hoofsaaklik ŉ verkenning studie om te bepaal watter virusse in klein soogdiere voorkom in SA, daar was egter 
nie ŉ in-diepte ondersoek na die diversiteit en ekologie van AstVs nie. Tydens die huidige studie was die 
diversiteit en ekologie van AstVs in SA vlermuise bestudeer deur gebruik te maak van molekulêre-, 
filogenetiese- en statistiese metodes.  
Vlermuis monsters wat gebruik is tydens die huidige studie, was verskaf deur samewerkende dierkundiges met 
etiese toestemming. Die meerderheid van die monsters was versamel deur nie-indringende metodes, wat vang 
en vrylating van die vlermuise vereis het. Tydens die versameling van vlermuise morfologiese data was 
gedokumenteer asook ekologiese data. 
ŉ Totaal van vyfhonderd mis monsters was getoets vir die teenwoordigheid van AstVs deur gebruik te maak 
van ŉ polimerase ketting reaksie (PKR). Die PCR toets teiken die RNA-afhanklike RNA polimerase (RdRp) 
geen van die virus. Om te verseker dat die PKR toets wat reg toegepas word, was ŉ plasmied positiewe kontrole 
geproduseer. Die plasmied positiewe kontrole was in vitro getranskribeer na RNA om te verseker dat al die 
stappe, vanaf omgekeerde transkripsie van onttrekte RNA, gevolg deur die AstV PKR toets, reg verloop. Die 
virus was opgespoor in 13% van al die monsters wat getoets was vir AstVs. Die opsporing het wel verskil 
tussen vlermuis spesies, met die hoogste voorkoms van die virus in Miniopterus natalensis (55%) gevolg deur 
Rhinolophus capensis (39%) en Rhinolophus clivosus (17%). Monsters wat positief getoets het vir AstV is 
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verder geanaliseer om ŉ groter fragment van die virus te probeer bekom, naamlik die kapsied proteïen 
voorloper geen (ORF2). ŉ PKR toets wat ontwikkel is deur Atkins et al., (2009) was gebruik. Aangesien die 
kapsied proteïen geen baie divers is, het meeste pogings misluk en slegs een ORF2 geen fragment is bekom.  
ŉ Totaal van 25 nuwe AstV RdRp gene asook een ORF2 geen is geïdentifiseer. Dit bring die totaal van AstVs 
RdRp geen volgordes wat beskikbaar is vir AstVs van SA vlermuise na 44. Die filogenetiese analise van die 
RdRp gene het gedui dat daar geen definitiewe patroon is in terme van groeperings nie, dit wil voorkom of SA 
vlermuis AstV nie beperk word deur gasheer spesie of geografiese verspreiding nie. Interessant genoeg het die 
maksimum waarskynlikheidsanalise van die ORF2 geen aangedui dat die SA vlermuis AstVs meer soortgelyk 
is aan mens AstVs as aan vlermuis AstVs. 
Tydens die studie was daar gebruik gemaak van twee real-time qPCR (werklike tyd kwantitatiewe polimerase 
ketting reaksie) toetse om AstVs asook caronavirusse te monitor in ŉ Neoromicia capensis vlermuis kolonie. 
Die resultate het getoon dat albei virusse een amplifikasie hoogtepunt bereik het na kolonie formasie na 
migrasie. Die piek in virus lading was nie geassosieer met die geboorte van nuwelinge nie, soos wat voorheen 
deur ander studies bevind was nie.  
Statistiese analises van ekologiese- en individuele vlermuis metings het getoon dat die volgende faktore 
moontlik kan bydra tot AstV positiwiteit in vlermuise: geslag (seksueel aktiewe mannetjies), spesies identiteit 
asook bioom (Sukkulente Karoo). 
Die huidige studie was die eerste ter wêreld om ŉ vlermuis AstV suksesvol te isoleer en propageer in vitro. 
Tydens die isolasie pogings was drie verskillende sellyne gebruik: menslike adenokarsinoom (Caco-2), 
Neoromicia capensis nier selle (NCK) asook hamster nier selle (BHK G43). Die isolasie was slegs suksesvol 
in die hamster nier selle. Daar is verskeie faktore wat ŉ bydra kon lewer tot die sukses van die isolasie poging 
naamlik die monster tipe wat gebruik was as inokulum, die media komposisie, sellyn tipe asook die inkubasie 
tydperk na die sellyn geïnokuleer is. Die suksesvolle isolasie van ŉ vlermuis AstV in vitro sal opkomende 
studies in staat stel om ook suksesvolle isolasies te doen asook verdere genetiese toetse bv. volledige genoom 
toetse. 
Die bevindinge van die huidige studie toon dat SA vlermuis AstVs relatief volop is en dat hul ook divers is. 
Vyf-en-twinting RdRp geen volgordes en een ORF2 geen volgorde is bekom in die studie. Filogenetiese 
analises van die RdRp geen volgordes het getoon dat die virus nie deur gasheer spesie of geografiese 
verspreiding beperk word nie. Interessant genoeg het die filogenetiese analise van die ORF2 geen volgorde 
getoon dat die SA vlermuis AstV nader verwant is aan menslike AstVs as aan vlermuis AstVs, wat moontlike 
zoonotiese potensiaal impliseer. Die suksesvolle isolasie van ŉ vlermuis AstV in vitro is ŉ groot bydra tot 
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Chapter 1 Introduction & Literature Review 
1.1 Emerging Infectious Diseases  
Emerging infectious diseases (EIDs) are defined as “infections that have newly emerged in a 
population or have existed but are rapidly increasing in incidence or geographic range” (Morse, 
1995). The majority of EIDs are zoonotic in origin. Zoonotic viruses are transmitted from animals to 
humans, either directly (e.g. bite from a rabid bat) or indirectly via an intermediate host or vector 
(Ludwig et al., 2003, Halpin et al., 2007; Mendenhall et al., 2015). Emergence of a disease is 
influenced by various factors which include but are not limited to: acquired resistance of pathogens 
to antibiotics and other antimicrobial medicine, an increase in the mobility of humans which enhances 
the spread of disease causing agents, host range, taxonomy of the pathogen, and molecular 
characteristics of the pathogen (Taylor et al., 2000, Cleveland et al., 2001, Jones et al., 2008, 
Mendenhall et al., 2015).  
1.2 Bats as important hosts of various EIDs  
In the search for wildlife that serve as hosts to potentially zoonotic diseases, bats have received 
increasing attention (Newman et al., 2011, Baker et al., 2013; Mendenhall et al., 2015). Bats belong 
to the order Chiroptera which consists of two suborders Yinpterochiroptera and Yangochiroptera 
(Teeling, 2009; Monadjem et al., 2010). Chiropterans are highly speciose, with more than 1300 
species described globally, occurring on almost all continents excluding Antarctica (Teeling et al., 
2005; Teeling, 2009). This fascinating group of flying mammals have divergent morphologies, 
ecologies and behaviours (Monadjem et al., 2010). There are ample characteristics (physiological and 
ecological) that make bats extraordinary evolutionary vessels to carry numerous pathogens, of which 
the most important will be discussed. 
Bats and their associated pathogens have co-evolved for 50 to 100 million years. In rare cases some 
pathogens carried by bats spilled over to humans, e.g. Hendra virus in Australia (Teeling, 2009; 
Playford et al., 2010; Wibbelt et al., 2010). This is largely due to habitat destruction and human 
encroachment of natural habitats, resulting in increased contact between bats and humans, as well as 
between bats and domesticated animals (Baker et al., 2013).  
Some infectious agents carried by bats may be transmitted through direct contact with the infected 
bat (e.g. a bite from a rabid bat) or indirectly through an intermediate or amplifying host. Findings by 
Corman et al. (2014) suggest that the Middle East respiratory syndrome coronavirus (MERS-CoV), 
isolated from camels and humans, potentially originated from bats. This study furthermore indicated 
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that the virus has undergone host switching events and that the origin of the virus may be in Africa, 
from where camels are imported into the Arabian Peninsula (Corman et al., 2014). It should however 
be mentioned that not all pathogens carried by bats will become emerging infectious diseases that 
will spill over to humans.  
Chiropterans are the only flying mammals on earth and this specific characteristic facilitates short- 
and long-distance dispersal of diseases, e.g. big brown bats (Eptesicus fuscus) can travel an average 
distance of 35 km per night. Migratory bat species are known to travel vast distances and even cross 
from one continent to another e.g. large flying foxes (Pteropus vampyrus) have been recorded to 
travel distances of up to 2 500 km during migrations, making them extraordinarily good long-distance 
dispersers of diseases (Halpin et al., 2007; Epstein et al., 2009; Monadjem et al., 2010; Wibbelt et al., 
2010; Mendenhall et al., 2015).  
Another trait that has also been identified as important to their ability to carry disease is their sociality. 
Bats display a range of social behaviour such as allogrooming and food sharing. Vampire bats 
(Desmodus rotundus) are known to share blood meals with roost members resulting in the spread of 
pathogens from one individual to another (Wilkinson, 1984).  
Roosting behaviour also differs between bat species, with some bats roost in isolation whilst others 
form large roosts. The largest known roost is located at Bracken Cave in the United States of America 
(USA) where millions of Mexican free-tailed bats (Tadarida brasiliensis) inhabit the cave. Maternity 
roosts are a particularly interesting roost type, as the roost consists solely of female bats and their 
pups. Not only does roosting increase contact rates between individual bats of the same species, but 
it also allows for interactions with other bat species, which could facilitate pathogen sharing (Calisher 
et al., 2006; Wibbelt et al., 2010).  
While it is evident that bats are important reservoirs for various pathogens, little is known about the 
underlying mechanisms that drive pathogen maintenance, spread, diversity and epidemiology within 
individual bats, within colonies and possibly between colonies and between species (Calisher et al., 
2006; De Benedictis et al., 2011; Drexler et al., 2011). Even though it is assumed that bats are 
asymptomatic whilst testing positive for various pathogens, e.g. detection of rabies in apparent 
healthy bats, a study by Mühldorfer et al. (2011) found that 12 % of bat fatalities investigated during 
their study could be attributed to infectious agents and parasites. The exact functioning of the bat’s 
immune system is not yet fully understood. Fortunately, research in this particular field is increasing 
(Kunz & Fenton, 2003; Calisher et al., 2006; Wibbelt et al., 2010; Moratelli & Calisher, 2015). 
Studies conducted on bat immunology have identified orthologous bat immune genes, which include 
major histocompatibility class II genes and numerous alleles in Noctilio albiventris and E. fuscus. 
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Some of the alleles identified have been linked to parasite burden. Antiviral, innate and interferon 
genes have also been identified in Pteropus vampyrus, P. lecto and Myotis lucifugus. Microbial 
pattern recognition receptors have also been detected in Pteropus genome scans (Wibbelt et al., 2010). 
These studies have highlighted the importance of continuing research into bat immunology (Moratelli 
& Calisher, 2015). 
1.3 Introduction to astroviruses  
Members of the family Astroviridae are non-enveloped, positive-sense, single-stranded RNA 
(ribonucleic acid) viruses with a characteristic star-like surface structure when observed under an 
electron microscope (Gray & Desselberger, 2009; De Benedictis et al., 2011; Osborne et al., 2015). 
The virus was first discovered in 1975 in stool samples from infants suffering from diarrhoea 
(Appleton & Higgins, 1975).  
1.4 Taxonomy  
The family Astroviridae has been divided into two genera based on the class of host the viruses infect, 
avastroviruses (infect birds) and mamastroviruses (infect mammals) (Mendez & Arias, 2007). The 
mamastrovirus genus contains 19 species whilst the avastrovirus genus contains three species. The 
current species classification of astroviruses (AstVs), from both mamastro- and avastrovirus groups 
is based on the host species from which the virus has been isolated, as such the species do not 
correspond to genetic phylogenies (Bosch et al., 2014). The classification of these viruses will be 
redefined based on the complete capsid region at the amino acid level (Boujon et al., 2017). According 
to the new method AstVs will then be divided into two genogroups: genogroup I and genogroup II 
(Boujon et al., 2017). The genogroups consist of various genotypes that infect different host species. 
The mean amino acid genetic distance (p-dist) between two genogroups is 0.704 ± 0.013. The amino 
acid genetic distance between genotypes within a genogroup ranges between 0.576 and 0.741. 
Mamastroviruses can also be divided into two genogroups based on the capsid protein amino acids, 
Genogroup I and Genogroup II (Figure 1.1.). The mean amino acid genetic distance (p-dist) between 
genogroups is 0.671 ± 0.016 and the genetic distance between genotypes ranges between 0.338 and 
0.783 (Bosch et al., 2012). Serotypes within genotypes are defined based on two-way cross-
neutralization titres (of 20-fold and greater) and are then given consecutive numbers (Bosch et al., 
2014).  
However, some evidence suggests that cross-genus and cross-species infection has taken place in the 
past e.g. an AstV isolated from a stranded California sea lion pup (Zalophus californianus) is thought 
to have originated through recombination of a human AstV isolate (belonging to genotype human 
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AstV-3 (HAstV-3)) with a marine mammal AstV, resulting in California sea lion AstV-3 (CslAstV-
3) (Rivera et al., 2010). Furthermore, inter-genotype recombination has been recorded for HAstV 
genotypes (Pativada et al., 2011), this has not yet been investigated for bats and other non-human 
hosts harbouring AstVs. There is also a large gap in the literature with regards to co-infections and 
the chance of recombination of AstVs strains in non-human hosts (Xiao et al., 2013; Mendenhall et 
al., 2015).  
 
Figure 1.1. Phylogenetic relationship between members of the family Astroviridae based on the analyses of 
the capsid polyprotein gene (King et al., 2012) (Image used with permission from Elsevier) 
1.5 Replication and pathogenesis  
Very little is known about AstV attachment and cell entry. Based on what is known about other RNA 
viruses, it is suggested that multiple receptors are utilized for virus attachment and entry, but no 
studies have identified the specific receptors. Donelli et al. (1992) suggest that AstVs might enter 
cells through receptor-mediated endocytosis. Once the virus enters a cell, the virus promotes 
intracellular membrane rearrangement to produce vesicle-like structures (singe- and double-
membrane vesicles), that are associated with protein and viral RNA synthesis as well as virus particle 
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assembly (Mendez & Arias, 2007). The release mechanism of virus particles from infected cells is 
also undetermined (Gray & Desselberger, 2009; De Benedictis et al., 2011). 
1.6 Genome structure 
The length of the AstV genomes varies from 6.1 to 7.3 kilobases (kb) (Mendez & Arias, 2007; Gray 
& Desselberger, 2009). The genome contains 5’ and 3’ untranslated regions (UTRs) and three open 
reading frames (ORFs); ORF1a, ORF1b and ORF2 (Figure 1.2.) (Mendez & Arias, 2007; Strain et 
al., 2009; Gray & Desselberger, 2009). ORF1a is 2.8 kb in length and encodes an 110kDa 
polypeptide, which contains an array of conserved motifs (e.g. immunoreactive epitope, putative 
nuclear localization signal, serine protease) (Mendez & Arias, 2007). The polypeptide is cleaved into 
five peptides by cellular proteases and viral proteases (Mendez & Arias, 2007). The three ORFs code 
for different proteins: ORF1a for non-structural proteins, ORF1b codes for RNA-dependent RNA 
polymerase (RdRp) and is separated from ORF1a by a frameshift. Between ORF1a and ORF1b there 
is an overlap of 70 bases containing sequences that direct ribosomal frameshifting (to a-1 frame) 
which enables reading of ORF1b (Gray & Desselberger, 2009). ORF1b is the most conserved region 
between the three ORFs and is usually used in genetic analyses to determine genetic relatedness of 
viruses (Strain et al., 2009). ORF2 codes for a structural viral polyprotein which is utilized in the 
production of virions and thus experiences more selective pressures and is therefore more divergent 
than the other ORFs that code for non-structural proteins (Gray & Desselberger, 2009). 
Approximately 56 complete AstV genome sequences are available on Genbank 
(http://www.ncbi.nlm.nih.gov/genome/?term=astrovirus on 1st of January-2019). However, there is a 
large amount of partial RdRp gene sequences available; the RdRp gene is the target of the detection 
assays used in this study which was designed by Chu et al. (2009). 
 
Figure 1.2. Genome organization of human astrovirus (Bosch, Pintó, Guix, 2014). “Genomic and 
subgenomic RNA organization, with ORF1a, ORF1b, ORF2, and putative ORFX represented as 
boxes. Nucleotide sequences represent highly conserved sequences located in the ribosomal 
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frameshift (RFS) signal and upstream of the initiation site of subgenomic RNA transcription. 
Putative RNA secondary structures conserved in the RFS and in the 3′ end of the genome are 
depicted.” With permission from the journal Clinical Microbiology Reviews.  
1.7 Astrovirus infection in humans 
AstVs are transmitted through the faecal-oral route, either through contact with contaminated surfaces 
or ingestion of food or water contaminated with infected faecal material (Moser & Schultz-Cherry, 
2005; Gray & Desselberger, 2009; De Benedictis et al., 2011). As is the case for many enteric viruses, 
AstVs are exceptionally durable in the environment, which increases the risk of exposure and 
infection of other individuals (De Benedictis et al., 2011; Krishnan, 2014; Mendenhall et al., 2015). 
The incubation period of the infection is two to three days whereafter symptoms appear, such as 
gastroenteritis and vomiting. More severe symptoms, such as encephalitis and hepatitis, have been 
documented in immunocompromised patients (Moser & Schultz-Cherry, 2005; Gray & Desselberger, 
2009; De Benedictis et al., 2011).  
Demographically children, the elderly and immunocompromised individuals are most susceptible to 
AstV infection (De Benedictis et al., 2011; Bosch et al., 2014; Jeong et al., 2012). These infections 
occur globally and the reported prevalence amongst children with gastroenteritis ranges from 2 to 9% 
annually. However, a pilot study conducted in South Africa (SA) screened faecal samples (n = 191 
adults and n = 105 children under the age of 5) of individuals with diarrhoea for the presence of AstVs 
and found a similar incidence in adults (3.1%) and children (4.8%). This study did not disclose 
whether the samples collected from adults were from individuals that could potentially be 
immunocompromised (HIV status) (Page, 2002). 
A higher incidence of infection is positively correlated with high population density areas, including 
hostels, old age homes and hospitals (Abad et al., 2001; Moser & Schultz-Cherry, 2008; Bosch et al., 
2014). AstV infections occur year-round, however seasonal variation has been documented in 
humans. In tropical areas high incidence is correlated with the rainy season and in temperate regions 
infections peak during the winter months (Pativada et al., 2012).  
Treatment is supportive as the infection is self-limiting and as such only the accompanying symptoms 
such as dehydration and vomiting are treated (Glass & Bresee, 2011; Bosch et al., 2014).  
1.8 Astrovirus infection in animals 
AstV screening in animals is not common practice and most reports of animal AstV infections have 
resulted from tests conducted on symptomatic infections in livestock and poultry, as well as 
Stellenbosch University https://scholar.sun.ac.za
7 
opportunistic screening of wildlife (Moser & Schultz-Cherry, 2008). Different AstVs presents with 
different symptoms in different hosts, e.g. in kittens and puppies, infection may cause mild diarrhoea 
and pyrexia, whereas in minks the virus causes debilitating shaking mink syndrome. Infected adult 
pigs and cattle seem to be asymptomatic, whereas infection in juveniles often lead to diarrhoea (Gray 
& Desselberger, 2009; De Benedictis et al., 2011; Krishnan, 2014). In captive cheetahs infection is 
associated with anorexia, lethargy, regurgitation and diarrhoea (Atkins et al., 2009).  
In avian hosts AstV infection can present as gastroenteritis, but stunted growth and fatal hepatitis 
have been observed in ducks, as well as interstitial nephritis in chickens (King et al., 2012).  
Numerous AstV infections have been described in wildlife species, which include but are not limited 
to cheetahs, roe deer, crab-eating foxes, sea lions, rodents and bats (Atkins et al., 2009; Chu et al., 
2011; Alves et al., 2018). AstV infection in bats seems to be asymptomatic, similar to numerous other 
viruses that infect this mammal group (Calisher et al., 2006; De Benedictis et al., 2011; Drexler et al., 
2011; Mühldorfer et al., 2011).  
1.9 Identification and diagnosis of infection  
Since the first observation of AstVs in 1975 using electron microscopy (EM), numerous other 
methods have been developed to identify and diagnose AstV infection in both humans and animals. 
With the virus being an enteric virus, it is common practice to collect faecal material from the 
suspected infected individual, however, some studies have also utilized other specimen types, such 
as the gastro intestinal tract (GIT), brain, sputum and urine samples (Boujon et al., 2017; Fischer et 
al., 2017; Alves et al., 2018). Although EM was one of the first methods used for diagnosing AstV 
infection, there are numerous shortcomings, e.g. high virus concentrations (107 particles per 10 grams 
of faecal material) are needed for successful identification, and misidentification is common as only 
10% of particles exhibit a star-like surface structure under EM (Busch et al., 2014). Misdiagnosis due 
to misidentification has therefore led to this method being phased out as a diagnostic tool (Pérot et 
al., 2017). Other AstV identification methods commonly used include virus isolation, 
immunodetection and antigenic typing, multiplex reverse transcription polymerase chain reaction 
(RT-PCR) panels, nanofluidic PCR, microarrays and next-generation sequencing (NGS).  
1.9.1. Molecular diagnostics: RT-PCR, Real-time PCR, NGS 
Since the development of molecular approaches that amplify the viral genome or transcripts the use 
of EM, virus isolation and immunoassays was phased out as diagnostic tools for AstV infections 
(Pérot et al., 2017). Molecular methods are widely used in clinical diagnostic and veterinary 
laboratories. RT-PCR allows detection and typing of AstVs. There is currently no universal PCR 
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setup for the detection of all known AstVs. Consensus primers such as those designed by Chu et al. 
(2011) detect a vast array of AstVs, but not all. The primers are routinely used in bat screening, but 
human, domesticated animal and wildlife samples usually have their own accompanying set of 
primers specific for the target of interest. The reason that a universal primer set has not been 
developed is probably due to high levels of genetic diversity between different AstV strains (Pérot et 
al., 2017). Real-time PCR methods can diagnose AstVs in a shorter time frame, it reduces the number 
of false positives and also enable viral load quantification.  
Next generation sequencing (NGS) is not routinely used as a diagnostic tool for AstV infection due 
to the high costs compared to conventional screening RT-PCR or real-time PCR assays. NGS is more 
commonly used as an exploratory investigative method in research settings and this technology has 
enabled researchers to obtain partial or complete AstV genomes, which in turn provide invaluable 
insight into pathogenesis, viral diversity and emergence of novel AstV strains (Pérot et al., 2017). It 
has successfully been used for both clinical specimens and specimens from wildlife and domesticated 
animals.  
Even though NGS is not usually used as diagnostic tool, it has aided in the diagnosis of neurotropic 
AstV infections (in humans, minks and cattle), that could not be detected through conventional 
screening PCR assays (Blomström et al., 2010; Ng et al., 2014; Nagai et al., 2015; Pérot et al., 2017). 
1.9.2. Virus isolation 
Isolation in cell culture is not routinely used as a diagnostic tool as it is labour intensive, time-
consuming and challenging (Pérot et al., 2017). Virus isolation is further complicated by the fact that 
most wild type AstVs do not grow in standard cell cultures that are routinely used in diagnostic 
laboratories. However, virus isolation is still a valuable tool to study AstVs, as various AstV strains 
have been successfully isolated in vitro (Table 1.1.), although no in vitro attempts to isolate and 
propagate bat AstVs had been successful to date. 
1.10 Current knowledge on bat astroviruses 
1.10.1 South African bat astroviruses  
From literature it is evident that AstV infectious dynamics has been biased towards human hosts and 
little attention has been given to the ecology and infection dynamics of AstVs in wild animals, this is 
particularly true for bat AstVs (Mendenhall et al., 2015). Little attention has been given to the 
evolution, phylogenetic relationship, ecology and diversity of AstVs in South African (SAn) bats 
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(Ithete, 2013). The only known study thus far to investigate SA bat AstVs was conducted by Ithete 
(2013).  
Table 1.1. Astroviruses and the cell lines that were successfully used to isolate and culture the virus 
AstV Cell line for culture 
Human AstV serotypes 1-7 Caco-2 Human colon adenocarcinoma 
T84 Human colon carcinoma 
HT-29 Human colon adenocarcinoma 
SK-CO-1 Human colon adenocarcinoma 
SK-CO-1 Human colon adenocarcinoma 
MA-104c African green monkey foetal kidney 
PLC/PRF/5 cell line 
PLC/PRF/5 hepatoma 
HAstV serotype 1 only HCT-15 Human colon adenocarcinoma 
Chicken astrovirus (CAstV) isolates LMH cell line 
Porcine AstV ESK Porcine embryonic kidney cell 
Feline AstV Feline embryonic kidney cell 
Bovine AstV Bovine embryonic kidney cell 
Sources: Shimizu et al., 1990; Taylor et al., 1997; Brinker et al., 2000; Moser & Schultz-Cherry, 2005; Crameri et al., 
2009; De Benedictis et al., 2011; Xiao et al., 2011; Xiao et al., 2013 
AstVs were identified in seven bat species from the Miniopteridae, Molossidae, Rhinolophidae and 
Vespertilionidae families. The sequences belonged to genus mamastrovirus in genogroup II, 
clustering with bat AstVs found in China (Chu et al., 2009). Genogroup II viruses can further be 
divided into four clades; clade 1 comprises of Chinese and SAn bat AstVs, clade 2 includes German 
and Chinese bat AstVs; clade 3 contains bat, mink, human and ovine AstVs and clade 4 consists of 
bat, rabbit and porcine AstVs. Bat AstVs occur in all four genogroup II clades. Another interesting 
finding by Ithete (2013) was that AstV strains isolated from a single bat species did not always cluster 
together, similar to the findings of Drexler et al. (2011). The viral sequences did not cluster according 
to geographical location and it was found that SAn strains clustered with AstV from China. Viral 
sequences isolated from Tadarida aegyptiaca and Miniopterus natalensis bats trapped at various 
locations in the Western Cape exhibited the highest sequence similarity (97%). The results suggested 
that BtAstV/MSTM12 and BtAstV/TAr1 could potentially have evolved from a common prototype 
strain or could have emerged as the result of recombination events (Ithete, 2013).  
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1.10.2 Bat astrovirus studies in other parts of the world  
The first ever study to discover AstVs in insectivorous bats was conducted by Chu et al. (2008) in 
China. This study built the framework for future bat AstV research studies, by developing a screening 
PCR that targets a conserved region of the genome, the RdRp gene. Since this study, various other 
research groups have investigated AstVs in bats. The literature shows that bat AstV studies are 
concentrated in certain areas (Figure 1.3.) and the majority are from China, Europe and West Africa. 
After the publication by Fischer et al. (2017), AstVs were investigated in three more locations  which 
include Madagascar, Singapore and Mozambique (Lebarbenchon et al., 2017; Mendenhall et al., 
2017; Hoarau et al., 2018).  
 
 
Figure 1.3. Geographic distribution of study sites for the detection of astrovirus RNA in bats (Fischer et al., 
2017). Image was used with permission of Elsevier.  
 
AstVs have been identified in one-third of known bat families (Table 1.2.) indicating the diversity of 
hosts within the order Chiroptera (Fischer et al., 2017). Noted from the literature is that the sequences 
were highly divergent and that the prevalence differed significantly between species, but also over 
time (Drexler et al., 2011; Fischer et al., 2017; Lebarbenchon et al., 2017; Mendenhall et al., 2017). 
It is thought that multiple factors, including ecological as well as host-factors, influence virus 







Table 1.2. Species and number of bats that were investigated for the presence of astrovirus RNA/genome by 
semi-nested RT-PCR. (Adapted from Lebarbenchon et al., 2017; Mendenhall et al., 2017; Fischer 
et al., 2017; Hoarau et al., 2018) 
Family Species Region Number Positive 
   of animals Results (%) 
Vespertilionidae Barbastella barbastellus Hungary 13 0 (0%) 
 Eptesicus nilssonii Czech Republic 1 0 (0%) 
 Eptesicus serotinus Hungary 3 0 (0%) 
  Hungary 7 0 (0%) 
  Czech Republic 1 1 (100%) 
 Hesperoptenus spp. Cambodia 1 0 (0%) 
 Hypsugo savii Czech Republic 4 1 (25%) 
 Ia io China 11 4 (36.4%) 
  Lao PDR 32 1 (3.1%) 
 Miniopterus gleni Madagascar 2 1 (50%) 
 Miniopterus griveaudi Madagascar 26 15 (57.7%) 
 Miniopterus inflatus Gabon 155 16 (10.3%) 
 Miniopterus magnate China (Hong Kong) 122 67 (54.9%) 
 Miniopterus pusillus China (Hong Kong) 73 31 (42.5%) 
 Miniopterus schreibersii China (Hong Kong) 3 3 (100%) 
  China 19 12 (63.2%) 
  China 187 22 (11.8%) 
  Hungary 15 12 (80%) 
 Myotis alcathoe Hungary 16 0 (0%) 
 Myotis bechsteinii Hungary 22 1 (4.5%) 
  Hungary 125 5 (4%) 
  Czech Republic 1 0 (0%) 
  Germany 321 35 (10.9%) 
 Myotis brandtii Hungary 3 0 (0%) 
 Myotis blythii Hungary 2 0 (0%) 
  Hungary 10 0 (0%) 
 Myotis chinensis China (Hong Kong) 9 3 (33.3%) 
 Myotis dasycneme Hungary 11 0 (0%) 
 Myotis daubentoniid Hungary 7 3 (42.9%) 
  Hungary 81 6 (7.4%) 
  Czech Republic 3 0 (0%) 
  Germany 47 30 (63.8%) 
 Myotis dasycheme Hungary 4 0 (0%) 
 Myotis emarginatus Hungary 5 1 (20%) 
  Czech Republic 1 1 (100%) 
 Myotis horsfieldii Cambodia 47 20 (42.6%) 
 Myotis goudoti Madagascar 11 1 (9%) 
 Myotis Hungary 6 0 (0%) 
  Hungary 29 0 (0%) 
 Myotis mystacinus Hungary 1 0 (0%) 
  Czech Republic 1 1 (100%) 
 Myotis nattereri Hungary 4 0 (0%) 
  Hungary 37 1 (2.7%) 
  Germany 248 99 (39.9%) 
 Myotis pilosus China (Hong Kong) 12 10 (83.3%) 
  China 16 2 (12.5%) 
  China 1 0 (0%) 
 Myotis spp.  China 5 3 (60%) 
  Singapore 1 0 (0%) 
 Nyctalus leisleri Hungary 6 0 (0%) 
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Family Species Region Number Positive 
   of animals Results (%) 
 Nyctalus noctula Hungary 14 4 (28.6%). 
  Czech Republic 7 1 (14.3%) 
 Nyctalus plancyi velutinus China 1 0 (0%) 
 Pipistrellus abramus China (Hong Kong) 2 1 (50%) 
  China 20 1 (5%) 
 Pipistrellus hesperidus Madagascar 5 0 (0%) 
 Pipistrellus nathusii Hungary 3 0 (0%) 
  Czech Republic 1 0 (0%) 
  Germany 22 6 (27.3%) 
 Pipistrellus Hungary 1 0 (0%) 
  Hungary 12 0 (0%) 
  Czech Republic 12 1 (8.3%) 
  Germany 7 0 (0%) 
 Pipistrellus pygmaeus Hungary 6 1 (16.7%) 
  Czech Republic 1 1 (100%) 
  Germany 12 6 (50%) 
 Pipistrellus stenopterus Singapore 1 0 (0%) 
 Pipistrellus spp. China 5 0 (0%) 
  Cambodia 29 0 (0%) 
 Plecotus auritus Hungary 11 1 (9.1%) 
  Hungary 29 1 (3.4%) 
  Czech Republic 2 0 (0%) 
  Germany 118 24 (20.3%) 
 Plecotus austriacus Hungary 3 0 (0%) 
  Czech Republic 2 0 (0%) 
 Scotophilus kuhlii China 38 6 (15.8%) 
  China 2 0 (0%) 
 Scotophilus spp. Cambodia 524 39 (7.4%) 
 Tylonycteris pachypus China 2 0 (0%) 
 Tylonycteris spp. Cambodia 1 0 (0%) 
 Vespertilio murinus Hungary 3 0 (0%) 
  Czech Republic 5 1 (20%) 
  TOTAL 2514 486 (19%) 
Rhinolophidae Rhinolophus affinis China 2 0 (0%) 
 Rhinolophus Euryale Hungary 3 0 (0%) 
 Rhinolophus ferrumequinum China 7 0 (0%) 
  China 4 2 (50%) 
  Hungary 12 0 (0%) 
 Rhinolophus hipposideros Hungary 3 0 (0%) 
  Czech Republic 2 1 (50%) 
 Rhinolophus Lepidus China 11 0 (0%) 
  Singapore 1 0 (0%) 
 Rhinolophus macrotis China 2 0 (0%) 
  China 1 0 (0%) 
 Rhinolophus pearsonii China 1 1 (100%) 
 Rhinolophus rouxii China (Hong Kong) 8 1 (12.5%) 
 Rhinolophus sinicus China 1 0 (0%) 
 Rhinolophus spp. Cambodia 53 1 (1.9%) 
  Lao PDR 102 4 (3.9%) 
  TOTAL 213 10 (4.7%) 
Hipposideridae Aselliscus stoliczkanus China 1 0 (0%) 
 Aselliscus spp. Lao PDR 7 0 (0%) 
 Hipposideros armiger China (Hong Kong) 10 0 (0%) 
  China 109 21 (19.3%) 
 Hipposideros gigas Gabon 226 7 (3.1%) 
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Family Species Region Number Positive 
   of animals Results (%) 
 Hipposideros larvatus China 29 4 (13.8%) 
  China 1 0 (0%) 
 Hipposideros Pomona China 95 13 (13.7%) 
  China 15 0 (0%) 
 Hipposideros ruber Gabon 394 17 (4.3%) 
 Hipposideros spp. Cambodia 4 1 (25%) 
  Lao PDR 26 1 (3.8%) 
 Paratriaenops furculus Madagascar 31 11 (35%) 
 Triaenops menamena Madagascar 40 0 (0%) 
  TOTAL 988 75 (7.5%) 
Pteropodidae Cynopterus bra chyotis Singapore 144 0 (0%) 
 Cynopterus sphinx China (Hong Kong) 11 0 (0%) 
 Cynopterus spp. Cambodia 321 0 (0%) 
  Lao PDR 19 0 (0%) 
 Eonycteris spelaea Singapore 169 30 (17.75%) 
 Eonycteris spp. Cambodia 28 0 (0%) 
  Lao PDR 51 3 (5.9%) 
 Macroglossus minimus Singapore 1 0 (0%) 
 Macroglossus spp. Cambodia 21 0 (0%) 
  Lao PDR 1 0 (0%) 
 Megaerops spp. Cambodia 29 0 (0%) 
  Lao PDR 69 0 (0%) 
 Penthetor lucasi Singapore 79 0 (0%) 
 Pteropus spp. Cambodia 10 0 (0%) 
 Rousettus aegyptiacus Gabon 162 2 (1.2%) 
 Rousettus leschenaultia China 59 1 (1.7%) 
 Rousettus madagascariensis Madagascar 41 2 (4.8%) 
 Rousettus spp. Cambodia 11 1 (9.1%) 
  Lao PDR 322 23 (7.1%) 
  TOTAL 1235 62 (5%) 
Emballonuridae Coleura afra Gabon 25 2 (8%) 
 Taphozous melanopogon China 172 160 (93%) 
 Taphozous spp. Cambodia 147 4 (2.7%) 
  TOTAL 344 166 (48.3%) 
Megadermatidae Megaderma lyra China 1 1 (100%) 
  Cambodia 21 2 (9.5%) 
  TOTAL 22 3 (13.6%) 
Molossidae Mormopterus jugularis Madagascar 40 0 (0%) 
 Otomops madagascariensis Madagascar 6 0 (0%) 
  TOTAL 46 0 (0%) 
 
1.10.3 Cross species transmission and zoonotic potential  
Until relatively recently AstV infections were thought to be species-specific. More and more findings 
are suggesting that the host tropism of AstVs might be wider than previously thought. Currently there 
exists no evidence of cross-species transmission of a bat AstV to a species of another mammalian 
order (Fischer et al., 2017). As there is no strict host restriction of bat AstVs within the Chiroptera 
group it could be that there have been cross-species transmission that are yet undiscovered. There is 
however evidence of cross-species transmission in other mammalian groups. Livestock farming 
readily puts different domesticated animals in close proximity to one another, increasing the 
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probability of spill-over from one species to another. Interestingly, a recent study reported a single 
AstV species that infected different host organisms in different geographical areas. The neurotropic 
AstV identified in a sheep in Sweden with encephalitis shared 95% amino acid similarity in the capsid 
protein gene region, with a bovine AstV identified in Germany (Boujon et al., 2017). As the similarity 
was so high between the capsid protein gene regions these AstV strains could be seen as the same 
species according to the International Committee on Taxonomy of Viruses (ICTV) guidelines 
(Boujon et al., 2017).  
Similar to most viruses that originated from animals, the same is true for newly discovered human 
AstV serotypes, HAstV-MLB1-3, HMO AstVs A, B, and C, and HAstV-VA1-4. These serotypes are 
phylogenetically more similar to AstVs isolated from animals than the “classical” human AstV 
serotypes (HAstV1-8) (Bosch et al., 2012).  
Another interesting study reported that non-human primates (NHP) harboured diverse AstV strains 
that were related to human and avian AstVs (Karlsson et al., 2015). This study revealed that members 
of the avastrovirus group could in fact spill over to mammals, which was thought to be restricted to 
birds (Karlsson et al., 2015). The study also identified an AstV strain in NHP, which was a 
recombination between a NHP AstV and a HAstV strain. These NHP were in close contact with 
human settlements and it is highly plausible that a spill-over event occurred. Also, of interest are the 
accounts of possible reverse zoonoses that were documented in captive cheetahs that were infected 
with an AstVs strain that was similar to a human AstV strain (Atkins et al., 2009).  
Considering the high diversity of AstVs and their ability to adapt to different environments and 
different hosts species, it would not be impossible for a bat AstVs to spill over to humans or other 
animals. This highlights the importance of disease surveillance efforts in both humans and bats. 
1.11 One Health Approach  
One Health is a concept that recognizes the interconnectedness of human, environmental and animal 
health (United Nations 2008; Narrod et al., 2012). This concept is not new to the 21st century (Evans 
& Leighton, 2014) and the first documented reference thereto can already be found in the writings of 
Hippocrates (460 BCE - 367 BCE) in ‘On Airs, Waters and Places’, where he discusses the 
interrelationship of human health and a clean environment (Evans & Leighton, 2014). Even though 
the fundamental concept of One Health has been acknowledged for hundreds of years, human and 
animal health remained separate fields of study until the 20th century. In recent years there has been 
a surge in emerging EID and zoonotic disease studies with a One Health focus (Narrod et al., 2012).  
Stellenbosch University https://scholar.sun.ac.za
16 
Many of these animal studies have investigated diseases carried by bats, as bats are important hosts 
for numerous EIDs. Several disease ecology studies have found that anthropogenic disturbances of 
natural habitats have caused bats to inhabit peri-urban areas, increasing the contact rates between bats 
and humans, as well as bats and domestic animals (Daszak et al., 2007; Narrod et al., 2012). This in 
turn leads to an increased likelihood of disease spill-over events, not only from wildlife to humans, 
but also from humans to wildlife (Daszak et al., 2007).  
The objectives of the current study fit well with the One Health concept for various reasons. Firstly, 
AstVs have been identified to be of medical and veterinary importance; secondly, the virus is 
regularly used as indicator of environmental contamination with human and animal waste, and lastly 
the virus has proven zoonotic potential (Meleg et al., 2006).  
A subsection of the current study investigated bats trapped at wastewater treatment works (WWTW) 
in Kwazulu Natal (KZN), to ascertain whether these bats were more likely to be infected with 
HAstVs, due to exposure to heavy metals and other pollutants. Naidoo (2012) reported that bats 
foraging at these specific WWTWs accumulated heavy metals in various soft tissue, which in turn 
reduced their immune system functioning.  
1.12 Rationale to proposed research project 
During the current study we aimed to investigate the diversity, ecology and zoonotic potential of 
AstV strains that occur in SAn bats. Information collected during the current study will also help 
frame the One Health implications of AstVs in SA. The zoonotic potential of bat AstVs is still 
undetermined, however literature indicates that cross-species transmission is possible (Atkins et al., 
2009; Mendenhall et al., 2015; Boujon, 2017; Waruhiu et al., 2017). A study by Xiao et al. (2011) 
revealed that bat AstVs are phylogenetically closely related to some other mamastroviruses (including 
HAstVs VA-1, -2 and -3), suggesting possible transmission to humans and other animals. Studying 
the occurrence, diversity and biology of bat AstVs could provide insight into the origin of viruses that 
are regarded as “human” viruses and could potentially lead to better preventative and / or 
management strategies in future.  
One might argue that more emphasis should be placed on viruses known to pose an immediate threat 
to humans, e.g. rabies and Ebola. However, these are the subject of extensive scientific studies 
already. Therefore, AstVs were chosen for this study for the following reasons: (1) they seem to occur 
commonly in various bat species (Chu et al., 2008; Drexler et al., 2011; Ithete, 2013; Dufkova et al., 
2015; Fischer et al., 2017; Lebarbenchon et al., 2017;); (2) they are RNA viruses like most emerging 
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viruses; (3) very little is known about AstVs in wild animal hosts; and (4) AstVs have been 
understudied in SAn bat species.  
The main focus of the current study was to investigate the diversity and ecology of AstVs in SA bats. 
However, there were subsections to the current project which enabled a more holistic approach to 
AstVs in SA bats, as well as the possible One Health implications of AstVs.  
The subsections of the current study were as follows:  
1) General surveillance of bats for the presence of AstVs. This was achieved through opportunistic 
sampling of bats throughout SA. Phylogenetic data (RdRp gene sequences and ORF2 sequence 
data) were used in phylogenetic reconstructions. Ecological and biological information of 
individual bats recorded during sampling, were statistically analysed to determine factors that 
could influence AstV positivity. 
2) Longitudinal surveillance of a N. capensis bat colony for AstVs and CoVs, via monthly faecal 
collections. This data was used to determine if the colony was co-infected with the virus, as well 
as how the viral loads fluctuated over time. 
3) Surveillance of bats at WWTW for the presence of human AstVs. Samples were collected from 
bats at the WWTW and from pristine sites that were far enough removed from the WWTW to 
allow for comparison. Furthermore, environmental samples, in the form of water samples were 
collected upstream and downstream from the WWTW and were also analysed for the presence of 
human AstVs. 
4) In vitro isolation of bat AstV in different cell lines that will enable indirect determination of 
zoonotic potential. 
The results of the four subsections would then be used to discuss the possible One Health implications 
of AstVs through framing it in the three subsections of the One Health principles; (1) Animal Health, 
general screening of bats for AstVs across SA; (2) Human health, determining zoonotic risk through 
in vitro isolation and via phylogenetic analyses of bat AstV sequences; and (3) Environmental Health, 
through collection and screening of WWTW samples for the presence of AstVs in conjunction with 
screening bats collected at these sites for AstVs to determine the impact of possible exposure to 
human AstVs.  
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1.13 Research Question, Hypothesis, Aims & Objectives 
1.13.1 Research question  
Which environmental and / or host factors drive the diversity and ecology of bat AstVs in selected 
SAn bat species?  
1.13.2 Hypothesis  
Host and environmental factors, such as species identity, age, reproductive state, rainfall and biome 
influence AstV diversity and ecology.  
1.13.3 Aims 
1. Describe the genetic diversity and ecology of AstVs occurring in various bat species across 
Southern Africa. 
2. Determine ecological and demographical factors (e.g. seasonality, age, reproductive state) that 
could influence AstV diversity and ecology in SAn bats. 
3. Determine the phylogenetic relatedness of SAn bat AstVs in relation to other mammalian AstVs. 
4. Describe the results of this study against the background of / in relation to possible One Health 
implications of AstVs. 
1.13.4 Objectives 
1. To use sequencing and phylogenetic techniques to characterize novel bat AstV RdRp strains 
detected during current study.  
2. To use quantitative real-time PCR to detect and monitor AstVs and CoVs in a Neoromicia capensis 
colony in Velddrif, Western Cape, over time.  
3. To analyse biological and ecological data collected on sampled bats to increase understanding of 
which ecological and demographic factors may drive AstV diversity in SAn bats. 
4. To attempt isolation and propagation of one or more bat AstV strains in vitro to determine the 
zoonotic potential of the virus. 
5. To determine whether bat populations near WWTW can become infected with human AstV strains 
by comparing the AstV strains from bats in this study to human AstV strains, as well as virus 
isolation from water samples collected at the WWTW.  
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Chapter 2 Materials & Methods 
2.1 Biosafety considerations 
This study used samples that were collected and stored in RNAlater® (Sigma-Aldrich, St. Louis, 
USA). These samples were handled under biosafety level (BSL) 2 conditions when standard 
molecular biology methods were used. Virus isolation attempts and cell culture techniques were 
performed in a BSL-3 laboratory in the Division of Medical Virology in accordance with various 
safety standard operating procedures as prescribed by the World Health Organization (World Health 
Organization 2004).  
2.2 Ethical considerations  
Samples were collected in collaboration with expert zoologists, Dr. Corrie Schoeman (University of 
KZN), as well as with the help of public collaborators (Quartus Laubscher and Tanja Jane Kerr). All 
fieldwork procedures adhered to established best practices under the guidance of trained zoologists 
with permits obtained from the relevant conservation authorities (Appendix A). The majority of 
samples were collected through non-invasive techniques to minimize disturbance to colonies and 
harm to animals. Tissue specimens were obtained from bats that were euthanized to obtain voucher 
specimens by Dr Richards at the Museum of Natural History. Ethics approval for the usage of the 
samples collected by collaborators was granted by the HREC of Stellenbosch University (SU-
ACUD16-00008). 
2.3 Sample processing  
The samples that were selected for processing (n = 500 faecal samples) during the current study were 
all processed by members of the emerging viruses research group and me. Where possible, our 
research group participated with sample collection with collaborating zoologists (especially in the 
Western Cape and Northern Cape regions). Virus recovery from water samples were also planned 
and executed by me with assistance from Mr Vurayai Ruhanya. In vitro virus isolation and cell culture 
experiments were all conducted by me.  
2.4 Sample availability and collection 
2.4.1 Previously collected samples / Archived samples 
Aliquots from previously collected samples (2011-2014) were stored in -80°C freezers and were 
available for use in this study. The available sample repository consisted of an estimated 590 bat 
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samples and included faecal material (n = 400), oral- (n = 60) and urine- (n = 30) swabs, as well as 
tissue samples (n = 100).  
2.4.2 Sample collection 
Samples were collected by collaborating zoologist, Dr Schoeman, from the University of KZN and 
his research group. Sampling sites were selected based on previous trapping experience of 
collaborating zoologists. Sample collection took place on two levels; colony surveillance and general 
surveillance across SA.  
General surveillance entailed the collection of samples from various bat species through opportunistic 
sampling across Southern Africa, aiding in determining the overall diversity of AstVs in various bat 
species across space and time. Where possible, samples were collected across different geographic 
locations and biomes in an attempt to obtain a diverse sample set. 
Colony surveillance involved a continuous surveillance of known bat colonies. Faecal material was 
collected monthly from a N. capensis colony in the Western Cape Province (Velddrif) with the help 
of public collaborator, Mr Laubscher. Standardized sampling protocols and personal protective 
equipment (PPE), such as gloves and masks, were supplied with clear instructions to the collaborating 
sample collectors. Colony samples were collected for the duration of one calendar year (2015-2016).  
2.4.3 Wastewater treatment works samples 
In an attempt to determine if bats feeding and drinking at WWTW were infected with human AstVs, 
bats were sampled from the selected WWTW; i.e. Verulam Wastewater Works (S29º38.38; 
E31º03.49) which is located on the Mdloti River, and the Umbilo Wastewater Works (S29º50.44; 
E30º53.31) on the Umbilo River (Naidoo et al., 2015). These two WWTWs both receive industrial 
and domestic wastewater. 
Bat trapping at WWTW 
N. nana bats were trapped at WWTW, as well as in pristine downstream localities (3 km away from 
the WWTW). A total of 50 N. nana bats were screened from WWTW and 47 N. nana from pristine 
areas.  
Collection of water samples from WWTW 
Ten litres of water was collected upstream and downstream of each WWTW. More details are given 
in Section 2.15.  
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2.4.4. Bat trapping, data recorded & sample collection  
During active sampling, bats were caught with mist nets and / or harp traps (Francis, 1989; Monadjem 
et al., 2010). Upon capture, bats were retained in a cloth bag until processing by the research team 
commenced. The following data was recorded: (1) morphological data (measurements of forearm, 
tail, tragus, wingspan and mass); (2) population demographic data (sex, age, reproductive state); and 
(3) locality data (GPS coordinates and biome type). Non-invasive sampling techniques were used, 
such as anal and oral swabs and collection of faecal pellets. Where possible, for further confirmation 
of species identity, an echolocation recording was taken (EM3 Wildlife Acoustics, Massachusetts, 
USA). After data collection, bats were released.  
2.4.5 Sample handling and storage 
Faecal samples of individual bats were placed in separate 2 ml cryogenic vials (Corning, New York, 
USA) containing either 1 ml RNAlater® (Sigma-Aldrich, USA) solution or 1 ml viral transport 
medium (VTM), consisting of DMEM (Lonza, Switzerland), Penicillin-Streptomycin (Lonza, 
Switzerland) and 10% foetal bovine serum (FBS) (Biowest, France). Anal and oral swabs were stored 
in 5 ml of VTM consisting of DMEM (Lonza, Switzerland), Penicillin-Streptomycin (Lonza, 
Switzerland) and 10% FBS (Biowest, France).  
2.5 Nucleic acid extraction from faecal material 
Following faecal disruption and homogenization, RNA was manually extracted using the 
NucleoSpin® RNA virus kit (Macherey-Nagel, Germany). The extraction protocol for samples 
collected as part of the colony surveillance required five faecal pellets (Drexler et al., 2011) to be 
homogenized in 1 000 μl of phosphate-buffered saline (PBS) (Gibco®, California, USA) with five 
metal beads. For samples acquired from individual bats, one faecal pellet was homogenized in 600 μl 
of PBS (Gibco®, USA) with five metal beads (Drexler et al., 2011). Faecal pellets were disrupted 
with the Qiagen TissueLyser LT (QIAGEN, Hilden, Germany), followed by centrifugation for 2 
minutes at 11000 x g (5424 Microcentrifuge, Eppendorf, Hamburg, Germany). The supernatant of 
approximately 150 μl was transferred to a 2 ml safe-lock tube (Eppendorf, Hamburg, Germany) and 
600 μl of the provided lysis buffer, RAV1, (RAV1 contains reconstituted carrier RNA) was added 
and vortexed (S0200, Labnet, New Jersey, USA) for 5 -10 seconds. Samples were incubated at 70°C 
for 5 minutes. After the incubation step, 600 μl molecular biology grade ethanol (Sigma-Aldrich, 
USA) was added to the sample and briefly vortexed (S0200, Labnet, USA). The sample was added 
stepwise to the column and centrifuged for 1 minute at 11 000 x g. The flow-through was discarded 
and the column placed back in the collection tube. The column was then washed with 500 μl of the 
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provided buffer, RAW, and centrifuged at 8 000 x g for 1 minute. The flow-through was discarded 
again and the column was placed in a new collection tube. A second wash step was performed by 
adding 600 μl RAV3 to the column and centrifuging it for 1 minute at 8000 x g. The flow-through 
was discarded once again and the column placed in a new collection tube. To ensure that all the 
residual ethanol was removed, the column was centrifuged again for 5 minutes at 11 000 x g. The 
column was then placed in a new 2 ml collection tube. Fifty microliters of nuclease-free water was 
added to the column and incubated at room temperature for 2 minutes and centrifuged for 1 minute 
at 8 000 x g. The eluted RNA was stored at -80°C until reverse transcription could be performed. 
2.6 Reverse transcription  
Extracted RNA was reverse transcribed to complementary DNA (cDNA) using RevertAid Reverse 
Transcriptase (ThermoScientific, USA). The reverse transcription took place in two reactions; the 
components are listed in Tables 2.1. and 2.2., respectively. Once the reagents listed in Table 2.1. were 
pipetted (Eppendorf, Germany) into PCR strip-tubes (Nest Scientific Inc., Wuxi, China), the mixture 
was briefly vortexed and centrifuged. The reaction mixture was incubated (9700 GeneAmp® 
thermocycler, Applied Biosystems, California, USA) at 65°C for 5 minutes and then chilled on ice 
for 1 minute before adding the second reaction’s master mix that consisted mostly of the enzyme 
components of the reaction (Table 2.2.). The combined reaction mixture was then incubated at 25°C 
for 10 minutes and 42°C for 60 minutes. The resulting cDNA was stored at -20°C until PCR screening 
commenced.  
Table 2.1. Reagents for the first reaction of reverse transcription 
Reagents Stock Final Volume 
 Concentration  per run (µl) 
Random hexamer primer (ThermoScientific, USA) 200 ng/µl 400 ng 2 
Diethylpyrocarbonate water (DEPC) (ThermoScientific, USA)   13 
RNA Template - - 10 
 
Table 2.2. Reagents used for the second reaction of reverse transcription  
Reagents Stock Final Volume 
 Concentration Concentration per run (µl) 
5x RT Buffer 5X 1X 4 
dNTP Mix (40mM) 10 mM  2 
RNase inhibitor 2 500 µl 20 U 0.5 




2.7 PCR positive control  
To ensure optimal running of the AstV screening PCR designed by Chu et al. (2008), plasmid positive 
DNA controls were generated to be used as DNA positive controls or in vitro transcribed to RNA. 
The process for creating the AstV positive control is described in short below.  
A 420bp RdRp gene fragment from a Miniopterus natalensis derived sequence was used that was 
obtained from a faecal sample by Ithete (2013). Shortly, the selected fragment was amplified using 
the PCR assay and primers designed by Chu et al. (2008) and purified with the Rapid PCR Enzyme 
Cleanup Set (New England Biolabs, USA) described in Section 2.10. The resulting positive control 
underwent in vitro transcription (Section 2.7.7.). The sensitivity of the PCR assay was then 
established through creating a serial dilution of the quantified positive control RNA (Section 2.7.9.) 
that underwent reverse transcription and amplification with the hemi-nested AstV RdRp PCR (Section 
2.8.1. & 2.8.2.). 
2.7.1 Ligation reaction  
A recombinant plasmid was constructed by covalently connecting the sugar backbone of the vector 
and the RdRp gene by using T4 DNA ligase enzyme (ThermoScientific, USA). The enzyme catalyses 
the formation of covalent phosphodiester linkages which permanently joins the nucleotides together. 
The InsTAclone kit (ThermoScientific, USA) was chosen for a few reasons; 1. It allows for relatively 
easy cloning of Taq-amplified PCR products, 2. It allows cloning of PCR products with TA overhangs 
and 3. Enables blue / white colony screening.  
The reaction was set up as indicated in Table 2.3. The amount of PCR product needed for the ligation 
reaction was calculated according to the manufacturer’s instructions (ThermoScientific, USA) as 
approximately 86 ng.  
Table 2.3. Reagents of the ligation reaction  
Reagents Volume per reaction 
Vector pTZ57R/T (0.17 pol ends) 3 µl 
5X ligation buffer 6 µl 
PCR product made up to 4 μl (~86 ng) 
T4 DNA ligase 1 µl 
Nuclease-free water made up to 29 µl 




The ligation reaction was run on the 9700 GeneAmp® Thermocycler (Applied Biosystems, USA) 
using the following temperature profile and cycling parameters as described in the InsTAclone kit 
user manual: 25°C for 120 minutes, 4 cycles: 4°C for 120 minutes, 1 cycle: 75°C 5 minutes, 4°C hold. 
2.7.2 Transformation  
After the ligation, the plasmid with the insert DNA is introduced through transformation into 
competent bacteria, Escherichia coli strain JM109. This E. coli strain contains a lacZΔM15 deletion 
mutation, while the plasmid vectors contain a short segment of the lacZ gene that codes for β-
galactosidase, an enzyme that metabolizes lactose. The plasmid vectors are manipulated in such a 
way that this α-complementation process serves as an indicator of successful recombination. Plasmid 
vector contains a multiple cloning site within the lacZ sequence, this sequence is altered by restriction 
enzymes to insert the desired gene. The transformation reaction was performed as described below.  
For transformation, agar plates were prepared by dissolving 10 g LB broth (Sigma-Aldrich, USA) 
and 7.5 g agar (Sigma-Aldrich, USA) in 500 ml distilled water. LB agar was autoclaved at 121°C for 
30 minutes at 100 kPA pressure (STA-400/STA-410, St. Francis, Taipei, Taiwan). After the mixture 
had cooled sufficiently, to about 60°C, 250 μl ampicillin, to a final concentration of 50-100 μg/ml 
(Melford Biolaboratories Ltd., Ipswich, UK) was added. Approximately 25 ml of agar was poured 
into sterile plastic Petri dishes (Gibco®, USA) and allowed to set. To allow for blue / white colony 
selection, each agar plate was treated with 16 μl X-gal ready to use solution, to a final concentration 
of 80 μg/ml and 40 μl IPTG, to a final concentration of 20 mM (ThermoScientific, USA) and 
incubated at 37°C for 30 minutes. Single-use tubes of Mix & Go cells (strain: JM109) (Zymo Research 
Corp, California, USA) were thawed on ice and 1-5 μl of ligation reaction was added and mixed 
gently for a few seconds. The cells were then incubated on ice for 2-5 minutes. To reduce overgrowth 
on plates, 25 μl of the transformation reaction was spread per plate. The plates were incubated 
overnight at 37°C. 
2.7.3 Colony picking  
The successful transformation of the vector, containing the foreign DNA, into competent cells will 
lead to the production of dysfunctional β-galactosidase resulting in white colonies. These colonies 
were picked and cultured in LB broth, to allow for production of more of the bacteria with the gene 
of interest. The colony picking process is described in detail in the following section.  
Luria broth (LB) media was prepared by adding 10 g LB broth (Sigma-Aldrich, USA) to 500 ml 
distilled water and mixing with magnetic stirrers, until all the particles were dissolved. To sterilize 
the LB broth, it was autoclaved at 121°C for 30 minutes at 100 kPA pressure (STA-400/STA-410, 
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St. Francis, Taipei, Taiwan). After the broth had cooled sufficiently to about 60°C, 250 μl of 
ampicillin (Melford Biolaboratories Ltd., Ipswich, UK) was added to a final concentration of 50-100 
μg/ml. Added ampicillin served as an inhibitor for other bacteria that might have been present, as the 
bacterial strain used during cloning is ampicillin resistant and its growth should not be affected. Five 
millilitres of LB broth was added to each 14 ml round bottom polypropylene tubes (Falcon™ Corning, 
New York, USA) and a single white colony was picked using a sterile pipette tip and placed in the 
Falcon tube (Corning, USA) containing the broth. The tubes with the picked colonies were incubated 
overnight at 37°C on a shaker at 200-250 rpm. 
2.7.4 Plasmid DNA purification  
Following overnight culture of successfully transformed bacterial cells, the plasmid DNA of interest 
was purified using the GeneJet Plasmid MiniPrep system (ThermoScientific, USA). Falcon® tubes 
(Corning, USA) containing bacterial growth were centrifuged (Eppendorf, Germany) for 2 minutes 
at 12 000 rpm. The supernatant was discarded, and the pellet was resuspended in 250 μl of 
resuspension solution and transferred into a 2 ml microcentrifuge tube. The solution was vortexed 
(S0200, Labnet, USA) until it was homogenous, where after 250 μl of lysis solution was added and 
mixed by inverting the tube 4-6 times, until the solution became viscous and slightly clear. The lysis 
solution was neutralized by adding 350 μl of neutralization solution. The mixture was then 
centrifuged for 5 minutes at 1 200 x g. The supernatant was transferred to the GeneJet spin column, 
and centrifuged (Eppendorf, Germany) for 1 minute at 12000 x g. The flow-through was discarded 
and the column placed back in the collection tube. The column was washed by adding 500 μl of wash 
solution to the column followed by centrifugation (Eppendorf, Germany) for 1 minute at 12 000 x g. 
The flow-through was discarded and the column placed back in the collection tube and the wash step 
was repeated. The column was placed back into the collection tube and centrifuged (Eppendorf, 
Germany) for an additional 1 minute to remove residual ethanol from the column. To elute the 
plasmid DNA, the column was placed in a new 1.5 ml microcentrifuge tube and 50 µl of elution 
buffer was added to the centre of the column and incubated for 2 minutes at room temperature. The 
column was then centrifuged (Eppendorf, Germany) for 2 minutes at 12 000 x g and the resulting 
purified plasmid DNA was stored at -20°C. 
2.7.5 Linearization and in vitro transcription  
Before the plasmid DNA can be transcribed into RNA the plasmid needs to be linearized as the T7 
RNA Polymerase enzyme used during transcription will not dissociate from the plasmid and will 
continue to transcribe around the circular template multiple times. This produces a transcript that is 
much longer that and that contains mostly vector-derived sequences. Linearization downstream from 
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the cloned target insert will produce an RNA transcript, of which the length is defined by the 3’ end 
of the template and the transcription product will only contain a small amount of vector sequence. 
During transcription RNA molecules are synthesized from the DNA sequence by utilizing the T7 
promotor sequence in the bacteriophage. Linearization and in vitro transcription was conducted as 
described in Sections 2.7.6. and Section 2.7.7.  
2.7.6 Linearization  
Linearization was conducted with a restriction enzyme, EcoRI (New England Biolabs, USA), 
according to the manufacturer’s instructions. The reagents for the reaction are listed in the table below 
(Table 2.4.). Once the reaction was set up it was incubated at 37°C for 1 hour followed by heat 
inactivation at 65°C for 20 minutes (9700 GeneAmp® thermocycler, Applied Biosystems, USA). 
 
Table 2.4. Reagents used during the linearization of the plasmid 
Reagents Volume per reaction 
Restriction Enzyme (EcoRI) 1 µl 
DNA 1 µl 
10X NEBuffer 5 μl 
DEPC Water (ThermoScientific, USA) made up to 18 µl 
Total reaction volume 20 µl 
 
 
Purification of linearized product was done to remove excess enzymes as well as to desalt the reaction 
and concentrate DNA. The purification was done with MinElute Reaction Cleanup Kit (QIAGEN, 
Germany) as mentioned in Section 2.11.1. with an amendment, instead of adding 5 volumes of the 
binding buffer to the sample, 300 µl of ERC buffer was added.  
2.7.7 In vitro Transcription 
The purified linearized product was then in vitro transcribed by adding the components in Table 2.5 
together and centrifuged (Eppendorf, Germany) before incubation at 37°C for 2 hours. 
Following in vitro transcription residual DNA template was removed through DNAse treatment. For 
each 1 µg of in vitro transcribed DNA 2 U of DNAse I (Thermo Fisher Scientific) was added and the 




Table 2.5. The components of the in vitro transcription reaction  
Reagents Volume per reaction 
5X TranscriptAid reaction buffer 4 µl 
ATP/CTP/GTP/UTP mix 8 µl 
Template DNA 1 μ1 
TranscriptAid enzyme mix 2 µl 
DEPC Water (ThermoScientific, USA) made up to 20 µl 
Total reaction volume 20 µl 
 
 
2.7.8 RNA purification  
Inactivation of the DNAse I reaction was achieved through RNA purification with the Purelink® RNA 
Mini Kit (Thermo Fisher Scientific, USA). One volume of lysis buffer was added to one volume of 
sample and mixed by vortexing. The mixture of sample and lysis buffer was added to the spin column 
and centrifuged for 15 seconds at 12 000 x g. The flow-through was discarded and two wash steps 
were performed with 500 µl wash buffer followed by centrifugation at 12 000 x g for 1 minute. The 
column was then transferred to an elution tube and 35 µl of RNAse free water was added to the centre 
of the column. The column containing RNAse free water was incubated at room temperature for 2 
minutes, whereafter it was centrifuged for 2 minutes at 12 000 x g to elute the RNA from the column.  
2.7.9 Quantification of RNA copies  
To determine the limit of detection of the screening PCR it was necessary to determine the copy 
number of the positive control. RNA concentration was determined with the Qubit® 3.0 fluorometer 
(ThermoScientific, USA). The protocol followed is described below. For each standard and sample, 
250 μl of Qubit® working solution was prepared by diluting the Qubit® RNA Reagent (1:200) in 
Qubit® RNA Buffer. Samples and controls for quantification were prepared according to Table 2.6. 
The components were added to 0.5 ml Qubit® assay tubes (ThermoScientific, USA), vortexed (S0200, 
Labnet, USA) for 2-3 seconds and incubated at room temperature for 2 minutes. The Qubit® was 
calibrated with the standards, followed by readings of the samples by following the prompts on the 
Qubit® 3.0 fluorometer (ThermoScientific, USA). The readings (ng/µl) were converted to copy 
number by using online tools (http://cels.uri.edu/gsc/cndna.html). To determine the limit of detection 
of the screening PCR, serial dilutions were made from the starting concentration of 1012 to 10 per μl. 
However, single use aliquots of concentration of 104 of the positive control were frozen and used as 




Table 2.6. Reagents used for RNA quantification in plasmid positive control 
Reagent Volumes for Standards Volumes for Samples 
Working Solution 190 μl 180-199 μl 
Standard 10 μl - 
Sample - 1-20 μl 
Total volume 200 μl 200 μl 
 
 
2.8 Astrovirus PCR assays  
2.8.1 General screening PCR for the detection of astroviruses 
The hemi-nested AstV screening PCR developed by Chu et al. (2008) amplifies the RdRp gene (422 
bp) of bat AstVs but also a host of other mammalian AstVs (Fischer et al., 2017). The hemi-nested 
PCR was successfully used by Ithete (2013) to detect AstV in SAn bats and as such this protocol was 
also used during the current study. The screening PCR consists out of a pre-nested amplification and 
nested amplification, as detailed below.  
2.8.2 PCR assay for amplification of the capsid protein gene (ORF2) 
AstV species classification and identification is based on the capsid protein gene (ORF2), which is 
important for virus phylogenetics and classification. The ORF2 region is notoriously difficult to 
amplify for bat AstVs, as such only a small number of these sequences are available on Genbank® 
(https://www.ncbi.nlm.nih.gov/nuccore/?term=bat+astrovirus+capsid+protein+gene, visited 10 
September 2018) (Fischer et al., 2017). The amplification of this region is either a hit or miss (personal 
communication Dr Freiden, St Jude Children’s Hospital, Memphis USA). Based on some partial 
ORF2 bat AstV sequences on Genbank®, it was suggested to use the primer set developed by Atkins 
et al., (2009). AstV samples that were identified as positive by hemi-nested AstV PCR (Chu et al., 
2008) and sequencing, were subjected to a second PCR reaction with primers targeting the capsid 
protein of the virus (Atkins et al., 2009) (Table 2.7.). The PCR assay also entails a pre-nested and 




Table 2.7. Summary table of the primer sets used with different PCR assays during in the amplification of 
two regions of the AstV genome. 
Screening assay & region of amplification Oligo Name 5’→3’ Oligo Sequences 
Pre-nested amplification of RdRp gene Pan-Astro_F1 GAR TTY GAT TGG RCK CGK TAY GA 
(Chu et al., 2008) Pan -Astro_F2 GAR TTY GAT TGG RCK AGG TAY GA 
 Pan-Astro_R GGY TTK ACC CAC ATN CCR AA 
Nested amplification of the RdRp gene Pan-Astro_HNF1 CGK TAY GAT GGK ACK ATH CC 
(Chu et al., 2008) Pan-Astro_HNF2 AGG TAY GAT GGK ACK ATH CC 
 Pan-Astro_R GGY TTK ACC CAC ATN CCR AA 
Pre-nested amplification of ORF2 gene Astr_4811F TTTGGNATGTGGGTNAARCC 
(Atkins et al., 2009) Astr_5819R TCATTNGTGTYNGTNANCCACCA 
Nested amplification of ORF2 gene Astr_5159F GGAGGGGMGGACCAAAG 
(Atkins et al., 2009) Astr_5819R TCATTNGTGTYNGTNANCCACCA 
 
 
2.8.3 Pre-nested amplification of the RdRp gene  
The pre-nested reaction was set up following the protocol by Chu et al. (2008), with TrueStart Hot 
Start Taq DNA polymerase (ThermoScientific, USA). The reagents and volumes used are listed in 
Table 2.8. After the reagents were added to a 2 ml microcentrifuge tube (Nest Scientific Inc., China), 
the mastermix was vortexed (S0200, Labnet, USA) and centrifuged briefly. A volume of 23 µl of 
mastermix was pipetted (Eppendorf, Germany) into PCR strip-tubes (Nest Scientific Inc., China) 
followed by 2 µL of cDNA template. The strip-tubes containing the reaction mixture and cDNA 
template was briefly vortexed (S0200, Labnet, USA) and centrifuged (Eppendorf, Germany). The 
reaction was run on the 9700 GeneAmp® thermocycler (Applied Biosystems, USA) using the 
following temperature profile: 95°C for 2 minutes, 40 cycles: 95°C for 30 seconds, 55°C for 30 
seconds, 68°C for 30 seconds and a final extension at 72°C for 5 minutes. 
Table 2.8. Reagents used for the pre-nested amplification reaction of the RdRp gene 
Reagents Stock Final Volume 
 Concentration Concentration per run (µl) 
Nuclease-free water   10.87 
TrueStart Buffer 10X 1X 2.5 
MgCl2 25 mM 1.5 mM 1.5 
dNTP Mix 10 mM 200 µM 0.5 
Pan-Astro_F1 10 µM 1 µM 2.5 
Pan-Astro_F2 10 µM 1 µM 2.5 
Pan-Astro_R 10 µM 1 µM 2.5 
TrueStart Taq 5 U/µl 0.625 U 0.125 
cDNA template - - 2 
Total reaction volume    25µl 
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2.8.4 Hemi-nested amplification of the RdRp gene  
The nested reaction was set up on ice following the protocol of Chu et al. (2008) with TrueStart Hot 
Start Taq DNA polymerase (ThermoScientific, USA). The reagents and volumes used are listed in 
Table 2.9. After the reagents were added to a 2 ml microcentrifuge tube (Nest Scientific Inc., China) 
the mastermix was vortexed (S0200, Labnet, USA) and centrifuged (Eppendorf, Germany) briefly. 
Each reaction consisted out of 48 µl of mastermix and 2 µL of pre-nested PCR product. The reaction 
was run on the 9700 GeneAmp® thermocycler (Applied Biosystems, USA) using the following 
temperature profile: 95°C for 2 minutes, 30 cycles: 95°C for 30 seconds, 55°C for 30 seconds, 72°C 
for 30 seconds and a final extension at 72°C for 5 minutes. 
Table 2.9. Reagents used for the nested amplification reaction of the RdRp gene 
Reagents Stock Final Volume 
 Concentration Concentration per run (µl) 
TrueStart Buffer 10X 1X 5 
MgCl2 25 mM 1.5 mM 3 
dNTP Mix 10 mM 200 µM 1 
Primer (Pan-Astro_HNF1) 10 µM 1 µM 5 
Primer (Pan-Astro_HNF2) 10 µM 1 µM 5 
Primer (Pan-Astro_R) 10 µM 1 µM 5 
TrueStart Taq 5 U/µl 1.25 U 0.25 
Nuclease-free water - - 23.75 
Pre-nested product - - 2 
Total reaction volume    50µl 
 
2.9 Amplification of AstV capsid protein gene (ORF2) fragment  
2.9.1 Pre-nested amplification of the ORF2 gene fragment 
The pre-nested reaction was set up on ice following the protocol of Atkins et al. (2009), using 
SuperScript™ III One-Step RT-PCR System with Platinum™ Taq DNA Polymerase 
(ThermoScientific, USA). The reagents and volumes used are listed in Table 2.10. After the reagents 
were added to a 2 ml microcentrifuge tube (Nest Scientific Inc., China), the mastermix was vortexed 
(S0200, Labnet, USA) and centrifuged briefly. A volume of 23 µl of mastermix was pipetted 
(Eppendorf, Germany) into PCR strip tubes (Nest Scientific Inc., China) and 2 µl of cDNA template 
was added. The strip-tube containing the reaction mixture and cDNA template was vortexed (S0200, 
Labnet, USA) and centrifuged (Eppendorf, Germany) briefly. The reaction was run on the 9700 
GeneAmp® thermocycler (Applied Biosystems, USA) using the following temperature profile and 
cycling parameters: 55°C for 30 minutes, 94°C for 2 minutes, 40 cycles: 94°C for 15 seconds, 55°C 
for 30 seconds, 68°C for 2minutes and a final extension at 68°C for 5 minutes.  
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Table 2.10. List of reagents used for the pre-nested amplification of the ORF2 gene  
Reagents Stock Final Volume 
 Concentration Concentration per run (µl) 
2x Reaction Mix - - 12.5 
Primer (Astr_5159F) 10 µM 1 µM 0.5 
Primer (Astr_5819R) 10 µM 1 µM 0.5 
SuperScript III RT/Platinum taq mix - - 1 
Nuclease-free water - - 5.5 
RNA template - - 5 
Total reaction volume    25µl 
 
 
2.9.2 Nested amplification of the ORF2 gene fragment  
The nested reaction was set following the protocol by Atkins et al. (2009), using SuperScript™ III 
One-Step RT-PCR System with Platinum™ Taq DNA Polymerase (ThermoScientific, USA). The 
reagents and volumes used are listed in Table 2.11. After the reagents were added to a 2 ml 
microcentrifuge tube (Nest Scientific Inc., China), the mastermix was vortexed (S0200, Labnet, USA) 
and centrifuged briefly. A volume of 20 µl of mastermix was pipetted (Eppendorf, Germany) into 
PCR strip tubes (Nest Scientific Inc., China) and 5 µl of pre-nested product was added. The strip-tube 
containing the reaction mixture and pre-nested product was vortexed (S0200, Labnet, USA) and 
centrifuged (Eppendorf, Germany) briefly. The reaction was run on the 9700 GeneAmp® 
thermocycler (Applied Biosystems, USA) using the following temperature profile and cycling 
parameters: 55°C for 30 minutes, 94°C for 2 minutes, 40 cycles: 94°C for 15 seconds, 55°C for 30 
seconds, 68°C for 2 minutes and final extension at 68°C for 5 minutes. 
Table 2.11. List of reagents used for the nested amplification of the ORF2 gene. 
Reagents Stock Final Volume 
 Concentration Concentration per run (µl) 
2x Reaction Mix - - 12.5 
Primer (Astr_4811F) 10 µM 1 µM 0.5 
Primer (Astr_5819R) 10 µM 1 µM 0.5 
SuperScript III RT/Platinum taq mix - - 1 
Nuclease-free water - - 5.5 
Pre-nested product - - 5 





2.10 Host species identification by cytochrome b gene amplification  
Bat species identification based on morphological features and echolocation can be complicated and 
unreliable, due to the existence of subspecies or cryptic species (Bradley and Baker, 2001; Bastos et 
al., 2011), thus species identity was confirmed using primers that target the cytochrome b gene of the 
host organism (Table 2.12.). The protocol by Bastos et al. (2011) was used with modifications to the 
cycling parameters.  
Table 2.12. Primer sets used in the amplification of the cytochrome b gene to determine host species identity 
(Bastos et al., 2011) 
Oligo Name 5’→3’ Oligo Sequences 
L14724 TGA YAT GAA AAA YCA TCG TTG 
H15915R CAT TTC AGG TTT ACA AGA C 
 
 
The reaction consisted out of the reagents listed in Table 2.13. A volume of 25 µl of mastermix was 
added to PCR strip tubes (Nest Scientific Inc., China), followed by 5 µl of DNA template. The mixture 
was vortexed (Labnet, USA) briefly and centrifuged (Eppendorf, Germany).  
The reaction was run on the 9700 GeneAmp® thermocycler (Applied Biosystems, USA) using the 
following cycling parameters: 95°C for 2 minutes, 2 cycles: 95°C for 12 seconds, 52°C for 30 seconds 
and 70°C for 60 seconds, followed by 3 cycles with a lower annealing temperature at 50°C and 45 
cycles with the annealing step at 48°C and final extension at 72°C for 5 minutes. 
Table 2.13. Reagents used for the amplification of the cytochrome b gene  
Reagents Stock Final Volume 
 Concentration Concentration per run (µl) 
10x PCR buffer 10X 1X 3.0 
Primer (L14724) 10 µM 0.4 µM 1.2 
Primer (H15915R) 10 µM 0.4 µM 1.2 
MgCl2 50 mM 1.5 mM 0.9 
dNTP Mix 10 mM 0.2 mM 0.6 
Platinum Taq - - 1.2 
Nuclease-free water - - 17.9 
cDNA template - - 5 





2.11 Visualization of PCR products 
PCR products were visualized using gel electrophoresis. The DNA electrophoresis workflow that was 
followed is described below (Brody & Kern, 2004).  
Sodium borate (SB) buffer was used during agarose gel electrophoresis, as it has a lower conductivity, 
runs at higher speeds and produces brighter bands compared to TBE and TAE buffers (Brody & Kern, 
2004). A stock solution of 20X SB buffer was prepared by adding 45 g Boric acid and 8 g NaOH to 
1 litre of distilled MilliQ water and mixing with magnetic stirrers. The stock solution was then diluted 
with distilled MilliQ water to produce 1X SB buffer solution that was used during gel electrophoresis.  
PCR products were visualised on a 2% agarose gel for fragments up to 1kb, and 1% agarose gel for 
larger fragments. The gel was prepared by mixing 2 g of Lonza® LE agarose (Lonza BioWhittaker, 
Verviers, Belgium) with 1X SB buffer to make a 100 ml mixture. The mixture was heated in a 
microwave for 3 minutes or until no undissolved particles were visible. The mixture was allowed to 
cool while stirring. Once cooled sufficiently 5 µl of Pronasafe gel dye (Laboratorios CONDA, 
Madrid, Spain) was added to the gel mixture. The gel mixture was poured into an electrophoresis tray 
and a gel comb, of approximately 1mm was placed in the tray. The gel was left to set for 30 minutes 
at room temperature. The comb was removed, and the gel was covered with 1X SB buffer.  
Five microliters of PCR product was mixed with 1 µl of 6X orange loading dye (ThermoScientific, 
USA) and loaded into the wells. Once the samples were loaded into the wells, a Generuler® 100 bp 
or 1 kb ladder (ThermoScientific, USA) was loaded to the gel as a reference sizing marker. The 
electrophoresis tray was connected to a power pack and run at 90 volts for 40 minutes. 
Following DNA electrophoresis, the PCR products were visualised using the UVItec gel 
documentation system, chemiluminescence and fluorescence system (UVItec Alliance, Cambridge, 
UK), using the transilluminator at 254 nm. Images were captured and enhanced using UVIband 
(UVItec Alliance, Cambridge, UK) software. The expected fragment size for the RdRp gene was 422 
bp, and the capsid protein gene fragment was 800 bp. Images were saved electronically and printed.  
2.12 PCR product purification 
Two PCR purification kits were used during the study. The Rapid PCR Enzyme Cleanup Set (New 
England Biolabs, USA) was used to purify small volumes of PCR product, and the MinElute® PCR 
purification kit (QIAGEN, Germany) was used when larger volumes of PCR product were purified.  
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2.12.1 Rapid PCR Cleanup Enzyme Set  
Positive PCR products were purified using the Rapid PCR Cleanup Enzyme Set (New England 
Biolabs, USA). To each 5 µl of PCR product, 1 µl of each enzyme, Exonuclease I and rSAP were 
added and briefly mixed by pipetting up and down. The reaction was run on the 9700 GeneAmp® 
thermocycler (Applied Biosystems, California, USA) using the following temperature profile and 
cycling parameters (per manufacturer’s instructions): incubation at 37°C for 5 minutes and heat 
inactivation at 80°C for 10 minutes. The purified PCR product was stored at -20°C until sequencing 
was performed.  
2.12.3 MinElute® PCR purification kit  
PB buffer (100 µl) was added to 20 µl of PCR product and vortexed (S0200, Labnet, USA) briefly. 
The MinElute® column was placed in a 2 ml collection tube and the sample was added to the column 
and centrifuged (Eppendorf, Germany) for 1 minute at 17 900 x g. The flow-through was discarded 
and the column placed back into the collection tube. The column was washed by adding 750 µl of the 
provided PE buffer, containing ethanol, to the MinElute® column and then centrifuged (Eppendorf, 
Germany) for 1 minute at 17 900 x g. The flow-through was discarded and the column placed back 
into the collection tube. The column was centrifuged (Eppendorf, Germany) for an additional 1 
minute at maximum speed to remove residual ethanol. The column was placed into a new 1.5 ml 
collection tube and 10 µl EB buffer was added to the centre of the membrane. The column was 
incubated for 1 minute at room temperature and centrifuged (Eppendorf, Germany) for 1 minute at 
17 900 x g. The purified DNA was stored at -20°C until sequencing commenced.  
2.13 Sequencing PCR  
Sanger sequencing was performed using the Big-dye terminator cycle sequencing kit v3.1 (Applied 
Biosystems, California, USA). A mastermix was prepared for each primer used for the specific region 
of interest being sequenced. According to the manufacturer’s instructions 2 µl of purified PCR 
product (15-25 ng) was added to a reaction mix containing the reagents mentioned in Table 2.14. The 
reaction was set up as follows on the PE GeneAmp® 9700 thermal cycler or the Veriti® (Applied 
Biosystems, USA) using the manufacturer’s protocol: 95°C for 1 minute, 30 cycles at 95°C for 10 




Table 2.14. Reagents used for the sequencing PCR setup  
Reagents Stock Final Volume 
 Concentration Concentration per run (µl) 
BigDye™ Terminator 3.1 Ready Reaction Mix - - 4 
Primer 2.5 µM 2.5 pmol 1 
Nuclease-free water - - up to 10 
PCR product - - 2 
Total reaction volume    10µl 
 
 
2.13.1 Sequencing clean-up  
Following the sequencing PCR, the PCR product was purified using the Big-dye X-terminator kit 
(Applied Biosystems, California, USA). To each sequencing reaction a mixture of 10 µl Big-dye X-
terminator and 45 µl SAM solution was added. The reactions were then placed on a shaker at 1800 
rpm for 30 minutes. After incubation, the reactions were centrifuged (Rotanta 460R Hettich 
centrifuge, Massachusetts, USA) at 2 000 × g for 5 minutes and the sequences were read on the 3130xl 
genetic analyser (Applied Biosystems, USA) using the standard protocol. The ORF2 fragments were 
sent to the Stellenbosch University’s Central Analytical Facility for sequencing.  
2.14 Sequence and phylogenetic analyses 
2.14.1 RdRp phylogenetic analyses 
The fragment used in the analyses is relatively small (420 bp), however due to the diversity of AstVs 
amongst bats, this conserved region of the AstV genome is readily used in the literature when 
performing phylogenetic analyses for bat AstVs (Fischer et al., 2016; Fischer et al., 2017; 
Lebarbenchon et al., 2017). As the sequences obtained during Ithete (2013) study were only used in 
a neighbour-joining phylogenetic reconstruction, they will also form part of the subsequent 
phylogenetic analyses and inferences. Sequences obtained by Ithete (2013) are denoted with NI at the 
end of the sequence label.  
2.14.2 ORF2 phylogenetic analyses 
The capsid protein gene is a highly diverse gene in the AstV genome, and notoriously difficult to 
obtain. During the study numerous attempts were made to amplify the capsid protein gene (ORF2). 
Twenty-five samples of which the RdRp gene of the virus was successfully sequenced, were used to 
try and amplify the ORF2 gene, however it was only successful for one sample. The ORF2 region 
highly diverse and difficult to amplify, as such not many bat ORF2 sequences are available on 
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GenBank (Fischer et al., 2017). One capsid protein gene (ORF2) sequence obtained from a M. 
natalensis bat was used for the phylogenetic analysis. The size of the fragment obtained by PCR was 
800 bp long. The ORF2 gene fragment obtained was compared to all the available ORF2 sequences 
on GenBank. Sequences with a similarity score greater than 50%, query coverage of 50% and above 
and an e-score value close to 0 were selected for the analyses.  
2.14.3 Phylogenetic reconstruction process that was followed 
Sequence data files were uploaded to Geneious R10 (Biomatters Inc., New Zealand) and analysed. 
Primers were trimmed and De Novo assembly function was used to create contigs for each sample, 
where possible. To determine whether the obtained sequences were bat AstVs, the National Centre 
for Biotechnology Information’s (NCBI) online Basic Local Alignment Sequence Tool (BLAST) was 
used. The related sequences were downloaded from GenBank®, which is the National Institute of 
Health’s genetic sequence database of all publicly available DNA sequences. It forms part of the 
International Nucleotide Sequence Database Collaboration, which comprises the DNA DataBank of 
Japan, the European Nucleotide Archive and GenBank®. A list of the sequences downloaded from 
GenBank® is included in Appendix B. 
Sequences were imported and edited in Geneious R10 (Biomatters Inc., New Zealand) and aligned 
using MAFFT online alignment tool. In MEGA7 (Pennsylvania State University, USA) neighbour 
joining (NJ) trees were created using the percentage distance model. Using the percentage distance 
model enables inferences about the phylogenetic relationship of the sequences to be made. To validate 
the accuracy of the consensus tree that was produced, 1 000 bootstrap replicates were performed.  
To determine the best model to use for phylogenetic inferences based on maximum likelihood, 
sequence alignments were run through JModelTest v2.1.4 (Darriba et al., 2012). Based on the results 
obtained by the program, the best model was selected, and sequence data was used in maximum-
likelihood analyses in PhyML v3.1 (Guindon et al., 2010). Tree editing was done in FigTree v1.4.3 
(Rambaut, University of Edinburgh, UK).  
To determine the nucleotide similarities in the sequences pairwise distance matrixes were generated 
in MEGA7 (Pennsylvania State University, USA) using p-distance model with 1 000 iterations.  
2.15 Quantitative Real-time PCR for monitoring of AstVs and CoVs in a N. capensis colony 
A bat colony in Velddrif in the Western Cape was monitored over time for the presence of AstVs and 
CoVs using two qPCR assays. These two viruses have been regularly found to co-infect bat species 
(Drexler et al., 2011; Kemenesi et al., 2014). Real-time assays were utilized to determine whether the 
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bat colony was co-infected with these two viruses, as well as how the relative viral loads fluctuated 
over time. qPCR assays are highly sensitive and more specific than conventional screening PCRs, 
especially when assays are probe-based. Conventional PCR does not allow for relative viral load 
quantification, which is needed to determine if there were fluctuations of the viruses over time, hence 
the use of qPCR assays (Arya et al., 2005). Realtime assays do however have some drawbacks, the 
region that they amplify is too small to utilize for phylogenetics.  
The AstV real-time assay designed was also assessed to determine how it compared in terms of limit 
of detection and percentage positive sample detection, in comparison with the conventional AstV 
screening PCR designed by Chu et al. (2008). 
2.15.1 Design of AstV qPCR probe and primers  
To develop primers and probes for the real-time PCR assay, RdRp sequences obtained during the study 
were aligned in Geneious R10 (Biomatters Inc., New Zealand) and primers were designed to target a 
fragment approximately 180 bp (Table 2.15.). For real-time PCR, it is important that the amplicon be as 
small as possible, as smaller amplicons amplify more efficiently and are more resistant to reaction 
conditions. For this real-time PCR assay, a FAM (6-carboxyfluorescein) reporter dye was attached at 
the 5’ end and a black hole quencher dye at the 3’ end of the probe. The following was also considered 
during primer design; the Tm of the primers should not differ more than 2°C, the GC content of the 
primers should range between 20-80% and the optimal length for single stranded primers should be 
between 15 and 20 bp (Arya et al., 2005).  
 
Table 2.15. Astrovirus real-time PCR primers and probe set designed to target a 180 bp of the RdRp gene  
Oligo Name 5’→3’ Oligo Sequences 
331_R (Primer) AGG YCA TGA TYA CAC TCT GT 
131_F (Primer) ACA GGA GAG GTT ACC GTA CA 
272 (Probe) FAM -CGT GAW TGG ZGG AAG TGT GA/3IABkFQ 
 
 
2.15.2 Betacoronavirus primers and probe  
Primers and probe for the real-time PCR assay for beta-CoVs were designed by Dr Ndapewa Ithete and 
Dr Nadine Cronje of our research group (Table 2.16.). The primer and probe set targets a 200 bp 
fragment of the RdRp gene.  
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Table 2.16. Real-time PCR primer and probe set designed to target a 200 bp fragment of the RdRp gene of 
βCoV  
Oligo Name 5’→3’ Oligo Sequences 
2c_RdRp_qPCR_F (Primer) GTG YGC TCA AGT GYT WAG TGA RTA TGT 
2c_RdRp_qPCR_R (Primer) CCA TTA GCR CYC ATA AGT GCA CTA ACA 
2c_RdRp_qPCR_P (Probe) FAM-GCW TAY GCC/ZEN/ AAT AGT GTY TTT AAC AT/3IABkFQ 
 
 
2.15.3 Astrovirus and Coronavirus RNA quantification standards 
The AstV standard used was created by myself and the CoV standard was created and supplied by Dr 
Nadine Cronje of our research group. In short, the CoV standard was created from a 900 bp fragment of 
the RdRp gene of a MERS-related beta-CoV detected in a N. capensis bat (Cronje, 2017). The AstV 
standard was generated by cloning the amplified region (3’ end of the genome) and in vitro transcribing 
the plasmid (as described in Section 2.7.6.). Quantification of RNA was performed as mentioned in 
Section 2.7.6. The viral copies per μl was 3.4 x 109 for AstV and 1.9 x 109 for CoV. Single-use aliquots 
were stored at -80°C and diluted before use. Ten-fold serial dilutions (104, 103, 102 and 101) were made 
and used as standards for each real-time reaction.  
2.15.4 Sample preparation for qPCR  
RNA was re-extracted from faecal material as previously described in Section 2.4.1. Single-use aliquots 
were prepared of each sample and stored at -80°C. Each sample was analysed in duplicate to eliminate 
technical variability.  
2.15.5 Quality of mRNA  
To determine the mRNA quality, spectrophotometer measurements are not sufficient for the following 
various reasons: (1) the measurements give no indication of degradation, it only supplies information 
about RNA; and (2) most samples contain rRNA and not only mRNA, which is targeted by the qPCR 
reaction. The spectrophotometer gives a reading of all the RNA (rRNA and mRNA), without being able 
to distinguish between the two (Eissa et al., 2016). To determine the mRNA integrity of the samples, 
the Tata Box binding protein housekeeping gene assay was used (Biesold et al., 2011). The reaction was 
set up with the primer and probe set mentioned in Table 2.17 and reagents mentioned in Table 2.18. 
Since the RNA was extracted from faecal material no normalization using Ct values of the housekeeping 
gene could be done as the number of cells shed by bats in their faecal material cannot be standardised. 
The number of faecal pellets used in the extraction was five pellets.  
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Table 2.17. Primers and probe of the Tata Box binding gene qPCR assay (Biesold et al., 2011) 
Oligo Name 5’→3’ Oligo Sequences 
bTBP_Fwd (Primer) TTGCTGCTGTGATCATGAGAATT 
bTBP_Rev (Primer) 6-FAM-CCCGGACCACGGCCCTGA-TAMRA 
bTBP_Pr (Probe) ACACCATCTTCCCAGAACTGAAG 
 
 
2.15.6 Real-time RT-PCR reaction 
The 20 μl SensiFAST™ Probe No-ROX One-Step kit (Bioline, London, United Kingdom) reaction was 
set up (on ice) as indicated in Table 2.18. The master mix and sample RNA was added to a Bio-Rad 
Hard-Shell® 96 well plate (Bio-Rad, California, USA). The plate was sealed with optically clear heat 
seal (Bio-Rad, USA) using the PX1 PCR plate sealer (Bio-Rad, USA) and covered with tinfoil, due to 
the light sensitivity of the probe. The plate was centrifuged (MPS 1000 mini plate spinner, Labnet, USA) 
for 2 minutes at 1 200 rpm to ensure mixing of RNA and master mix and to eliminate air bubbles. 
Following the Bio-Rad CFX program manager prompts, the plate setup was entered, and the cycling 
parameters were selected. The different cycling parameters of each qPCR assay is given below in 
Sections 2.14.8-2.14.10. 
 
Table 2.18. Reagents used for the qPCR reactions  
Reagents Stock Final Volume 
 Concentration Concentration per run (µl) 
2x SensiFAST™ No-ROX One-Step Mix - 1X 10 
Forward primer 10 µM 400 nM 0.8 
Reverse primer 10 µM 400 nM 0.8 
Reverse transcriptase - - 0.2 
RiboSafe RNAse Inhibitor - - 0.4 
EEPC-treated water (TermoScientific, USA) - - 3.6 
RNA template - - 4 
Total reaction volume    20µl 
 
 
2.15.7 Cycling parameters of the AstV qPCR 
The cycling parameters were as follows; 45°C for 20 minutes, 95°C 2 minutes, 45 cycles: 95°C for 5 
seconds, 51.9°C for 20 seconds. Due to a probe being used, no melting curve analyses was conducted.  
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2.15.8 Cycling parameters of the CoV qPCR assay  
The cycling parameters were as follows; 45°C for 20 minutes, 95°C 2 minutes, 40 cycles: 95°C for 5 
seconds, 60°C for 20 seconds.  
2.15.9 Cycling parameters of the housekeeping gene assay  
The cycling parameters were as follows; 95°C for 30 seconds, 45 cycles: 95°C for 5 seconds, 58°C for 
30 seconds.  
2.15.10 Comparing qPCR and conventional AstV screening PCR detection results 
To compare the sensitivity and detection for each of the screening methods used during this study, 
150 samples were randomly selected to be screened using the AstV qPCR screening assay. The 
percentage difference in detection was calculated between the assays.  
2.16 WWTW water sample collection and analyses 
To determine how potential exposure to HAstVs through ingestion of water from wastewater works 
affects bat AstV diversity, water samples were collected from these WWTW and analysed for the 
presence of AstVs. As viruses are highly diluted in water bodies, the viruses needed to be concentrated 
by using glass wool and polyethylene glycol (PEG). 
2.16.1 Water sample collection and preparation  
Water samples were collected upstream and downstream from each WWTW (Umbilo (S29º50.44; 
E30º53.31) and Verulem (S30º04.29; E30º51.26)). Ten litres of water was collected upstream and 
downstream from each site. Samples were kept at 4°C and shipped overnight from the University of 
KZN to the Division of Medical Virology, Faculty of Medicine and Health Sciences, Stellenbosch 
University.  
2.16.2 Viral adsorption-elution (VIRADEL) using glass wool 
To concentrate viruses from large volumes of water samples, a widely used method of glass wool 
filtration was employed. Custom filter casings needed to be built to allow for work with the glass 
wool. The filter casings were constructed out of irrigation piping with a length of 20 cm and internal 
diameter of 30 mm. Each column was packed with 15 g of Sodocalcic glass wool (Merck, Darmstadt, 
Germany). To positively charge glass wool to allow for adsorption of virus particles, the glass wool 
was chemically pre-treated by soaking it in sterile distilled water, and then consecutively treating it 
with 40 ml 1M HCl (Merck, Germany), 100 ml sterile distilled water, and 40 ml 1M NaOH (Merck, 
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Germany). The pH of the charged glass wool was adjusted to 7 using distilled water (Venter, 2004; 
Vivier et al., 2004).  
2.16.3 Seeding experiment to validate filtration method  
To validate the glass wool filtration method, 1 litre of sterile reverse osmosis water was spiked with 
0.5 ml of Coxsackie virus B6 (CV-B6 TCID50 1.5 x 107 /ml), provided by National Health Laboratory 
Service (NHLS) Tygerberg Medical Virology laboratory. A qPCR was performed on the samples by 
the NHLS and the sample tested positive for the virus (estimated copy number 1.48 x 102). 
2.16.4 Filtration of water samples  
No pre-treatment of water samples was necessary due to the use of positively charged glass wool 
filters. Water samples were filtered through the glass wool columns with the use of a vacuum pump 
(2522 WOB-L Welch®, Welch-Ilmvac, Illinois, USA) and vacuum trap, constructed out of a five litre 
Erlenmeyer flasks and rubber stoppers with serological pipettes. 
2.16.5 Elution  
Sterile glycine-beef-extract buffer pH 9.5 (GBEB: 3.754 g/l glycine (Merck, Germany); 5 g/l beef 
extract powder (Merck, Germany)) was used to elute viruses that bound to the glass wool column. 
The elution buffer (GBEB) was left in contact with the glass wool for 15 minutes before being passed 
through the filter under vacuum. The pH of the eluate was adjusted to 7.0 with 1 M HCl (Merck, 
Germany). The flow-through was collected and used for secondary precipitation using PEG (Abcam, 
Cambridge, USA) (Vivier et al., 2004, Venter, 2004). 
2.16.6 Secondary virus precipitation  
A secondary virus precipitation method is routinely employed in conjunction with glass wool filtration. 
Precipitating the virus after filtration contributes to the successful detection of the virus in downstream 
analyses. Various viruses have been successfully precipitated using PEG 8000 as precipitation agent 
(Lewis and Metcalf, 1998; Vilaginès et al., 1997; Mattison and Bidawid, 2009). For each 10 ml of water 
sample, 2.5 ml of PEG (Abcam, USA) solution was added and vigorously vortexed and incubated at 
4°C overnight on a shaker. Samples were centrifuged (Eppendorf, Germany) at 3 200 x g for 30 minutes. 
The supernatant was removed, and the white pellet was resuspended with 100 μl of virus resuspension 
solution (Abcam, USA). Samples were stored at -80°C until RNA extraction could be performed. 
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2.16.7 RNA extraction, cDNA generation and Screening by PCR 
Following the precipitation of virus using PEG, viral RNA was extracted using the same protocol as 
mentioned in Section 2.4.1. using the NucleoSpin® RNA virus kit (Macherey-Nagel, Germany). cDNA 
was made using the protocol described in Section 2.5 using RevertAid reverse transcriptase 
(ThermoScientific, USA). The AstV screening PCR described in Section 2.6. was used to screen for all 
known mammalian AstVs in the water samples. Extracted RNA was screened for the presence of AstVs 
using the hemi-nested screening PCR of Chu et al. (2008) and the AstV qPCR assay designed during 
the current study. 
2.17 Virus isolation in vitro  
AstVs are classified as a BSL II virus, however isolation and propagation were performed in a BSL 
3 laboratory (Marvin, Meliopoulos and Schults-Cherry. 2014). Experiments were conducted in 
duplicate and negative controls were also utilized to ensure no contamination has taken place. More 
details about the experimental design is given in Appendix I. 
2.17.1 Isolation and propagation of bat astroviruses in human cell line 
To determine whether bat AstVs are capable of infecting human cells, and as such pose a possible 
zoonotic threat, human intestinal adenocarcinoma cells (Caco-2) were used during attempted isolation 
and propagation. The Caco-2 cells used were supplied by the University of the Western Cape, Faculty 
of Biomedical Sciences (ATCC, catalogue number: HTB-37). 
Caco-2 cells are the most preferred cell lines for studying AstVs in cell culture, due to their ability to 
form differentiated intestinal epithelium that mimics that of the human intestine (Brinker, Blacklow, 
and Herrmann, 2000).  
2.17.2 Propagation and isolation attempt of bat astroviruses in bat cells and BHK G43 cells 
Bat AstVs have not yet been successfully isolated and propagated in cell culture. A bat derived cell 
line (N. capensis kidney cells (NCK)) established by Dr Tasnim Suliman in collaboration with the 
Institute of Virology, University of Bonn Medical Centre, Germany, was used to attempt isolation of 
bat AstVs in vitro.  




2.17.3 Cell line resuscitation and maintenance 
Cryovials containing aliquots of cell lines of interest, previously frozen in DMSO, were removed 
from liquid nitrogen storage and thawed in a dry bath (AccuBlock digital dry bath, Labnet, USA) set 
to 37°C. Cells were gently swirled in the dry bath while defrosting. The vial containing the cells was 
transferred to a laminar flow hood (NU-425-400 Series-24, NuAire, Minnesota, USA) where it was 
sterilized with 70% ethanol. Complete media, pre-warmed to 37°C, was added into a 15 ml Falcon® 
tube (Corning, USA), cells were transferred to the tube dropwise. The suspension was centrifuged 
(Rotanta 460R Hettich centrifuge, Beverley, Massachusetts, USA) at 200 x g for 5 minutes. The 
supernatant was removed via aspiration (Gilson Safe Aspiration Station F110741, Gilson, Wisconsin, 
USA) without disturbing the cell pellet. The cell pellet was gently resuspended in complete media 
and transferred into a cell culture flask (Corning, USA). Cells were placed in an incubator (Air-
Jacketed DHD Autoflow Automatic CO2 incubator, NuAire, Minnesota, USA) at 37°C with 5% CO2. 
Cells were inspected daily under a microscope (Nikon, Eclipse TS 100, Minato, Tokyo, Japan) to 
establish the state of their growth and confluence. Media was changed when necessary. Media was 
aspirated (Gilson, Wisconsin, USA), and cells were washed with 1x PBS (Gibco®, USA). Fresh 
complete media was then added to the flask (Table 2.19.). 
 
Table 2.19. Recipes for the different media used during cell culture maintenance and inoculation of cell 
cultures with virus 
Media type Reagents 
Complete Media used for cell line 
growth and maintenance DMEM (Lonza BioWhittaker®, Verviers, Belgium) solution with: 
- 1% penicillin/streptomycin mixture (Lonza BioWhittaker®, Belgium) 
- 1% non-essential amino-acids (Lonza BioWhittaker®, Belgium) 
- 1% sodium pyruvate (Lonza BioWhittaker®, Belgium) 
- 1% L-glutamine (Lonza BioWhittaker®, Belgium) 
- 10% FBS (foetal bovine serum) (Gibco®, USA) 
Serum Free Media (SF) used for  
inoculation of cell cultures with virus DMEM (Lonza BioWhittaker®, Belgium) solution with:  
- 1% penicillin/streptomycin mixture (Lonza BioWhittaker®, Belgium) 
- 1% non-essential amino-acids (Lonza BioWhittaker®, Belgium) 
- 1% sodium pyruvate (Lonza BioWhittaker®, Belgium) 
- 1% L-glutamine (Lonza BioWhittaker®, Belgium) 
 
 
2.17.4 Passaging of cells 
When cells reached 80-90% confluency they were passaged. The supernatant was aspirated (Gilson, 
Wisconsin, USA), and the cells washed with 1X PBS (Gibco®, USA). Cells were then detached using 
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Accutase® (Biowest, France) or 1X trypsin EDTA (Gibco®, USA) and incubated at 37°C for 2-5 
minutes, or until all cell detached from the surface of the cell culture flask. The cell suspension was 
then transferred to a Falcon tube (Corning, USA) and centrifuged (Rotanta 460R Hettich centrifuge, 
Massachusetts, USA) at 1 000 x g for 5 minutes. The supernatant was aspirated (Gilson, Wisconsin, 
USA), and the cell pellet resuspended in DMEM (see Table 2.20. for volumes). For the specific 
protocol used for the propagation of AstVs in cell culture (Marvin, Meliopoulos, and Schults-Cherry, 
2014), a specific number of cells needed to be seeded into new flasks. Cell counting, and seeding was 
performed as described in Section 2.15.5.  
2.17.5 Cell counting and seeding  
Cells were counted manually using a haemocytometer and microscope (Nikon, Tokyo, Japan). The 
haemocytometer and coverslip were cleaned using 90% ethanol (Sigma-Aldrich, USA). The coverslip 
was moistened and affixed to the haemocytometer. Newton’s refraction rings were used to determine 
if adhesion was successful before continuing. The protocol used for counting of cells is given in 
Appendix C. 
 
Table 2.20. Volumes of reagents per volume flask for the different treatment steps during passaging of cells 
Treatment Reagent Volume of reagent  
  per volume of flask 
Wash PBS (1x PBS) if Accutase® is used for detachment) T25 ~ 1 ml 
 Repeat wash X 3 (1x PBS) if trypsin EDTA is used for detachment T75 ~ 7 ml 
  T175 ~ 25 ml 
Detach cells Trypsin EDTA or Accutase® T25 ~ 1 ml 
  T75 ~ 3 ml 
  T175 ~ 7 ml 
Resuspension DMEM Supplemented T25 ~ 4 ml 
  T75 ~ 7 ml 
  T175 ~ 21 ml 
Seeding DMEM Supplemented (+ cell suspension) T25 ~ 5 ml total 
  T75 ~ 18 ml total 




2.18 Bat astrovirus isolation and propagation attempt  
2.18.1 Identification and selection of astrovirus positive bat samples  
Samples stored in VTM that were confirmed to be AstV positive were identified and used during the 
isolation and propagation attempts. Saliva and urine swabs were used from two bat species 
(Rhinolophus clivosus and M. natalensis) from the same locality, Steenkamps Kraal in the Northern 
Cape. For each attempt approximately 500 µl sample was filter sterilized with a 0.4 µm syringe filter, 
before infecting cell lines to reduce chances of contamination with bacteria and other pathogens that 
could be present in the sample. The filtered sample was then supplemented with 2.5 ml SF media 
containing 5 µg/ml porcine trypsin (Sigma-Aldrich, USA).  
2.18.2 Human astrovirus positive control 
PCR-confirmed AstV-positive human stool samples were supplied as positive controls for the 
experiment. The stool samples were courier overnight from the National Institute of Communicable 
Diseases (NICD) in Johannesburg to the Division of Medical Virology, Faculty of Medicine and 
Health Sciences, Stellenbosch University. Samples were filter sterilized before infecting cell lines.  
2.18.3 Protocol for the propagation of astroviruses in cell culture 
T75 flasks (Corning, USA) were seeded with 2.5-5 x 106 various cells lines in complete media (Table 
2.19.). Two flasks were prepared for each cell line, one for the virus infection experiment and one to 
serve as negative control. For the human positive control one flask of Caco-2 cells were prepared.  
Cells were grown at 37°C with 5% CO2 for 3-4 days until cells reached 100% confluency. Media was 
aspirated (Gilson, Wisconsin, USA), and cells were washed with 1x PBS (Gibco®, USA).  
AstV positive samples that were prepared as mentioned in Section 2.15.6.1. were added to the cells 
and incubated for 90 minutes at 37°C (Air-Jacketed DHD Autoflow Automatic CO2 incubator, 
NuAire, Minnesota, USA). 
The infective media was aspirated and 7 ml SF media with 10 μg/ml porcine trypsin (Sigma-Aldrich, 
USA) was added. 
Cells were then incubated for 3-4 days at 37°C with 5% CO2 (Air-Jacketed DHD Autoflow Automatic 
CO2 incubator, NuAire, Minnesota, USA).  
Supernatant and cells were collected 3-4* days post inoculation and stored at -80°C. For cells infected 
with bat AstV positive samples supernatant was collected 5 days post-inoculation. 
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2.18.4 Blind passaging of bat astrovirus infected cells and supernatant 
AstV isolation in cell culture is further complicated by the fact that cytopathic effects are rarely 
observed, thus the presence of the virus could only be confirmed molecularly. Inoculated cells and 
supernatant were passaged blindly to increase the chances of successful virus isolation. Cells were 
prepared as mentioned earlier (Section 2.15.2-2.15.5.4). Once the cells reached 90-100% confluency, 
1 ml AstV infected cells and supernatant were used to infect the new cultures. The protocol mentioned 
in Section 2.15.6.3. was followed and supernatant and cells were removed 5 days post infection and 
stored at -80°C.  
2.19 Screening of cells and supernatant for AstV 
Viral RNA was extracted as mentioned in Section 2.4. and screened for the presence of AstVs using 
the qPCR assay (Section 2.14.). 
2.20 Data analyses 
Statistical analyses were conducted in R v3.4.3 (Foundation for Statistical Computing, Vienna, 
Austria) and Statistica R13.3 (Tibco, California, USA).  
The morphological and ecological data recorded for individual bat samples (n = 495) were used for 
the analyses, the database used for the analyses is included in Appendix D. The data was divided into 
bat biological data (bat individual measurements; sex, age, forearm mass index (FMI), species 
identity) and ecological data (biome, altitude and rainfall) and analysed separately to determine if 
either host or environment have a significant effect on AstV positivity.  
2.20.1 Bat morphological and biological data recorded 
Measurements taken on the individual bat level included sex, age and forearm mass index (FMI). Sex 
is a relatively straight forward category to comprehend, bats were classified as either male or female. 
The reproductive statuses for males were: scrotal, non-scrotal. For females the reproductive statuses 
were: pregnant, not-pregnant, lactating, post-lactation.  
Bat age is determined by epiphyseal-diaphyseal fusion. By examining the closure or fusion of the 
cartilaginous epiphyseal growth plates of the fourth metacarpal-phalangeal joint, through illumination 
with a flashlight the age of the bat is determined. If the joint was fused, the bat was classified as adult 
and if the joint was not fully fused, the bat was classified as sub-adult or juvenile (Brunet-Rossinni 
and Wilkinson, 2009). As only a small number of juvenile bats (n = 10) were sampled, age was not 
used in any analyses.  
Stellenbosch University https://scholar.sun.ac.za
47 
FMI is a relatively new method of determining the overall body condition of the bat (Meng et al., 
2016). It is similar to the body condition index that is used as a proxy for human health. FMI 
calculation was made by using the following formula: 
FMI = 
𝑤𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑡ℎ𝑒 𝑏𝑎𝑡 (𝑘𝑔)
𝑓𝑜𝑟𝑒𝑎𝑟𝑚 𝑙𝑒𝑛𝑔𝑡ℎ (𝑚2)
 
2.20.2 Statistical analyses of bat morphological and biological data 
Most of the variables recorded on the individual bat level were classified as categorical variables (sex, 
reproductive status, species identity), except FMI which was classified as a continuous variable. 
Categorical variables take on a value or within a specified set of categories (Joshi, 1990). As opposed 
to continuous variables that can take on an infinite number of variables (Joshi, 1990).  
The database of bat morphological and biological variables was imported from Excel into statistical 
software, R v3.4.3 (Foundation for Statistical Computing, Vienna, Austria). 
Individual Chi-squared analyses were conducted on the variable sets where the dependent variable 
(AstV status) and independent variable (sex, reproductive status, species identity) were classified as 
categorical. 
• Sex, reproductive status and AstV positivity  
Sex and reproductive status were used in individual Chi-squared analyses. To account for 
dependencies of observations within trapping site (locality), the Roa-Scott adjustment was used.  
• Species identity and AstV positivity 
To account for differences in sample size between bat species, the screening results (AstV status per 
species) were converted to percentages and then used in a Chi-squared analyses. Due to small counts 
in the cells for the crosstab table, the generalized Fisher exact test was also performed. Both the Fisher 
exact test and the Chi-squared analysis indicated that species identity was a significant (p = 0.01) 
factor for AstV positivity. To account for repeated measures within locality (trapping site), Roa-Scott 
adjustment was incorporated.  
• FMI and AstV positivity  
FMI was the only continuous variable in the dataset. The FMI measurements were used in a mixed 
model one-way ANOVA with Restricted Maximum Likelihood (RMl). To account for repeated 
measures in the dataset, locality (trapping site) was selected as a random effect in the analyses.  
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2.20.3 Ecological variables 
The biome variable was classified as one of seven different vegetation types: Succulent Karoo, Nama 
Karoo, Savanna, Grasslands, Forests or Albany thicket. Altitude was a measure of the trapping 
location’s position in meters above sea level. This was determined by taking the GPS coordinates of 
the trapping location and importing it into GPS visualizer software to determine the altitude. The 
database of ecological variables was imported from Excel into statistical software, R v3.4.3 
(Foundation for Statistical Computing, Vienna, Austria). 
2.20.4 Statistical analyses of ecological variables  
The Generalized Estimating Equations (GEE) approach was used to determine which ecological 
factors (biome, altitude and rainfall) might have contributed significantly to AstV positivity. GEE 
was selected to take into account repeated measures within the locality (trapping site) units. AstV 
status was the dependent variable and also binary in nature and therefore the Binomial distribution 
was selected as underlying distribution. Dependent variables included in the analyses were biome, 
altitude and rainfall. GEE results indicated that biome significantly (p = 0.01) influenced AstV 
positivity. Fisher LSD post-hoc test was used to determine the significance between the different 
biomes.   
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Chapter 3 Results 
Chapter Outline 
This chapter is structured in such a way as to reflect the outline of Chapter 2 as far as possible. This 
chapter starts with the AstV PCR screening results and sample localities where bats that tested 
positive for AstV RNA were trapped. Thereafter the phylogenetic relationships of the obtained RdRp 
sequences and ORF2 sequence follows. Based on the sequences obtained, real-time PCR assays were 
designed to monitor the amplification of AstVs and CoVs in a colony over time. To determine how 
AstV diversity in bats might be impacted by exposure to human AstVs at WWTW, bat faecal material 
and water samples were screened for the presence of AstVs. In vitro isolation of bat AstVs were 
attempted and the findings presented. The last section of the results focuses on the statistical analyses 
of the screening results and the comparison between the screening results of the qPCR and 
conventional PCR assay.  
3.1 Identification and characterization of astroviruses in South African bats  
3.1.1 Screening results of individual bat samples 
During the current study 500 individual bat faecal samples were screened for the presence of AstV 
RNA. The overall prevalence of the virus across the nine species was 13%. Prevalence on species 
level was highly variable ranging from the highest of 55% for M. natalensis to the lowest of 4% in 
N. nana (Table 3.1.). The only other available study that investigated bat AstVs in SA is that of Dr 
Ithete (2013). The screening results of Ithete (2013) and that of the current study were combined in a 
summary table to depict all SAn bat species that have tested positive for AstV RNA (Table 3.2.). The 
spatial distribution of sample localities across SA is given in Figure 3.1.a), and the localities where 
bats tested positive for AstV RNA is given in Figure 3.1.b). A detailed list of sample localities and 




Table 3.1. Prevalence of AstV RNA detected in different SA bat species using primers designed by Chu et al. 
(2008) that targets the RdRp gene of the virus 
Family Species Total AstV AstV Prevalence 
  Screened Negative Positive (%) 
Miniopteridae M. natalensis 22 10 12 55 
Molossidae Chaerephon pumilus 13 13 0 0 
 Mops midas 6 6 0 0 
 Myotis bocagii 5 5 0 0 
 Tadarida aegyptiaca 15 13 2 14 
Rhinolophidae R. capensis 23 14 9 39 
 R. clivosus 121 101 20 17 
 R. darling 10 10 0 0 
 R. denti 10 10 0 0 
 R. simulator 14 14 0 0 
 R. smithersi 1 1 0 0 
 R. swinnyi 10 10 0 0 
Vespertilionidae Myotis tricolor 16 15 1 7 
 N. capensis 120 107 13 11 
 N. nana 47 45 2 4 
 Pipistrellus hesperidus 56 50 6 11 
 Kerivoula lanosa 1 1 0 0 





Table 3.2. Summary of all South African bat species that have tested positive for AstV RNA during the 
current study and during the study by Ithete (2013) 
Family Species Total PCR Prevalence 
  Screened Positive (%) 
Hipposideridae Hipposideros caffer 6 2 33 
Miniopteridae  M. natalensis (Ithete, 2013) 13 12 92 
 M. natalensis 22 12 55 
 M. fraterculus (Ithete, 2013) 6 6 100 
Molossidae Tadarida aegyptiaca (Ithete, 2013) 3 2 67 
 Tadarida aegyptiaca 15 2 13 
Rhinolophidae R. clivosus (Ithete, 2013) 8 1 13 
 R. clivosus 121 20 17 
 R. swinnyi (Ithete, 2013) 3 1 33 
 R. capensis 23 9 39 
Vespertilionidae N. nana (Ithete, 2013) 6 1 7 
 N. nana 47 2 4 
 N. capensis (Ithete, 2013) 10 8 80 
 N. capensis 120 13 11 
 Myotis tricolor 16 1 6 





Figure 3.1. a) Localities sampled during the course of this study;  
b) Spatial distribution of all PCR positive sample localities in SA including those detected by 
Ithete (2013). Maps were created using GPS visualizer online software 
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3.2 Phylogenetic analyses  
3.2.1 Phylogenetic analyses based on the RNA dependant RNA polymerase (RdRp) gene  
Using the conventional hemi-nested AstV screening PCR (Chu et al., 2008) which targets a 420 bp 
fragment of the AstV genome, a total of 25 novel RdRp sequences were obtained during the current 
study. Bringing the total number of SA bat AstV RdRp sequences to 44 (Ithete, 2013). The 
phylogenetic relationship of all available SA bat AstVs and their related sequences is depicted in 
Figure 3.2., and magnifications are presented in Figures 3.3-3.5. 
The novel RdRp sequences were also used to determine their relationship within the larger scope of 
AstV sequences available on GenBank, a ML tree was constructed that included members of 
Mamastrovirus genogroup I and genogroup II (Appendix F). 
The evolutionary divergence of the RdRp gene sequences as determined by pairwise distance matrix 
analysis is given in Appendix G.  
3.2.2 Phylogenetic inferences based on the RdRp gene fragment  
Based on the phylogenetic reconstruction depicted in Figure 3.2., the following observations can be 
made; the sequences are highly diverse with numerous clusters having poor bootstrap support, there 
is not one clear trend with regards to the clustering of sequences with some sequences seen to cluster 
according to bat genera whilst others cluster according to locality. Figure 3.2. was split into three 
sections for better illustration of the clustering of sequences and each section will be discussed in the 
following subsections. Only clusters with bootstrap support values above 70 were discussed. 
• Section A  
Section A (Figure 3.3.) is a magnification of Figure 3.2. and the grouping of sequences will be 
discussed systematically from the bottom (avastrovirus outgroup) to the top, numbered from 1-5. 
Sequences at position 1 indicate two sequences isolated from the same bat species, N. capensis, from 
the same colony trapped in Greyton in the Western Cape (BatAstV/Greyton/NC7 & 
BatAstV/Greyton/NC1). From Figure 3.3, the cluster of sequences from SA at position 1 appears to 
share a common ancestor with several sequences obtained from Miniopterus bats from China (Chu et 





Figure 3.2. Phylogenetic relationship of SAn bat AstVs with related bat AstV sequences. The RdRp fragment 
(420 bp) (corresponding to positions 3659-4041 bp in HAstV NC_001943.1) was used to 
construct a maximum likelihood tree on the nucleotide level in PhyML. The evolutionary history 
was inferred using the General Time Reversible model with Gamma distribution and invariant 
sites (GTR+G+I) (Nei & Kumar 2000) with 1000 Bootstrap replicates. Bootstrap support values 
above 50% are indicated at supported nodes. The tree is outgroup rooted with avastrovirus 
sequences. Each sequence is designated by a unique sequence name comprising of GenBank 
accession number, virus abbreviation (Appendix H), bat host species abbreviation, individual 
sample ID, country of origin and year when the sample was collected. The SAn bat sequences are 









The sequence clustering indicated by number 2 is two SAn bat AstV sequences 
(BatAstV/TableMountain/MSTM1 & BatAstV/Greyton/Tar1) from different bat species, M. 
natalensis and T. aegyptiaca, sampled at different locations, Greyton and Table Mountain. The next 
two sequences at position 3 were obtained from the same bat species, M. natalensis, from two 
different provinces in SA, Pietermaritzburg in KZN and Table Mountain in the Western Cape. In 
Figure 3.3, above the two Miniopterus sp.-derived sequences at position 3, is a sequence 
(BatAstV/TableMountain/HC3) from a different bat species, H. caffer, also from Table Mountain. 
The two Miniopterus derived sequences possibly share a common ancestor with the Hipposoderus-
derived sequence. At position 4 two sequences (BatAstV/TableMountainMSTM12 & 
BatAstV/Greyton/NC5) obtained from two bat species from different locations, M. natalensis and N. 
capensis, cluster together. The Miniopterus-derived sequence was from a bat trapped at Table 
Mountain and Neoromicia-derived sequence from a bat trapped at Greyton. At position 5, a SAn bat 
AstV sequence (BatAstV/Hopefield/HFP1RCL9) from a R. clivosus bat appears to cluster with a bat 
AstV sequence from a M. schreibersci bat from China (GenBank ID: JQ814862.1) (Wu et al., 2012).  
 
Figure 3.3. Magnification of section A of Figure 3.2. Sequence groupings with significant bootstrap support 
(>70%) were numbered 1-5. 
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• Section B  
The magnified section B (Figure 3.4.) of Figure 3.2. shows various sequences obtained from bats in 
SA clustering with Chinese bat AstV sequences (Chu et al., 2008; Zhu et al., 2009; Wu et al., 2012). 
The cluster of sequences at position 1 in Figure 3.4. shows SA bat AstV sequences 
(BatAstV/Hopefield/HFPRCL1, BatAstV/Hopefield/HFPRCL13 & BatAstV/Babanango/BVL1RCL1) 
appearing to share a common ancestor with a Chinese bat AstV sequences (Genbank ID: 
EU847193.1). The SAn bat sequences at position 1 were all obtained from bats within the same genus, 
Rhinolophus. Interestingly, the Chinese sequence (GenBank ID: EU847193.1) with which these 
sequences appear to cluster was obtained from a bat from a different family, Miniopteridae. Although 
the SAn sequences at position 1 were all obtained from R. clivosus bats, sampling took place at 
different localities, namely Hopefield in the Northern Cape, and Babanango in KZN. The second 
cluster of interest in Section B of Figure 3.2. at position 2 depicts a SAn bat AstV sequence 
(BatAstV/Hopefield/HFPMN3) obtained from M. natalensis, being ancestral to Chinese sequences 
(Genbank IDs: JQ814868.1, JQ814870.1, JQ814856.1 & JQ814858.1) that were also obtained from 
species within the Miniopteridae family.  
 
Figure 3.4. Magnification of section B of Figure 3.2. Sequence groupings with significant bootstrap support 
(>70%) were numbered 1-2. 
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• Section C 
At position 1 in Section C of Figure 3.5., is a single cluster of SA AstV sequences of particular 
interest. The cluster consisted of six sequences, four sequences obtained from N. capensis bats, one 
from a R. clivosus and one from Pipestrellus hesperidus. Three of the four N. capensis sequences in 
the cluster were obtained from a single colony in Velddrif (BatAstV/Velddrif/VD34, 
BatAstV/Velddrif/VD44 and BatAstV/Velddrif/VD59) in the Western Cape of SA. The other N. 
capensis sequence (BatAstV/Napier/HWKNC4) in the cluster was obtained from the same bat species 
but from a different locality, Napier in the Western Cape. The Rhinolophus derived sequences 
(BatAstV/Steenkampskraal/SKKRCL9) was obtained from a R. clivosus bat collected from a 
decommissioned radioactive mine in the Northern Cape. There was also an AstV sequence obtained 
from a P. hesperidus bat (BatAstV/Ph2NGR/Pip hesperidus) that was collected in Greyton.  
 
Figure 3.5. Magnification of section C of Figure 3.2. The sequence grouping with significant bootstrap 
support (>70%) was numbered. 
3.3 Phylogenetic analyses based on the Capsid Protein Gene (ORF2) 
3.3.1 Phylogenetic inferences based on ORF2 fragment  
The SA bat ORF2 sequence obtained from a Miniopterus natalensis bat appears to share a common 




Figure 3.6. Phylogenetic relationship of AstVs based on a partial capsid protein precursor sequence using 
the ML method on the nucleotide level. A ML phylogenetic tree was constructed using AstV capsid 
protein precursor sequences (800 bp in size) (corresponding to positions 4583-5383 bp in HAstV 
NC_001943.1) including the sequence obtained during this study. The evolutionary history was 
inferred by using the General Time Reversible model with Gamma distribution and invariant sites 
(GTR+G+I) (Nei & Kumar 2000) with 1000 Bootstrap replicates. Bootstrap support values above 
40% are indicated at supported nodes. The tree is outgroup rooted (AstV). Each sequence is 
designated by a unique sequence name containing the isolate or species name, virus abbreviation, 
host species abbreviation, country of origin and year when the sample was collected. The SAn bat 
ORF2 sequence is highlighted in green. 
3.3.2 Pairwise distance matrix  
To further investigate the evolutionary distance between the SAn bat AstV ORF2 sequences and 
related ORF2 sequences, a pairwise distance matrix was constructed. Pairwise distance matrixes 
measure the number of nucleotide substitutions occurring between the sequences in question. This 
matrix analysis of the ORF2 sequences indicated that the SA bat ORF2 sequence was in fact more 
similar to bat AstV sequences than to the human AstV sequences (Table 3.3.) The bat AstV ORF2 
sequences with the highest similarity to the SAn bat ORF2 sequence were FJ571069 (22%) and 
EU847155 Mamastrovirus isolate number 18 (22%). The sequences that differed the most from the 
SAn bat AstV ORF2 sequence was the Turkey AstV sequences (47%), followed by the human AstV 





Table 3.3. Estimates of Evolutionary Divergence between ORF2 Sequences. The number of base differences per site from between sequences are shown. The analysis 
involved 15 nucleotide sequences using the p-distance model with 1000 iterations. Evolutionary analysis was conducted in MEGA7 (Kumar et al., 2016). 
1 Turkey_AstV 1 2 3 4 5 6 7 8 9 10 11 12 13 14 
2 AB025808_Human AstV4/isolate: _O-24/93-439 48%              
3 AB025812_HumanAstV4/isolate: _O-33/87-25 48% 0%             
4 AB025811_HumanAstV4/isolate: _O-29/90-276 48% 1% 1%            
5 AB025809_HumanAstV4/isolate: _O-25/93-197 48% 0% 0% 0%           
6 FJ571074_BatAstV/Guangxi/LC03/2007 51% 36% 36% 37% 37%          
7 FJ571068_BatAstV_Ha/Guangxi/LS11/2007 50% 36% 36% 36% 36% 28%         
8 EU847155_Mamastro18/isolate_AFCD337 50% 39% 39% 39% 39% 27% 27%        
9 Bat AstV/HFPMN1/South Africa 47% 32% 32% 32% 32% 32% 27% 22%       
10 FJ571069_BatAstV/Guangxi/LD04/2007 46% 38% 38% 38% 38% 27% 25% 21% 22%      
11 FJ571072_BatAstV/Guangxi/LD45/2007 48% 39% 39% 39% 39% 27% 20% 22% 25% 15%     
12 FJ571073_BatAstV/Guangxi/LD54/2007 48% 37% 37% 38% 38% 28% 30% 23% 26% 15% 17%    
13 FJ571065_BatAstV/Guangxi/LD38/2007 47% 36% 36% 36% 36% 28% 26% 20% 25% 17% 17% 15%   
14 FJ571070_BatAstV/Guangxi/LD27/2007 48% 38% 38% 38% 38% 28% 25% 23% 26% 16% 18% 16% 11%  





3.3 Real-time PCR results  
3.3.1 Amplification of AstVs and CoVs in a bat colony 
The amplification of AstV and CoV was monitored in a N. capensis bat colony in the Western Cape 
of SA, using real-time PCR assays. During the month of January AstV RNA was detected in the 
colony, but CoV RNA was absent (Figure 3.7.). From February until April, no AstV RNA was 
detected. During April CoV RNA was present in the colony. The relative viral loads (AstV 240 per 5 
faecal pellet and CoV 155 per 5 faecal pellets) indicated that the amplification of both viruses 
increased significantly in September and steadily declined towards the end of November (Figure 3.7.). 
The absence of samples from May until August is due to the bats migrating from the roost. During 
September, the bats recolonized the roost again.  
 
Figure 3.7. AstrV and CoV amplification in a bat colony over the span of a calendar year (2015). AstV is 
indicated in orange and CoV in yellow. The gap from May until August corresponds with the 
migration of the bats from the roost and as such no samples were collected during this time. The 
y-axis represents the relative viral copy number per 5 faecal pellets, the amount of faecal material 
was used as a normalizer.  
3.3.2 Real-time PCR screening assay versus conventional PCR screening assay 
To determine whether the AstV real-time PCR assay designed during the current study could serve 
as an alternative improved screening and detection tool, 150 selected samples were re-screened using 
both the conventional hemi-nested AstV PCR assay (Chu et al., 2008) and the AstV qPCR assay 









































The results indicated that the real-time assay was more sensitive, as it was able to detect as low as 10 
viral RNA copies per reaction, compared to the conventional PCR only being able to detect 102 viral 
RNA copies per reaction. The results of both assays are given in Table 3.4. The samples that were 
found to be positive by conventional AstV screening PCR were also positive using the qPCR 
screening and the qPCR detected more positives than the conventional AstV screening assay.  
Table 3.4. Comparison of the screening results of the conventional AstV screening assay with the Real-time 
PCR assay 
Calculated Conventional PCR Real-time PCR 
Positives 17 47 
Negatives 133 103 
% positives 11.4 31.5 
% negatives 88.6 68.5 
% difference in positives  20 
 
3.4 Wastewater treatment works samples 
3.4.1 Water samples  
Water samples that were collected upstream and downstream from two WWTWs in KZA; Verulam 
Wastewater Works (S29º38.38; E31º03.49) and Umbilo Wastewater Works (S29º50.44; E30º53.31) 
were analysed for the presence of AstVs as described in Section 2.14. The water collected from the 
two facilities tested negative for the presence of AstVs. 
3.4.2 Bat samples 
The N. nana samples collected from WWTW only delivered one positive sample out of 50 (field code 
DC 28 for reference in phylogenetics). No N. nana bats tested positive in the pristine localities. 
3.5 In vitro virus isolation 
Three different cell lines were used during the attempts: Caco-2, BHK-G43 and NCK cells. A human 
AstV positive stool sample was used as a cell culture positive control to infect Caco-2 cells. Images 
were taken of the cell cultures before and after infection (Zeiss Axiocam ERc 5 S, Zeiss, Oberkochen, 
Germany), however AstV infected cells do not exhibit cytopathic effects (CPE) (Brinker et al., 2000). 
It should be noted that in the post-infection images (Figures 3.8.-3.10.), cells are clumping and 
detached, this is due to the minute amounts of porcine trypsin which was added to the SF media. The 





Figure 3.8. a) Human colon adenocarcinoma cells (Caco-2) at 90-100% confluency, pre-infection.  
b) Caco-2 cells three days post infection with a human AstV positive faecal sample.  
c) Caco-2 cells four days post infection with human AstV positive faecal sample. Images were taken with Zeiss Axiocam ERc 5 S (Zeiss, Oberkochen, 
Germany). 
 
Figure 3.9. a) Baby hamster kidney cells (BHK-G43) at 90-100% confluency pre-infection.  
b) BHK-G43 cells day three post infection with an AstV positive bat sample.  
c) BHK-G43 cells day five post infection with AstV positive bat sample. Images were taken with Zeiss Axiocam ERc 5 S (Zeiss, Oberkochen, Germany). 
b c a 






Figure 3.10. a) Neoromicia capensis kidney cells (NCK) at 90-100% confluency pre-infection.  






To determine whether the cells were infected with AstV, the supernatant and cells were harvested on 
day five post-infection. Extracted RNA was screened using both conventional hemi-nested AstV 
screening PCR assay (Chu et al., 2008) and the AstV qPCR assay developed during the current study 
(Section 2.13.). The qPCR results indicated that a bat AstV from a M. natalensis bat (field code 
SKKMN1) was successfully isolated and propagated in BHK-G43 cells after the first passage 
(Figures 3.11. & 3.12.). These results were also confirmed with Sanger sequencing. The cell culture 
positive control was also confirmed with the hemi-nested AstV screening PCR and Sanger 
sequencing. 
 
Figure 3.11. Amplification of bat AstV (SKKMN1) in BHK-G43 cells five days post-inoculation (bright pink 
curve) and five days post inoculation after the first blind passage (purple curve). The lowest 
amplification was that of the supernatant of the infectious material that was removed after the 
90-minute incubation on the cells during infection.  
 
Figure 3.12. Amplification of bat Astrovirus SKKMN1 in BHK G43 cells and supernatant. Passage one of 





3.6 Statistical analyses of factors associated with astrovirus positivity 
For the statistical analyses, only individual bat samples with host biological data documented, were 
included (n = 497) in the database. The database consisted of ecological data collected about the 
trapping location (altitude, rainfall, biome) and biological and morphological data of the individual 
bats sampled (sex, age, reproductive status, FMI, weight).  
3.6.1 Morphological and biological variables of individuals bats  
Statistical analyses were conducted on the data collected from individual bats. Most of the factors 
were categorical variables, excluding FMI, and were used in individual Chi-squared analyses.  
3.6.1.1 Sex, reproductive status and astrovirus positivity 
Chi-squared analysis of the individual bat data indicated that scrotal (sexually reproductive male) 
bats, were significantly (p < 0.05) more likely to be positive for AstVs than females of all 
reproductive stages. A visual representation of the results is given in Figure 3.13.  
 
Figure 3.13. Visual representation of differences in AstV positivity between male and female bats. On the x-
axes AstV positive status is indicated by 1 and a negative status by 0.  
3.6.1.2 Species identity and astrovirus positivity 
Chi-squared analyses and Fisher exact tests of the screening results between bat species indicated that 
species identity was a significant (p = 0.01) factor for AstV positivity. When adjusting for repeated 
measures within locality (trapping site) with Roa-Scott adjustment, the species identity was not 





Figure 3.14. AstV screening results per bat species. On the y-axes of the graphs are the number of bats sampled 
(number of observations) and on the x-axes is the AstV status,  positivity is demarcated with 1 
and negativity with 0.  
3.6.1.3 FMI 
The mixed model one-way ANOVA with AstV positivity as the fixed effect and location (trapping 
site) as random effect, indicated a weak trend (p = 0.07) between lower FMI measurements and AstV 
positivity.  
3.6.2 Environmental factors  
GEE results indicated that biome significantly (p = 0.01) influenced AstV positivity (Table 3.5.). The 
best model that predicts AstV positivity is biome (Model: Astro~Biome) (Table 3.5.). The LSD post-
hoc analyses indicated that bats trapped in the Succulent Karoo (SK) were more likely (p < 0.05) to 





Table 3.5. GEE model output for environmental factors 
 Distribution: binomial Model: ASTRO ~ ALT+RAIN+Biome 
 Df Wald p value 
ALT 1 2.15 0.14 
RAIN 1 0.23 0.63 
BIOME 6 5 573.3 0.01* 
 
Wald(6)=5573.30, p<0.01
Vertical bars denote 0.95 confidence intervals






























Figure 3.15. LSD post-hoc analyses results of GEE on AstV positivity in different biomes. Abbreviations of 
biome names: G: Grasslands, AT: Albany Thicket, F: Fynbos, S: Savannah, NK: Nama Karoo, 





Chapter 4 Discussion & Concluding Remarks 
Chapter Outline 
The overall objective of this study was to investigate the ecology and diversity of AstVs in SAn bats 
using molecular, phylogenetic and statistical tools. This study was only the second to investigate 
AstVs in SAn bats and builds on the initial study by Dr Ndapewa Ithete in 2013 (Ithete, 2013). The 
structure of this chapter will mirror that of the methods and results chapters as far as possible.  
4.1 Prevalence of AstV RNA detected in South African bats compared to other studies 
During this study, AstVs were detected in eleven different bat species belonging to four families; 
Miniopteridae, Molossidae, Rhinolophidae and Vespertilionidae (Table 3.1.). The overall prevalence 
of AstV RNA across all individual bat samples screened was 13% (65/500). A summary of the 
prevalence rates recorded by various studies is given in Table 4.1. There are substantial differences 
in the prevalence rates of the virus reported by different published studies (Xiao et al., 2011; Hu et 
al., 2014; Kemenesi et al., 2014; Rougeron et al., 2016; Lacroix et al., 2017). The cause for this 
variability is unclear, but it seems that study design, host species sampled, sample type, geographical 
location, and time of year when sampling occurred could be the most important contributing factors 
(Fischer et al., 2017).  
The highest AstV prevalence was reported by Chu et al. (2008) with 46% (121 positives out of 264 
samples) across the nine different bat species sampled. Similar results were obtained by Zhu et al. 
(2009) who detected AstV RNA in 44.8% of 500 individual bat samples. Other studies that recorded 
higher prevalences compared to the results of the current study, include Fisher et al. (2011) with an 
overall prevalence of 25.8% in 653 bats sampled in Germany, with the highest prevalence noted in 
one colony at 65%. A recent study conducted in Madagascar reported an overall prevalence of 22% 
(Lebarbenchon et al., 2017). It is difficult to interpret these differences as these studies were 
conducted in different parts of the world, with their own unique species and habitat types, utilizing 
different sampling and testing protocols, all of which are factors that could influence the prevalence 
of virus detection. A summary of all presently published bat AstV studies listing the study location, 
number of samples, sample type, prevalence recorded, and sample handling is presented in Table 4.1.  
A recent meta-analysis of bat virus discovery studies found that the following factors significantly 
influenced the probability of a single sample testing positive for a virus: (1) specimen type; (2) 
detection methods; (3) viral family tested; and (4) number of specimens tested (Young & Olival, 




specimen type for AstV detection was faecal material. Even though AstVs were also detected in urine, 
this sample type had a much lower median viral prevalence (Young & Olival, 2016). All the studies 
mentioned in Table 4.1. used the primer sets developed by Chu et al. (2008). The study by Young 
and Olival (2016) did however not elaborate whether the use of different DNA polymerases may 
affect the probability of detection of a virus. Some of the studies used different DNA polymerases, in 
conjunction with the PCR assay developed by Chu et al. (2008), which could also significantly affect 
virus detection, as experienced in our own research group. For example, Dr Cronje found that using 
Maxima Hot Start Taq DNA Polymerase (ThermoScientific, New York, USA) worked better for the 
detection of CoVs compared to Go Taq (Promega, Wisconsin, USA) (Cronje, 2017). During the 
current study TrueStart Hot Start Taq DNA polymerase (ThermoScientific, USA) worked best for the 
detection of the RdRp gene fragment of AstVs, compared to Go Taq (Promega, Wisconsin, USA). 
For the amplification of the larger ORF2 gene fragment SuperScript™ III One-Step RT-PCR System 
with Platinum™ Taq DNA Polymerase (ThermoScientific, USA). 
4.2 Variation in the detection rate of astroviruses between bat species  
The results obtained by this study showed a significant difference in detection rates of AstV RNA 
between bat species. The highest detection was found in M. natalensis with 55% (12/22), followed 
by R. capensis with 39% (9/23) and R. clivosus with 17% (20/121). Interestingly only two 
Rhinolophid individuals (2/7) tested positive for AstV RNA during Ithete's study (2013), while during 
the current study it was found abundantly in both Rhinolophid species screened (R. capensis in 39% 
and R. clivosus in 17%). Ithete (2013) detected AstV RNA abundantly in members of the Miniopterus 
genus, with a 100% (6/6) detection rate in M. fraterculus followed by a 92% (12/13) detection rate in 
M. natalensis. Overall a higher prevalence rates were noted across the species screened by Ithete 
(2013), even though the sample size (n = 82) was much smaller than that of the current study 
(n = 500). This could in part be due to the fact that most individuals from one species were trapped 
at a single location belonging to a single roost. Interestingly during the current study and Ithete’s 
(2013) study, the highest detection rates for AstV RNA were documented in species belonging to the 
Miniopterus genus. Various other studies have also found that species of Miniopterus genus have the 
highest detection rates of the virus (Zhu et al., 2009; Xiao et al., 2011; Hu et al., 2014; Rougeron et 
al., 2016). The study by Rougeron et al. (2016) conducted in Gabon found that the detection rate was 
significantly higher in M. inflatus (10.9%) compared to Coleura afra (8%), R. aegyptiacus (1.23%), 





Table 4.1. Summary table of all known bat astrovirus research studies conducted globally adapted from Fischer et al. (2017) 
Study location Sample size Overall 
Prevalence 
Type of specimens 
screened 
Sample storage condition Kits 
Mozambique 






20.1% Mayotte: Rectal swabs 
(21) & faecal samples (58) 
Mozambique: Rectal 
swabs (180) & oral swabs 
(180)  
VTM and flash frozen in liquid 
Nitrogen 
Extraction: QIAamp Viral RNA Mini Kit 
(Qiagen, California, USA) 
cDNA&screening: ProtoScript II Reverse 
Transcriptase (New England BioLabs, USA) 
Chu et al., 2008 hemi-nested screening PCR 
Cambodia & Lao 







5.5% Faecal pellets (187), 
oral swabs (1211), 
rectal swabs (1684) & 
328 organs (328) 
Phase 1 collection: VTM and flash 
frozen in liquid Nitrogen  
Phase 2: collection from guano farms 
– RNAlater.  
Dead bats RNAlater / VTM 
RNA Extraction: QIAamp viral RNA mini kit 
(Qiagen, Hilden, Germany) and RNeasy Mini 
Kit (Qiagen, Hilden, Germany) 
cDNA & screening: SuperScript III kit 
(Invitrogen, USA) 
Chu et al., 2008 hemi-nested screening PCR  
Madagascar 
(Lebarbenchon et al., 
2017) 
178 22% Rectal swabs (178) Swabs were placed in brain heart 
infusion medium (Conda, Spain) 
supplemented with penicillin G (1000 
units/mL), streptomycin (1 mg/mL), 
kanamycin (0.5 mg/mL), gentamicin 
(0.25 mg/mL) and amphotericin B 
(0.025 mg/mL). Frozen in liquid 
nitrogen. Stored in − 80°C freezer @ 
research facility.  
RNA Extraction: QIAamp Viral RNA Mini 
Kit (Qiagen, Valencia, CA, USA). 
Reverse transcription: ProtoScript II Reverse 
Transcriptase (New England BioLabs, USA) 
Screening PCR: GoTaq G2 Hot Start Green 
Master Mix (Promega, Wisconsin, USA) 




Study location Sample size Overall 
Prevalence 
Type of specimens 
screened 
Sample storage condition Kits 
Singapore 





9.9% (oral & 
rectal swabs) 
Faecal pellets, oral swabs & 
rectal swabs 
Not mentioned.  Extraction: QIAamp virus 
RNA mini kit (Qiagen, Germany) 
Super Script III One Step RT-PCR Kit 
(Invitrogen, USA) 
Hemi-nested: Accuprime Taq DNA 
polymerase (Invitrogen, USA) 
Chu et al., 2008 hemi-nested screening PCR 
assay 





12.8% Faecal pellets 
Collected at roost site, did 
not sample individual bats 
(1029) 
 
Collection with polythene sheets 
underneath bat roosts (left at roost 
about 11 hours). Individual faecal 
pellets per tube with RNAlater 
(Qiagen, Germany). Samples were 
transported from sample site in 
cooled iceboxes. Stored at -80℃ at 
lab. Identification of bat species at 
roost site by chiroptologist & 
cytochrome b. 
RNA Extraction: High pure Viral RNA kit 
(Roche, Mannheim, Germany) 
RT-PCR & Screening: Invitrogen OneStep-
RT PCR kit using gene specific primers (Chu 
et al., 2008) 





Study location Sample size Overall 
Prevalence 
Type of specimens 
screened 
Sample storage condition Kits 





23.5% Oral swabs (47), urine 
swabs (430) & faecal 
pellets (480) 
  
Cell culture media (Minimal 
Essential Medium; Collection of Cell 




Extraction: Viral RNAMini Kit (Qiagen, 
Germany) 
cDNA & Pre-nested: Super Script III One 
Step RT-PCR Kit (Invitrogen, USA) 
Hemi-nested PCR: PWO DNA Polymerase 
Kit (Roche, Germany) 
Chu et al., 2008 hemi-nested screening PCR  
Gabon, Central 
Africa 
(Rougeron et al., 
2016)  
962 4.57% Organs – intestine samples 
(962) 
Trapping locations were in caves. 
Organs were frozen in field and 
transported to lab and frozen @ -80℃ 
Extractions: EZ1 RNA Tissue Mini Kit 
(Qiagen, Germany) 
cDNA & Screening: Superscript III One-step 
RT-PCR kit (Invitrogen, USA) 
Chu et al., 2008 hemi-nested screening PCR 
assay 
Czech Republic 
(Dufkava et al., 
2015) 
43 20.9% Intestine samples of 
deceased bats (40) & 
3 pooled faecal samples 
40 deceased animals  
3 Mist netted individuals 
No information with regards to 
storage.  
Extraction: QIAamp Viral RNA Mini Kit 
(Qiagen, Germany) 
cDNA: Transcriptor First Strand cDNA 
Synthesis Kit (Roche, Germany) 





Study location Sample size Overall 
Prevalence 
Type of specimens 
screened 
Sample storage condition Kits 
China  
(Hu et al., 2014) 
620 7.6% Rectal swabs (620) Rectal swabs placed in RNAlater and 
stored at -80℃ 
Extraction: QIAamp virus 
RNA mini kit (Qiagen, Germany) 
Super Script III One Step RT-PCR Kit 
(Invitrogen, USA) 
Hemi-nested: Accuprime Taq DNA 
polymerase (Invitrogen, USA) 
Chu et al., 2008 hemi-nested screening PCR 
Hungary 
(Kemenesi et al., 
2014) 
  
60 8.3% (5/60) Faecal pellets (60) Faecal pellets collected from 
individual caught bats, placed in bat 
bags for approx. 30 min. medium 
stored in is unclear.  
Extraction: DiaExtract Viral RNA Isolation 
Kit (DIAGON Ltd., Hungary) 
cDNA & Screening: OneStep RT-PCR Kit 
and Dia Taq Kit (DIAGON Ltd., Hungary) 
Chu et al., 2008 hemi-nested screening PCR 
Hungary 
(Kemenesi et al., 
2014) 
 
447 6.93% Faecal pellets (447) Faecal pellets collected from 
individual caught bats, placed in bat 
bags for approx. 30 min. Pellets were 
stored in PBS and kept on dry ice. 
Stored at -80℃ @ research facility. 
Extraction: DiaExtract Viral RNA Isolation 
Kit (DIAGON Ltd., Hungary) 
cDNA & Screening: OneStep RT-PCR Kit 
and Dia Taq Kit (DIAGON Ltd., Hungary) 





Study location Sample size Overall 
Prevalence 
Type of specimens 
screened 
Sample storage condition Kits 
Southern China 
(Xiao et al., 2011) 
321 9% (29/321) Rectal swabs (321) Rectal swabs placed in RNAlater 
and stored at -80℃ 
Extraction: Roche High Pure Viral RNA Kit 
(Roche, Germany) 
cDNA: AMV Reverse Transcriptase (Promega, 
USA) 
Pre-nested and Hemi-nested PCR: Ex Taq Hot 
Start Version Kit (TaKaRa) 
Chu et al., 2008 hemi-nested screening PCR 
China  
(Zhu et al., 2009) 
500 44.8% 
(224/500) 
Rectal swabs (500) Rectal swabs placed in VTM QIAamp virus 
RNA mini kit (Qiagen, Germany) 
Super Script III One Step RT-PCR Kit 
(Invitrogen, USA) 
Hemi-nested: Accuprime Taq DNA polymerase 
(Invitrogen, USA) 
Chu et al., 2008 hemi-nested screening PCR 
China  





8% oral swabs 
(19/246) 
Rectal swabs (250) & 
oral swabs (246) 
Swabs placed in VTM QIAamp virus 
RNA mini kit (Qiagen, Germany) 
Super Script III One Step RT-PCR Kit 
(Invitrogen, USA) 
Hemi-nested: Accuprime Taq DNA polymerase 
(Invitrogen, USA) 




4.3 South African bat Astrovirus diversity based on phylogenetic analyses 
During this study, 25 AstV RdRp sequences and one capsid protein (ORF2) sequence were obtained, 
bringing the available bat AstV sequences from SA to 44 RdRp sequences and one ORF2 sequence 
(not yet available on GenBank) (Ithete, 2013). Multiple attempts were made to obtain more RdRp 
gene sequences and ORF2 sequences, but some were of very poor quality even after attempting to 
clone them. According to the ICTV AstVs are classified as species based on the capsid protein gene 
(ORF2) (Fauquet et al., 2005). The ORF2 region of the AstV genome is more variable compared to 
the conserved RdRp gene (Fischer et al., 2017; Rougeron et al., 2016; Chu et al., 2008). This region 
has successfully been obtained for many other AstVs infecting mammals and birds, but amplification 
of the ORF2 gene of bat AstVs has been relatively challenging as this region is highly diverse 
(Shimizu et al., 1990; Koci & Schultz-Cherry, 2002; Chu, 2011; Karlsson et al., 2015; Fischer et al., 
Eloit, 2017; Alves et al., 2018).  
Only a few studies have managed to obtain the ORF2 sequence of bat AstVs as reflected by the 
limited number of bat AstV ORF2 sequences available on GenBank (approximately 14 ORF2 
sequences are available on GenBank, 
(https://www.ncbi.nlm.nih.gov/nuccore/?term=bat+astrovirus+capsid+protein/ visited 23 January 
2019)) compared to the number of RdRp sequences (approximately 600) (Chu et al., 2008; Zhu et al., 
2009; Rougeron et al., 2016; Fischer et al., 2017). It is therefore common practice to use the smaller, 
more conserved RdRp region of the genome for diversity and phylogenetic analyses (Chu et al., 2008; 
Chu, 2011; Rougeron et al., 2016; Lebarbenchon et al., 2017; Mendenhall et al., 2017; Waruhiu et 
al., 2017; Hoarau et al., 2018).  
4.3.1 Phylogenetic inferences based on the RdRp phylogeny 
ML analyses of the RdRp gene sequences of SAn bat AstVs (Ithete, 2013) place them in genogroup 
II in the Mamastrovirus genus. The SA bat RdRp sequences were separate from all other mammalian 
AstV sequences. The sequences obtained were not closely related to any other mammalian AstV 
sequence. Many studies on bat AstV sequences have similar results (Chu et al., 2008; Chu, 2011; 
Rougeron et al., 2016; Lebarbenchon et al., 2017; Waruhiu et al., 2017; Hoarau et al., 2018), however 
there are studies that have found that their bat AstV sequences were closely related to sequences 
originating from avian and other mammalian hosts. The bat AstV sequences found by Fischer et al. 
(2016) were closely related to AstV sequences originating from humans, birds, foxes and rodent hosts.  
The results of the current study support the suggestions made by Xiao et al. (2011) that bat AstVs do 




suggest that clustering does not follow geographical location, as sequences from different localities 
were observed clustering. Similar findings were made by Rougeron et al. (2016) in Gabon where 
sequences obtained from different bat species inhabiting three different roosts clustered together. 
Furthermore, the results of the current study also indicated that sequences did not cluster according 
to host species. Hoarau et al. (2018) also found that AstVs sequences from different bats species from 
different geographic locations clustered together, suggesting that host species restriction is limited. 
The SAn bat AstVs were found to be highly diverse with no apparent trend in terms of restriction of 
sequence clustering. Poor bootstrap support was also noted for most sequence clusters, which is a 
common phenomenon noted in AstV phylogenetic analyses (Rougeron et al., 2016; Waruhiu et al., 
2017; Hoarau et al., 2018). The poor resolution of the phylogenetic trees can be attributed to limited 
sequences available for SA bat AstVs, the size of the RdRp gene used for the phylogenetic analyses 
and the high saturation of their genome (Mendenhall et al., 2015; Hoarau et al., 2018). Groupings that 
had significant bootstrap support of more than 70% will be discussed (Efron et al., 1996).  
Three types of sequence clusters were noted: (1) clusters of sequences from the same species from 
the same location; (2) clusters of sequences from species within the same bat family from different 
locations; and (3) clusters of sequences from different species from different locations. The 
phylogenetic tree was split into three sections (A, B, & C) for ease of reference. Groupings with 
significant bootstrap support will be discussed.  
4.3.1.1 Clustering of sequences from the same species from the same locality  
The first grouping of interest in Section A (Figure 3.3.) is that of two RdRp sequences derived from 
N. capensis bats (BatAstV/Greyton/NC7 and BatAstV/Greyton/NC1) from the same locality, Greyton 
in the Western Cape. The pairwise distance matrix indicated that these two sequences are highly 
similar, with a 1% difference at the nucleotide level (Appendix G). This grouping could potentially 
suggest that these two bats from the same roost had two very similar, if not the same, AstV strain. It 
was not uncommon for bats from the same roost to be infected with the same AstV strain, e.g. the 
Myotis myotis colony studied by Drexler et al. (2011) was infected with the same AstV strain. AstV 
strains discovered in Kenyan bats were highly diverse, but there were sequences from the same bat 
species, Cardioderma cor from the same location that clustered together (Waruhiu et al., 2017). 
4.3.1.2 Clustering of AstVs RdRp sequences derived from bat species belonging to the same 
genus from different localities across South Africa 
There was also a grouping in Section B (Figure 3.4.) of sequences from members of the same bat 




(BtAstV/Pietermaritzburg/Mf2/Min fra/KZN) and M. natalensis from Table Mountain 
(BtAstV/TableMountain/MSTM9/Min nat/WP). According to the pairwise distance matrix these two 
sequences had a nucleotide similarity of 94% (Appendix G). These sampling locations are very far 
apart (approximately 1 500 km) and it would be unlikely for individuals to migrate between these 
areas (Monadjem et al., 2010). Rougeron et al. (2016) reported that bats that inhabited different cave 
systems had similar AstV strains circulating in them, and that individuals from the same cave roost 
had more divergent strains. The most plausible explanation is that these sequences evolved through 
convergent evolution.  
4.3.1.3 Clustering of sequences from different species sampled from different geographical 
locations  
In Section A (Figure 3.3.), there are two sequence clusters that include sequences found in bats from 
Greyton and bats occurring on Table Mountain. The different clusters were between T. aegyptiaca 
(BatAstV/GreytonTAr1) and M. natalensis (BatAstV/TablemountainMSTM1), and N. capensis 
(BatAstV/Greyton/NC5) and M. natalensis (BatAstV/TableMountainMSTM12) sequences. Based on 
the pairwise distance matrix these sequence clusters were highly similar with a 0% difference on the 
nucleotide level. The two sampling locations are approximately 160 km apart. It is however 
documented in the literature that M. natalensis can migrate distances of up to 250 km between roosts, 
this could suggest that M. natalensis co-roosted with T. aegytiaca in Greyton and migrated back to 
the roost on Table Mountain. The study by Voigt et al., (2014) found that M. natalensis exhibited 
seasonal elevational movements in search of cold hibernacula at higher elevations at Mount 
Kilimanjaro. This could also be the case for M. natalensis in the Western Cape, where they might 
utilize caves on Table Mountain as winter hibernacula (Voigt et al., 2014), making it more plausible 
that M. natalensis transmitted the virus between multiple bat colonies. As with many bat species little 
information is available on T. aegyptiaca’s home range size or migratory ecology (Monadjem et al., 
2010). As such it is speculated that M. natalensis might be the carrier of the virus between the different 
roosts.  
The third cluster of interest in Section C (Figure 3.5.) consisted of six sequences obtained from three 
different bat species, belonging to different bat genera, sampled at four different locations. Based on 
the pairwise distance matrix these sequences were 100% similar on nucleotide level (Appendix G). 
Four of the six sequences were obtained from N. capensis, one sequence from a R. clivosus and one 
sequence from a P. hesperidus. Three of the four N. capensis sequences in the cluster were obtained 
from a single colony in Velddrif located in the Western Cape of SA (BatAstV/Velddrif/VD34, 




(BatAstV/Napier/HWKNC4) in the cluster was obtained from a different sampling locality, 
Haarwegskloof Nature Reserve in the Overberg in the Western Cape. The Rhinolophus-derived 
sequence (BatAstV/Steenkampskraal/SKKRCL9) was obtained from a R. clivosus bat collected from 
a decommissioned radioactive mine in the Northern Cape. There was also an AstV sequence obtained 
from a P. hesperidus bat (BatAstV/Ph2NGR/Pip hesperidus) that was collected in Greyton. These 
four localities are far apart from each other, about 280-350 km. It would be most unlikely for the bats 
to fly these distances between the roosts. A more likely scenario is that these bat colonies have co-
evolved with a common AstV strain.  
These findings are in contrast with those by Dufkova et al. (2015). AstV sequence similarity was 
greater between different bat species at the same location compared to sequences derived from the 
same species, but from different geographical locations (Dufkova et al., 2015). The study by Zhu et 
al. (2009) also suggested that bat AstVs group according to host bat species, family or genera; this 
was not the case during the current study. Our findings were more similar to those of Rougeron et al. 
(2016), who found that their bat AstVs were not species-specific or limited by geography of the bat 
species. This could be suggestive of a long evolutionary history between bats and AstVs. As the RdRp 
gene region is highly conserved, it is possible that the different bat species co-evolved with a common 
prototype AstV strain. To ascertain whether these sequences are truly as similar as suggested by the 
phylogenetic reconstruction of the RdRp region, it will be invaluable to obtain the capsid protein gene 
(ORF2) sequences as this region is more variable.  
4.3.1.4 Clustering of South African bat astrovirus sequences with sequences from China 
In Section A (Figure 3.3.) a SAn R. clivosus-derived sequence (BatAstV/Hopefield/HFP1RCL9) 
appears to share a common ancestor with a sequence derived from a Chinese M. schreibersci bat. In 
Section B (Figure 3.4.) a cluster of SAn Rhinolophus-derived sequences 
(BatAstV/Hopefield/HFPRCL1, BatAstV/Hopefield/HFPRCL13 & 
BatAstV/Babanango/BVL1RCL1) share a common ancestor with sequence (GenBank ID: 
EU847193.1) derived from a bat within the Miniopteridae family from China. In section B (Figure 
3.4.) a second cluster of SAn and Chinese sequences was noted. The SAn sequence 
(BatAstV/Hopefield/HFPMN3) appears to be ancestral to the Chinese bat AstV sequences (GenBank 
ID’s: JQ814868.1, JQ814870.1, JQ814856.1 & JQ814858.1) that were obtained from M. pteridae.  
The phylogenetic analyses of the current study found that there was no strict level of host restriction 
or geographical distance. The findings further mirror the suggestions and findings of other studies in 
that bat AstVs are highly diverse, adaptable to new environments and new host species, and that they 




able to make more meaningful deductions about the co-evolution between bats and AstVs, more 
studies are needed on the basic ecology of SAn bats, as there is a large gap in available knowledge 
(Monadjem et al., 2010; MacEwan et al., 2016; African Bats NPC, 2018). To better understand the 
true diversity of AstVs in SAn bats, or bats in general, it is of utmost importance to obtain more 
sequences of the ORF2 gene, which is a better reflection of true diversity, as it is under constant 
evolutionary pressure (Bosch et al., 2014).  
4.3.2 Phylogenetic analyses of ORF2 
The SAn ORF2 bat AstV sequence was found to be more similar to HAstV sequences than bat AstV 
sequences. This is not an uncommon finding, as Fischer et al. (2016) discovered two sequences from 
M. nattereri bats clustering with human AstVs. The cluster of the SA bat AstV ORF2 sequence and 
the HAstV strains had weak bootstrap support, possibly due to the fact that there are not many ORF2 
bat sequences available for analysis and that the SAn bat-derived sequence is more similar to 
fragments in the human ORF2 sequences compared to other known bat ORF2 sequences. Another 
factor that could have influenced the results could be the different lengths of the sequences used 
during the analysis. The ORF2 fragment obtained during the current study was shorter (1 kb) than the 
other sequences used (2 kb – 2,5 kb) (Xia, 2016). Furthermore, the alignment of multiple highly 
divergent sequences could result in poor sequence alignment that in turn affected the subsequent 
phylogenetic analyses (Xia, 2016).  
Interestingly the pairwise distance matrix analysis of the ORF2 genes (on the nucleotide level) 
indicated contrasting results, suggesting that the bat ORF2 sequences were more similar (similarity 
of 73-78%) compared to the human ORF2 sequences (similarity of 68%). One plausible explanation 
for the difference between the phylogenetic output is the fact that the phylogenetic models used for 
the ML analysis takes different aspects into account and is more in-depth than the pairwise distance 
matrix analysis (Tamura et al., 2010; Kumar et al., 2016; Xia, 2016). The ORF2 ML analysis further 
suggests that SAn bat AstVs could be more diverse than depicted by the shorter RdRp gene analyses, 
highlighting the importance to attempt to obtain more ORF2 sequences in future studies, perhaps 
through NGS methods.  
4.4 Astrovirus and Coronavirus amplification within a Neoromicia capensis colony  
A colony of N. capensis bats residing in bat boxes on a farm in Velddrif, on the West Coast of SA, 
were monitored over a period of twelve months during 2015. The bat boxes were affixed to the outside 
of a farm storage building. The colony consisted of both sexes and the colony size was estimated at 




colony migrated during the winter months (May-July) and only recolonized the roost in late August. 
The colony was monitored for two different viruses, AstVs and MERS-related beta-CoVs, using real-
time PCR assays (Section 2.13.1, Methods Chapter), as bats are regularly co-infected with these two 
viruses (Chu, 2008; Drexler et al., 2011; Seltmann et al., 2017). A single amplification peak was 
noted for both viruses, with the relative viral loads reaching a peak during September, correlating 
with the recolonization of the roost (Figure 3.7.). The increase in viral loads of both species did not 
seem to correspond to changes in seasonality, however, seasonal variation cannot be excluded as there 
was a gap in sampling during the winter months. During the current study there was no correlation 
between the increase in viral loads and the pupping season of N. capensis, which usually takes place 
during November (Taylor, 2000; Monadjem et al., 2010). This could in part be due to the drought 
that was experienced in the area. A study by Adams (2010) documented that a reduction in 
precipitation and water available as drinking sources for bats can lead to a 50% decline in bat 
reproduction. Furthermore, the survival of pups during drought periods are very low, hence it is 
plausible that pups that might have been born during November might have succumbed and not 
contributed immunologically naïve individuals to the colony that could have led to an increase in 
viral loads (Voigt & Kingston, 2016).  
Another study that also monitored the amplification of AstVs and CoVs in a bat colony was conducted 
by Drexler et al. (2011). The study conducted by Drexler et al. (2011) span over three years and the 
amplification of AstVs and CoVs were monitored in a Myotis myotis maternal colony. The results of 
their study indicated that the AstVs also had a single amplification peak which is similar to the results 
of the current study, except for the third year of the study where a second amplification peak was 
noted and correlated to the introduction of a novel AstV strain. The peak in amplification of the AstV 
was associated with colony formation and parturition. There were differences between the current 
study and the one conducted in Germany. The Myotis myotis colony monitored by Drexler et al. 
(2011) was much larger in size (maximum population size 200 individuals compared to 50) and was 
a maternity roost, only consisting out of female bats and their pups (Drexler et al., 2011). Another 
aspect that differed between the two roosts was that the roost monitored by Drexler et al. (2011) was 
enclosed within a roof of a building, with samples collected from plastic sheets placed on the roof 
floor, i.e. inside, whereas the N. capensis roost was in a bat box affixed to a barn and pellets were 
collected from below the bat box, subjecting the samples to possible UV radiation, heat etc. The 
results also indicated that the viral loads were much lower (highest viral load 240 for AstVs and 150 
for CoVs) than that found by Drexler et al. (2011), ranging from 103 to 108 for AstVs and 103 to 1010 
for CoVs. This could be attributed to colony size, differences in sample collection and sample 




recolonization only started during the end of August, thus no virus data was recorded to rule out that 
the viral loads were not subject to seasonal changes. A study by Seltmann et al. (2017) noted that 
AstV shedding fluctuated seasonally and was positively correlated with the rainy season. For the 
current study it seems that both viruses reached their peak amplification during the end of September, 
this is most likely when the roost was recolonized, and the population reached the critical population 
size for the virus to replicate and spread (Chu, 2011, Drexler et al., 2011). However, 2015 was also 
the first year of a four-year draught cycle that was experienced in the Western Cape of SA. It was 
noted that the bats left the roosts completely during 2016, which could be attributed to the drought. 
This halted the long-term surveillance of AstVs and CoVs in the colony. 
4.5 Virus isolation in vitro  
Various mammalian and avian AstVs have been successfully isolated and propagated in cell culture 
(Lee & Kurtz, 1981; Shimizu et al., 1990; Brinker et al., 2000; Fischer et al., 2017). The only available 
account of a failed bat AstV isolation attempt in vitro is that of Chu (2011). The present study 
describes the first isolation and propagation of what is likely to be a bat AstV in BHK-G43 cells. The 
sample material used as inoculum during the isolation attempts were saliva and urine samples 
collected from R. clivosus and M. natalensis bats, the samples were pre-screened for AstVs using 
hemi-nested screening PCR (Chu et al., 2008) and confirmed as a bat AstV through Sanger 
sequencing. The inoculum that led to the successful isolation was the saliva sample collected from a 
M. natalensis bat (field code SKKMN1). Three days post-inoculation changes were observed in the 
cell cultures, cells started to detach and clump, it was difficult to ascertain whether the changes 
observed were due to cytopathic effects of the virus or due to the porcine trypsin (Figures 3.8-3.10.). 
The isolation results were confirmed by Sanger sequencing and qPCR. Sanger sequencing confirmed 
that it was in fact a bat AstV that was isolated and not contamination. The qPCR results confirmed 
that the viral loads increased following the first passage and that it was not merely residual virus 
particles left behind after inoculation. Factors that could have played a role in the successful isolation 
include sample type used as inoculum, cell line, media constitution and post infection incubation 
period.  
4.5.1 Samples used as inoculum  
Most AstV isolation studies conducted on mammalian AstVs have used faecal material as inoculum 
for cell cultures (Shimizu et al., 1990; Brinker et al., 2000; Moser & Schultz-Cherry, 2005; Crameri 
et al., 2009; De Benedictis et al., 2011; Xiao et al., 2011; Xiao et al., 2013). During the current study’s 




positive stool sample was used as a positive isolation control. The human stool sample was used to 
inoculate Caco-2 cells (Marvin, Meliopoulos, and Schults-Cherry, 2014). 
4.5.2 Cell lines used for virus isolation attempts 
From the literature successful AstV isolation attempts utilized either kidney or colon derived cell 
lines (Shimizu et al., 1990; Brinker et al., 2000; Moser & Schultz-Cherry, 2005; Crameri et al., 2009; 
De Benedictis et al., 2011; Xiao et al., 2011; Xiao et al., 2013). As mentioned in the literature review, 
the cell receptors used by AstVs to gain entry into the cell are still undetermined, contributing to the 
complexity of in vitro isolation of this virus (Brinker et al., 2000). During the current study three cell 
lines were experimented with during the isolation attempts namely, Caco-2, BHK-G43 and NCK 
cells. Isolation and propagation were only successful in BHK-G43 cells, while isolation in NCK and 
Caco-2 cell lines could not be achieved. It is unclear why the NCK cells were not permissive to 
infection, it could be that the cells were not adapted to grow in SF media. Another possibility could 
be that bat cell lines are more resistant to infection compared to the baby hamster kidney cell line 
used. A study by Hoffman et al. (2013) found that lung and kidney bat cell lines from both 
Yinpterochiroptera and Yangochiroptera were not susceptible to infection by transmissible 
gastroenteritis virus (TGEV), a porcine CoV or SARS-CoV. They propose that bat cell lines might 
be more resistant to infection with the CoVs through receptor-dependent restriction. This might also 
be the case for the Neoromicia cell line used in the current study. BHK-G43 cells are transgenic BHK-
21 cell clones that can be manipulated to express vesicular stomatitis virus (VSV) G protein with 
mifepristone (Moreira et al., 2016). During the current isolation attempts the BHK-G43 cells were 
not manipulated to express VSV G proteins, as such they can be regarded as BHK-21 cells (Kalhoro 
et al., 2009). in Vitro bat AstV isolation attempts by Chu (2011) made use of primary cell lines (lung 
and kidney) derived from M. magnater, as well as Caco-2 cells. All attempts of AstV isolation and 
propagation by Chu (2011) were unsuccessful. Table 4.2. compares the methods used during the 
current study with those used by Chu (2011). 
Table 4.2. Comparison between bat astrovirus isolation and propagation attempts 
Cell culture factors Current study Chu (2011) 
Cell lines Caco-2, BHK-G43 & NCK M. magnater primary cell lines (lung 
  & kidney) & Caco-2 
Media type DMEM MEM 
Sample type (as inoculum) Urine & saliva Not specified 
Porcine trypsin added 5 µg / ml during inoculation step 10 µg / ml 
 10 µg / ml during post-inoculation  
 incubation 




Incubation post-inoculation 5 days 14 days 
Passaging Yes, once five days post inoculation. Yes, once 14 days post-inoculation.  
 Both cells and supernatant were passaged. Not mentioned 
 
4.5.3 Media 
Serum free media has been used for the isolation and / or propagation of numerous viruses. Scientists 
were able to propagate a chimeric parainfluenza virus type 3 respiratory syncytial virus to 100-fold 
higher titres in Vero cells with the use of SF media compared to serum-rich media (Yuk et al., 2006). 
Numerous AstVs have been successfully isolated in cell culture by using SF media with the addition 
of porcine trypsin (Lee & Kurtz, 1981; Shimizu et al., 1990; Brinker et al., 2000; Marvin et al., 2014). 
It is postulated that porcine trypsin activates the proteins in the capsid of the virus which might play 
a role in the attachment of the virus to the cell and cell entry (Lee & Kurtz, 1981). Experiments have 
shown that CPE-causing AstVs ceased to cause CPE in the absence of porcine trypsin (Lee & Kurtz, 
1981; Brinker et al., 2000). It was also found that more virus particles were released from cells when 
porcine trypsin was added to the media, resulting in higher virus titres (Lee & Kurtz, 1981). Many 
publications were not forthcoming with the exact concentration of porcine trypsin that should be 
added to the SF media, which could have hampered previous bat AstV isolation attempts. The virus 
isolation protocol used during this study is routelinely used for the isolation of HAstVs in vitro 
(Marvin et al., 2014). The exact composition of the SF media with the addition of porcine trypsin 
plays an important role in isolation attempts (Lee & Kurtz, 1981). For isolation of laboratory strains 
of viruses, no antibiotic and antimycotics are added, however during the current isolation attempts 
antibiotics and antimycotics were added, as the sample material was collected from animals and other 
microorganisms could be present in the sample. AstVs have been successfully isolated from faecal 
samples of pigs with diarrhoea with the use of SF media with antibiotics and antimycotics added 
(Shimizu et al., 1990).  
4.5.4 Incubation period post inoculation 
Another factor that might have played a role is the incubation period post-inoculation of the cell 
cultures. The protocol that was used during this study was based on HAstVs strains with high viral 
titres infecting Caco-2 cells, according to the protocol cells should be incubated three to four days 
post-inoculation. However, it was suggested by collaborating AstV isolation expert Dr. Meliopoulos 
(St. Jude’s Children’s Research Hospital, Memphis, USA) that the bat AstV infected cells be 
incubated for at least five days, as the titre of the virus in the sample was unknown. Furthermore, 
there are no known protocols for the successful isolation and propagation of bat AstVs. The cells 




a second batch of BHK-G43 cells, resulting in the first blind passage. These cells were also incubated 
for five days following inoculation. The blind passage might play an important role in increasing the 
viral load, as the qPCR results indicate that the amplification was higher in the second passage 
compared to the initial inoculation.  
Some viruses might take months to be isolated successfully in cell culture, and as there is no protocol 
for isolation of bat AstVs in vitro previous attempts could have failed due to the incubation period 
post-inoculation being too short or too long. The bat AstV isolation attempt by Chu (2011) reported 
a post-inoculation incubation period of 14 days. This period might have been too long. The optimal 
post-inoculation period should be investigated in future studies.  
4.6 Statistical analyses  
Statistical analyses correlating viral presence with host biological measurements or environmental 
measurements are useful tools to gain insight into the ecology of viruses in their hosts. To make more 
meaningful assumptions, long-term longitudinal studies need to be conducted. The statistical analyses 
indicated that bat species identity, sex and biome where the bats occurred in were significant 
contributors to AstV positivity. Statistical analyses on the ecological and biological data recorded 
during the current study provided a snapshot in time of factors that could possibly have played a role 
in virus prevalence, as the ecological fallacy points out some factors might be overshadowed due to 
the scale of the investigation. “The ecological fallacy consists in thinking that relationships observed 
for groups necessarily hold for individuals” (Freedman et al., 1998).  
4.6.1 Individual bat factors that possibly play a role in astrovirus positivity 
Species identity was indicated as a possible significant contributing factor in terms of AstV positivity 
in bats sampled in SA. A closer look at the ecology of the three bat species with the highest AstV 
prevalence might provide additional information on the ecology of the virus itself.  
4.6.1.1 Miniopterus natalensis 
The highest detection rate of AstV RNA was recorded in M. natalensis (55%). This species is widely 
distributed throughout Africa and the Arabian Peninsula. The extent of occurrence of M. natalensis 
is estimated to be 1 387 139 km2 (Figure 4.1.), due to its large extent of occurrence and adaptability 
this species is classified as least concern by the IUCN (Monadjem et al., 2010; MacEwan et al., 2016). 
This species is predominantly cave roosting, but they have also been documented roosting in crevice 
type roosts. Interestingly, they make use of two different cave systems, cooler cave systems are used 




et al., 2016). The females migrate between the cave systems and the distances between caves can 
range up to 260 km. The size of the colony in a specific roost can vary from a few individuals to more 
than 2 500 animals; at De Hoop Guano Cave on the Western Cape's south coast the colony size is 
estimated to be 200 000 during certain seasons (Monadjem et al., 2010). The migratory nature of this 
species coupled with its ability to form large roosts could be important factors in the maintenance and 
spread of AstVs. Another interesting aspect of their ecology that could play a role in virus 
dissemination is the use of different cave systems during the year.  
 
Figure 4.1. Distribution of Miniopterus natalensis in South Africa (MacEwan et al., 2016) 
4.6.1.2 Rhinolophus capensis 
R. capensis was the species with the second highest detection rate of AstV RNA in the current study 
(39%). This species is endemic to Southern Africa and is restricted in distribution to the coastal belt 
of the Southern Cape (Figure 4.2.) and is readily found in the Succulent Karoo and Fynbos biomes 
(Monadjem et al., 2010). According to the IUCN red list R. capensis is of least concern, due to the 
documentation of large colonies and their occurrence within protected areas (MacEwan et al., 2016). 
The estimated extent of occurrence of this species is 639 540 km2. This species prefers roosting in 
coastal sea caves but is also readily found in abandoned mines and dark lofts. They readily co-roost 
with R. clivosus and M. natalensis (Monadjem et al., 2010). This species is not known for long-




coastal areas the temperatures allow for abundant prey during the winter months, hence the rarity of 
hibernation in this species (Monadjem et al., 2010). Ecological factors that could possibly be of 
importance for the spread and maintenance of AstVs is their co-roosting behaviour, colony size and 
potentially roost sites (Nunn et al., 2015). Co-roosting behaviour could enhance interspecies transfer 
of the virus resulting in recombinant strains. As mentioned earlier, M. natalensis is a migratory 
species, and as these two species readily occur together M. natalensis could serve as a source of novel 
viruses when returning to communal roosting sites after migration.  
 
Figure 4.2. Distribution of Rhinolophus capensis in South Africa (MacEwan et al., 2016) 
4.6.1.3 Rhinolophus clivosus  
During the current study AstV RNA detection was recorded at 17% in R. clivosus bats. R. clivosus 
share many ecological similarities with R. capensis. This species roosts in caves, rock crevices, 
abandoned mines, rural and urban buildings and hollow baobab trees (Adansonia species) (Monadjem 
et al., 2010). They also make use of feeding roosts during the evening, where they eat their insect 
prey before returning to their roosts (Monadjem et al., 2010). Unlike R. capensis this species’ 
distribution is not limited to coastal areas or even to SA (Stoffberg et al., 2012; Stoffberg, 2013). 
They occur in a wide variety of biomes throughout SA and greater Africa and is classified as least 
concern by the IUCN. The estimated extent of occurrence is 1 196 606 km2 (Figure 4.3.), however 




et al., 2012; Stoffberg, 2013). Another fascinating difference between R. clivosus and R. capensis is 
that R. clivosus undergoes prolonged periods hibernation, which is less common in R. capensis. 
Hibernation could also play an important role in virus maintenance and spread. A study by George et 
al. (2011) on hibernation’s effect on rabies in big brown bats (E. fuscus), found that the incubation 
period of the rabies virus and the reduced metabolic effect of colder temperatures during hibernation 
supress virus activity. This causes a temporal maintenance reservoir of the rabies virus, keeping the 
virus dormant until the hosts emerge from hibernation and naïve individuals are introduced into the 
colony via parturition (George et al., 2011).  
 
Figure 4.3. Distribution of Rhinolophus clivosus in South Africa (MacEwan et al., 2016) 
Observations made by collaborating zoologists who conducted the sampling of bats, could also shed 
some light as to why Rhinolophus bats were found to have high detection rates of AstV RNA. One 
sampling locality where numerous R. clivosus bats tested positive for AstV RNA was located in an 
abandoned mine in Babanango in KZN. It was noted that most of the cave system where the bats 
roosted was waterlogged. It was postulated that these colonies of hundreds of individuals, defecate in 
the stagnant water, which could then serve as a reservoir for virus maintenance within the cave 
system, as these bats might drink the water. 
Another interesting observation made is that of colony size at trapping locations. Sites with larger 




colony size was not recorded for all sampling localities and could therefore not be used in statistical 
modelling.  
4.6.2 Sex a significant predictor of astrovirus positivity  
The findings of the current study suggest that sexually active male bats were more likely to have 
active AstV infections (40/242, 17%) than females (23/255, 9%). Male-biased infection rates of 
AstVs in bats were also documented by Mendenhall et al. (2017). However, several other bat AstVs 
studies did not document a significant difference in infection between male and female bats 
(Mendenhall et al., 2017; Hoarau et al., 2018). 
Various physiological and behavioural differences exist between male and female bats, which could 
significantly influence their susceptibility to different infections (Christe et al., 2007). Hormones 
could play an important role; testosterone is a known immunosuppressant and it is widely documented 
that the production of this hormone increases susceptibility to infections (Klein, 2012).  
Monadjem et al. (2010) noted differences in the roosting behaviour between male and female bats of 
M. natalensis. At De Hoop Guano cave, it was found that males and females of the species M. 
natalensis inhabited different sections of the cave. These different sections have different 
temperatures and most likely different microclimates, which could be important to AstV transmission. 
Furthermore, roosting behaviour during different times of the year differ significantly between the 
sexes. As mentioned in the previous section, it is documented that female M. natalensis bats migrate 
from the coastal regions of the Western Cape to more inland locations during the winter, to induce 
hibernation, whereas the males tend to stay behind at the roost.  
Differences in torpor behaviour between male and female bats could also play a role. Torpor is a 
physiological mechanism bats use to reduce their energy consumption by lowering their metabolism 
and body temperature. It is suggested that intrahost pathogen replication could be temperature-
dependent, and that seasonal torpor could suspend virus replication (Sadler & Enright, 1959; Sulkin 
et al., 1960; Luis & Hudson, 2006). Thus, species and sex differences in torpor behaviour might affect 
the co-evolution of pathogen variants and their transmission. 
4.6.3 Environmental factors  
The results of the generalized estimating equation suggest that biome type, specifically Succulent 
Karoo, could play an important role in AstV positivity in bats. This could be linked to the species in 
which the virus was found during this study. AstV RNA was frequently detected in R. capensis and 




in SA and no data currently exists that could explain why AstVs might be more prevalent in bats 
trapped in this biome. Further studies are required to elucidate these findings in the future. 
4.7 qPCR vs conventional astrovirus screening PCR  
During this study a real-time PCR assay was designed based on the bat AstV RdRp sequences 
obtained. The qPCR assay was a probe-based assay that enhances specificity. The qPCR assay was 
used to monitor the relative viral load fluctuations within a bat colony over time as well as to assess 
the virus isolation attempts. The assay was also assessed to determine if it could provide a more 
sensitive detection tool compared to the conventional hemi-nested screening PCR developed by Chu 
et al. (2008). For the subset of samples that were rescreened (n = 150), the real-time assay detected 
20% more positives than Chu's assay, including all the samples in the subset that had been positive 
via the screening PCR. The results indicated that the real-time PCR assay developed is highly 
sensitive and able to detect the presence of AstVs at low copy numbers, suggesting that qPCR assays 
could be alternative AstV screening tools. Studies that have investigated AstVs in sewage and 
WWTW routinely use real-time assays, as they are able to detect AstVs at low concentrations (Le 
Cann et al., 2004). qPCR assays could also be used to detect AstV in samples that might have lower 
viral loads, which are not detectible with the conventional hemi-nested screening PCR assay. 
However, it is important to consider that sequence data cannot be generated from qPCR reactions, 
and that the sequence fragment would be insufficient for phylogenetic analysis due to the small size 
of the amplicon. If positives are identified they can be re-screened using the hemi-nested PCR assay 
developed by Chu et al. (2008) to allow for Sanger sequencing. 
4.8 Possible One Health implications of AstVs in South Africa 
The One Health concept acknowledges that the health of humans, animals and the environment are 
interlinked and dependant on one another. One of the aims of the study was to frame the results as 
possible One Health implications.  
During the current study the host species that was studied was bats (Chiroptera) and the AstVs that 
they harbour. The zoonotic potential of wildlife AstVs, including those harboured by bats, has not yet 
been determined, however numerous studies suggest that the zoonotic potential of wildlife AstVs is 
high due to limited host species restriction, cross species transmissions, as well as the error proneness 
of the viral genome. However, numerous factors influence the zoonotic potential of a virus, including 
the number of viruses harboured by the primary host organisms, phylogenetic proximity between the 
host organism and humans, contact rates between the host and humans, habitat destruction and virus 




The possible zoonotic potential of SAn bat AstVs were deduced from the results obtained from the 
phylogenetic analyses of the ORF2 gene fragment and the in vitro isolation and propagation attempts. 
The phylogenetic results of the ORF2 gene suggest that bat AstVs are more closely related to HAstVs 
than to bat AstVs and could potentially pose a threat to human health. As the analyses only included 
one SAn bat AstV ORF2 gene, it would be advisable to obtain more ORF2 gene fragments to support 
this theory. Furthermore, as clinical samples of patients with gastroenteritis are not routinely screened 
for the presence of AstVs there is not a lot of genetic data available on SAn HAstVs (Pager, 2002; 
Nadan et al., 2003). To better understand the phylogenetic relationship between SAn bat AstVs and 
SAn HAstVs it will be crucial to obtain more SAn HAstV sequences. 
The in vitro isolation and propagation attempt of the bat AstV revealed that it was not capable of 
propagating in Caco-2 cell lines, but the virus was however capable of propagating in BHK-G43 cells. 
This could suggest that the virus could make use of an intermediate rodent or murine host through 
which it can then potentially adapt to infect humans. It could also suggest that the Caco-2 cell line 
does not have the correct receptors to allow bat AstV entry and replication. More in-depth research 
should be conducted to further elucidate the true zoonotic risk of bat AstVs.  
The potential impact of AstVs on environmental and animal health in terms of anthropogenic 
alteration of environments through the possible contamination of water sources with HAstVs were 
investigated at WWTW in KZN. Bats were trapped at various WWTW in KZN and tested for the 
presence of AstV RNA. In conjunction with bat samples, water samples were also collected from the 
WWTW sites and tested for the presence of AstV RNA. Interestingly only one bat (out of 50) tested 
positive from these sites. Furthermore, the phylogenetics of the RdRp sequence derived from the bat, 
were also not closely related to HAstVs, suggesting limited reverse zoonotic potential of the virus. 
The WWTW water samples were analysed and tested negative for the presence of AstV RNA. This 
could be indicative that the WWTW that were investigated were functioning optimally and posed 
limited threat in terms of environmental contamination with HAstVs. 
4.7 Conclusion  
The current study aimed to investigate the diversity and ecology of AstVs in SAn bats using 
phylogenetic-, molecular-, cell culture- and statistical methods.  
The results of the current study demonstrated the diversity of AstVs in SA bats, as predicted in the 
hypothesis. Twenty-five novel RdRp sequences and one ORF2 sequence were obtained during the 
current study bringing the available bat AstV RdRp sequences to forty-four. The phylogenetic 




identity or host geographic distribution. The phylogenetic analysis of the ORF2 gene fragment 
suggests that SAn bat AstVs might be more similar to human AstVs than bat AstVs.  
The monitored N. capensis colony was co-infected with AstVs and CoVs, but the amplification of 
these viruses was not correlated to seasonality. The single peak in virus amplification corresponded 
with the recolonization of the roost after migration during September, and not with seasonality. 
Furthermore, the peak in virus amplification was not associated with the pupping season of N. 
capensis, which was the case for a Myotis myotis bat colony monitored by Drexler et al. (2011). These 
results disproved the hypotheses that AstVs and CoV infection in this specific bat colony would be 
correlated to seasonality. The results did however support the hypothesis that the N. capensis colony 
would be co-infected with AstVs and CoVs.  
Host and environmental factors were found to influence AstV detection in bats. The statistical 
analyses indicated that bat species identity, being a sexually active male bat and occurring in the 
Succulent Karoo, are important factors in bat AstV positivity. This also supports the hypotheses that 
both host factors and environmental factors influence AstVs positivity. 
The current study was the first to successfully isolate and propagate a bat AstV in vitro using a saliva 
sample collected from a M. natalensis bat in BHK-G43 cells. The methods used during the isolation 
attempts might enable other studies to successfully isolate bat AstVs in vitro. The successful isolation 
of a bat AstV in vitro will enable future studies to obtain larger fragments of the genome or full 
genomes with NGS technology.  
The results of the current study provided some insight into the possible One Health implications of 
bat AstVs in SA. Phylogenetic analysis of the ORF2 gene suggests that bat AstVs are more similar 
to HAstVs than to bat AstVs, and as such could potentially pose a threat to human health. The in vitro 
isolation and propagation of a bat AstV in vitro demonstrated that the virus is capable of infecting 
cells originating from hamsters, which suggest that the virus can easily cross the species barrier and 
can be of possible veterinary importance. The analyses of water samples from WWTW for the 
presence of AstVs were indicative that these treatment works were functioning optimally and pose 
little threat environmentally. 
The current study contributes significantly towards the body of knowledge of AstVs in SAn bats in 
terms of phylogenetic networks and factors that influence AstVs positivity. Furthermore, an 
optimized protocol for the successful isolation of bat AstVs in vitro was developed, which is 




4.7.1 Shortcomings of the current study 
The current study investigated AstVs in numerous insectivorous bats occurring in SA, however no 
fruit bat samples were screened, as these bats were not sampled by our collaborators. Future studies 
should attempt to include as many bat species as possible to enable comparability with other studies. 
Furthermore, the samples used during the current study was collected opportunistically and could 
obscure the true prevalence of the virus. Direct sampling of sufficient numbers of each bat species 
will give a more accurate indication of virus prevalence and diversity. 
Only a few juvenile bats were sampled during the current study, as such the influence of age on AstV 
prevalence in bats could not be determined. Future studies should include more juvenile bats to 
elucidate the influence of age on AstV prevalence.  
Even though the study was the first to obtain a SAn bat AstV ORF2 fragment, only one sequence was 
obtained and only limited phylogenetic inferences could be made. It would have been advantageous 
to explore NGS methods to obtain longer ORF2 fragments or complete genome sequences, however 
due to time and financial constraints these methods could not be employed during the current study. 
The longitudinal surveillance study of AstVs and CoVs in a N. capensis colony provided some 
valuable insights into the ecology of both viruses, however it would have been more advantageous if 
the monitoring could have been for two or three years. With the extreme drought conditions in the 
area the bats completely vacated the roost, resulting in the shorter timeframe for monitoring.  
4.7.2 Future directions  
One very important aspect that is lacking in bat virus research in general is the lack of information 
on the ecology and habits of the bats. To fully understand the intricate role bats play as carriers of 
various zoonotic diseases, it is of utmost importance to understand their ecology and behaviour. This 
could be achieved through in-depth longitudinal research that focuses on species specific colonies 
that documents their ecology and behaviour using radio telemetry or GPS trackers, as well as 
behavioural observations by researchers.  
To obtain a better understanding of potential One Health implications of bat AstVs, the surveillance 
of this virus in bats should be coupled with screening of clinical as well as environmental samples. It 
would be advantageous to test bat colonies that live in close proximity to humans, and then also screen 




The optimised protocol developed in this study for the isolation and propagation of a bat AstV in 
vitro, can be used in future studies to obtain whole genome sequences of these viruses and virus 
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Appendix A - Ethics approval of collaborators for trapping of bats 
Cape Nature Permit number: 0056-AAA041-00091 
Ezemvilo Permit number: 3899/2015 





Appendix B - Genbank identification number and description of sequences 
downloaded for RdRp phylogenetic analyses 
JQ814870 Tylonycteris robustula astrovirus 1 RNA-dependent RNA polymerase (RdRp) gene, partial cds 
JQ814856 Miniopterus schreibersii astrovirus 1 RNA-dependent RNA polymerase (RdRp) gene, partial cds 
JQ814868 Myotis ricketti astrovirus 1 RNA-dependent RNA polymerase (RdRp) gene, partial cds 
EU847198 Bat astrovirus 1 isolate AFCD271 polyprotein 1AB gene, partial cds 
EU847207 Bat astrovirus 1 isolate AFCD94 polyprotein 1AB gene, partial cds 
KU510453 Bat astrovirus strain 09GB409Mi RNA-dependent RNA polymerase-like (RdRp) gene, partial 
sequence 
KY575651 Astrovirus sp. RNA-dependent RNA polymerase gene, partial cds 
KY575647 Astrovirus sp. RNA-dependent RNA polymerase gene, partial cds 
KY575652 Astrovirus sp. RNA-dependent RNA polymerase gene, partial cds 
FJ571065 Bat astrovirus Tm/Guangxi/LD38/2007 non-structural polyprotein 1AB (pol) gene, partial cds; 
and capsid protein precursor (ORF2) gene, complete cds 
KU510460 Bat astrovirus strain 09GB552Hg RNA-dependent RNA polymerase-like (RdRp) gene, partial 
sequence 
KY575670 Astrovirus sp. RNA-dependent RNA polymerase gene, partial cds 
EU847211 Bat astrovirus 1 isolate AFCD198 polyprotein 1AB gene, partial cds 
EU847213 Bat astrovirus 1 isolate AFCD254 polyprotein 1AB gene, partial cds 
EU847203 Bat astrovirus 1 isolate AFCD317 polyprotein 1AB gene, partial cds 
EU847154 Bat astrovirus 1 isolate WCF214 polyprotein 1AB gene, partial cds 
EU847164 Bat astrovirus 1 isolate WCF96 polyprotein 1AB gene, partial cds 
EU847195 Bat astrovirus 1 isolate AFCD208 polyprotein 1AB gene, partial cds 
JQ814871 Miniopterus schreibersii astrovirus 13 RNA-dependent RNA polymerase (RdRp) gene, partial cds 
KJ571393 Bat astrovirus Mm/NX29/Hainan nonstructural polyprotein 1AB gene, partial cds 




KY575661 Astrovirus sp. RNA-dependent RNA polymerase gene, partial cds 
JQ814865 Miniopterus schreibersii astrovirus 10 RNA-dependent RNA polymerase (RdRp) gene, partial cds 
JQ814862 Miniopterus schreibersii astrovirus 7 RNA-dependent RNA polymerase (RdRp) gene, partial cds 
EU847147 Bat astrovirus 1 isolate WCF98 polyprotein 1AB gene, partial cds 
KJ571381 Bat astrovirus Ms/LS007/Hainan nonstructural polyprotein 1AB gene, partial cds 
EU847191 Bat astrovirus 1 isolate AFCD166 polyprotein 1AB gene, partial cds 
KU510456 Bat astrovirus strain 09GB438Mi RNA-dependent RNA polymerase-like (RdRp) gene, partial 
sequence 
EU847159 Bat astrovirus 1 isolate WCF16 polyprotein 1AB gene, partial cds 
KU510474 Bat astrovirus strain 09GB1224Mi RNA-dependent RNA polymerase-like (RdRp) gene, partial 
sequence 
FJ571077 Bat astrovirus Ms/Guangxi/A629/2005 RNA-dependent RNA polymerase (pol) gene, partial cds 
KJ571431 Bat astrovirus Myr/QX60-2/Guangxi nonstructural polyprotein 1AB gene, partial cds 
BtAstV/CGC/Neo_capensis4/WC/South_Africa 
KY575665 Astrovirus sp. RNA-dependent RNA polymerase gene, partial cds 






Appendix C - Protocol for counting cells with haemocytometer 
Preparing the cell suspension for cell counting 
Media was aspirated (Gilson, Wisconsin, USA) from the cell culture flask and cells were washed with 1x PBS 
(Gibco®, USA). Trypsin EDTA was added and the flask was incubated for 2-5 minutes, or until all the cells 
completely detached from the flask’s surface. Media was added to neutralize the trypsin. Cells were then 
transferred to a 50 ml Falcon tube (Corning, USA). Cells were resuspended by gently pipetting up and down. 
The cell suspension was centrifuged (Rotanta 460R Hettich centrifuge, Massachusetts, USA) for 5 minutes at 
1 000 x g. The supernatant was aspirated (Gilson, Wisconsin, USA), and care was taken not to disrupt the cell 
pellet. The cell pellet was resuspended with growth media to the original volume used in the starting culture 
and 0.5 ml of cell suspension was transferred to a sterile 2 ml tube (Eppendorf, Germany). In a new 2 ml tube 
(Eppendorf, Germany), 100 μl of cell suspension was added to 400 μl (0.4%) Trypan Blue (MBL international, 
Massachusetts, USA) and mixed gently by inverting the tube (“Counting cells using a haemocytometer | 
Abcam,” n.d.).  
Counting of cells 
A volume of 100 μl of the Trypan Blue (MBL international, USA) treated cell suspension was added to the 
chambers underneath the coverslip of the haemocytometer. The haemocytometer was viewed under the 10x 
objective of the microscope (Nikon, Eclipse TS 100, Minato, Tokyo, Japan). Cells that were unstained, 
indicative of live cells, were counted in all 4 sets of 16 squares (Figure 1.) (“Counting cells using a 
haemocytometer | Abcam,” n.d.).  
  
Figure 1. Representation of the 4 grids of the haemocytometer used during manual cell counting 
Calculating the number of viable cells per ml 
The following equation was used to determine the number of viable cells per ml:  
Viable cells per ml = (
𝑐𝑒𝑙𝑙 𝑐𝑜𝑢𝑛𝑡
4
× 104) × 5 (𝑡𝑜 𝑐𝑜𝑟𝑟𝑒𝑐𝑡 𝑓𝑜𝑟 𝑡ℎ𝑒 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑤𝑖𝑡ℎ 𝑇𝑟𝑦𝑝𝑎𝑛 𝐵𝑙𝑢𝑒)  
Cells were counted in 




Appendix D - Snapshot of the datasheet used for data analyses  
month Prov site sample_ 
code 
alt bio sex age rep. 
state 
mass FA FMI AstV Train 
January KZN LNR NC11 1568 G F SA NP 6 34 5.190311 0 130.2 
October EC ABA PH10 57 AT M A NS 4.5 33 4.132231 0 25.4 
October EC ABA PH13 57 AT F A P 8 34 6.920415 0 25.4 
October EC ABA PH9 57 AT F A NP 5.5 34.5 4.620878 0 25.4 
October EC ABA PH5 57 AT F A P 8.5 34 7.352941 0 25.4 
July EC ABA NC1 57 AT M A NS 7.5 34 6.487889 0 108.4 
July EC ABA PH1 57 AT F A NP 8.5 36 6.558642 0 108.4 
July EC ABA NC2 57 AT M A NS 6.5 34 5.622837 0 108.4 
July EC ABA NC3 57 AT M A NS 6.5 35 5.306122 0 108.4 
July EC ABA NC4 57 AT M A NS 7.5 34 6.487889 0 108.4 
July EC ABA NC5 57 AT M A NS 6 34 5.190311 0 108.4 
July EC ABA NC7 57 AT M A NS 6 33.5 5.346402 0 108.4 
October EC ABA PH11 57 AT F A P 7.5 34 6.487889 0 25.4 
October EC ABA PH2 57 AT M A S 5.5 33 5.050505 0 25.4 
October EC ABA PH4 57 AT F A P 9 33.5 8.019603 0 25.4 
October EC ABA PH6 57 AT F A P 8.5 35 6.938776 0 25.4 
October EC ABA PH7 57 AT F A P 8.5 36.5 6.380184 0 25.4 
October EC ABA PH8 57 AT F A P 9.5 35 7.755102 0 25.4 
October EC AEL PH4 83 AT F A NP 8.5 34 7.352941 0 94.6 
October EC AEL PH3 83 AT F A P 8 34 6.920415 0 94.6 
January EC AHHB NC4 1227 G M A NS 7 33 6.427916 0 52.2 
January EC BCHB NC1 1229 G M A NS 6 33 5.509642 0 52.2 
January EC BCHB NC2 1229 G F A  PL 5 34 4.32526 0 52.2 
January WC CCK NC1 17 F F A NP 8 37 5.843682 0 9.6 
January WC CCK NC7 17 F F A NP 9 38 6.232687 0 9.6 
January WC CCK NC3 17 F M A S 8 37 5.843682 0 9.6 





Appendix E - Table with Bat trapping sites. All bat trapping sites, with 
abbreviated site codes, where samples were collected. 
Province  Site and code in brackets GPS coordinates 
Eastern Cape 
 
Aardvark Backpackers, Addo (ABA)  -33.5350 25.6955 
Arena Resort East London (AEL) -32.8839 28.0612 
Arminel Hotel Hogsback (AHHB) -32.5919 26.9332 
Sleepy Hollow Maitland (SHM) -33.9568 25.3132 
Table Farm Grahamstown (TFG)  -33.2853 26.4276 
KwaZulu-Natal 
Albert Falls (AF)  -29.4452 30.4301 
Babanango Exploratory Mine 2 (BVLEM2)  -28.2852 31.0137 
Babanango Exploratory Mine 1 (BVLEM1)  -28.2871 31.0129 
Babanango Main Mine (BVLMM)  -28.2867 31.0133 
Babango Valley (BVL)  -28.2867 31.0133 
Buffelsdrift (BDF)  -29.7567 30.6791 
Doornhoek Mine (DHM)  -29.6000 30.5200 
Hilton Train Tunnel (HTT)  -29.5497 30.2958 
Inkunzi Lodge. Babanango (ILB)  -28.5617 31.2404 
Lotheni Nature Reserve (LNR)  -29.4375 29.5150 
Mooiplaas Gold Mine (MPG) -28.5582 31.1653 
Spionkop Lodge (SKL)  -28.6950 29.5355 
Umbilo WWTW (DC2)  -29.8455 30.8919 





Royal Macadamia (LRM)  -23.0553 30.1495 
Kim's Farm (LKF) -23.0222 29.7989 
Peter Taylor's House (LPT) -23.0326 29.9296 
Northern Cape 
La Fugue Guesthouse (LFU) -28.4402 21.2945 
Blinkklip Grotte (BKP)  -28.3001 23.1156 
Hopefield Farm 1 (HFP1)  -28.6188 23.3242 
Hopefield Farm 2 (HFP2)  -28.6305 23.3397 
Western Cape 
Steenkampskraal Mine (SKK)  -30.9750 18.6343 
Cloeteskraal Farm Velddrif * (CCK)  -32.8732 18.2236 
De Kelders Cave 1 (CDK1)  -34.5556 19.3642 
De Kelders Cave 2 (CDK2)  -34.5500 19.3710 
Drie Kuilen Nature Reserve (CDK)  -33.5815 20.0312 
Forest Edge Knysna (FEK)  -33.9294 22.9386 
Gecko Rock Cottage (CGC)  -33.5184 20.1310 
Gecko Rock Main House (CGR) -33.5184 20.1188 
Haarwegskloof Nature Reserve (HWK)  -34.3383 20.3261 
Knysna Millwood Mines (KMM)  -33.8900 22.9910 





Appendix F - Phylogenetic relationship of novel astroviruses with in the 






Appendix G - Estimates of evolutionary divergence between RdRp sequences. The number of base differences per site 
between sequences are shown. The analysis involved 45 nucleotide sequences using the p-distance model with 1000 
iterations. Evolutionary analysis was conducted in MEGA7 (Kumar et al., 2016) 
1 GreytonTAr1Tad_agy_WP_SA2012 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44
2 MSTM1Min_nat_WP_SA2010 0%
3 BtAMSTM10Min_nat_WP_SA2010stV 21% 21%
4 BtAstVMSTM9Min_nat_WP_SA2010 16% 16% 23%
5 Mf2Min_fra_SA2013 16% 16% 21% 6%
6 HCA3_Hip_caf_SA2013 16% 16% 21% 8% 7%
7 GreytonTAr2Tad_agy_WP_SA2012 18% 18% 34% 18% 18% 17%
8 MSTM5Min_nat_WP_SA2010 22% 22% 27% 27% 23% 21% 17%
9 GreytonNC4_WP_SA2012 23% 23% 27% 23% 15% 20% 16% 25%
10 CDK2RCL13 33% 33% 41% 31% 31% 39% 23% 37% 28%
11 M-52Mus_mus_USA2008 29% 29% 44% 25% 29% 31% 28% 49% 34% 27%
12 HWKNC4 27% 27% 29% 32% 24% 22% 34% 38% 30% 29% 37%
13 VD_44 27% 27% 29% 32% 24% 22% 34% 38% 30% 29% 37% 0%
14 VD_34 27% 27% 29% 32% 24% 22% 34% 38% 30% 29% 37% 0% 0%
15 VD59 27% 27% 29% 32% 24% 22% 34% 38% 30% 29% 37% 0% 0% 0%
16 SKKRCL9 27% 27% 29% 32% 24% 22% 34% 38% 30% 29% 37% 0% 0% 0% 0%
17 DC28 28% 28% 33% 23% 20% 26% 38% 40% 24% 23% 32% 14% 14% 14% 14% 14%
18 CGCNC4 26% 26% 25% 25% 20% 23% 29% 36% 27% 23% 41% 21% 21% 21% 21% 21% 19%
19 GreytonNC5_WP_SA2012 23% 23% 25% 12% 18% 19% 16% 29% 22% 25% 27% 48% 48% 48% 48% 48% 35% 34%
20 MSTM12Min_nat_WP_SA2010 23% 23% 25% 12% 18% 19% 16% 29% 22% 25% 27% 48% 48% 48% 48% 48% 35% 34% 0%
21 GreytonNC2_WP_SA2012 23% 23% 23% 25% 23% 22% 27% 28% 25% 30% 42% 27% 27% 27% 27% 27% 25% 20% 25% 25%
22 HFPMN1 29% 29% 29% 23% 18% 23% 28% 23% 19% 19% 38% 21% 21% 21% 21% 21% 18% 13% 29% 29% 11%
23 Rsw2_Rhi_swi_SA2013 23% 23% 25% 23% 18% 16% 26% 24% 23% 30% 41% 19% 19% 19% 19% 19% 20% 18% 34% 34% 8% 8%
24 GreytonNC6_WP_SA2012 32% 32% 26% 26% 21% 25% 35% 35% 29% 26% 36% 20% 20% 20% 20% 20% 25% 22% 29% 29% 15% 11% 11%
25 Mf5Min_fra_SA2013 24% 24% 25% 31% 25% 25% 33% 30% 18% 19% 39% 14% 14% 14% 14% 14% 13% 17% 34% 34% 14% 12% 13% 15%
26 Mf6Min_fra_WP_SA2013 17% 17% 25% 24% 19% 21% 28% 30% 21% 20% 39% 20% 20% 20% 20% 20% 16% 16% 33% 33% 10% 10% 7% 12% 7%
27 BVL1RCL1 32% 32% 33% 27% 29% 27% 31% 37% 29% 29% 39% 29% 29% 29% 29% 29% 34% 22% 29% 29% 20% 13% 19% 17% 25% 19%
28 HFPRCL1 32% 32% 33% 27% 29% 27% 31% 37% 29% 29% 39% 29% 29% 29% 29% 29% 34% 22% 29% 29% 20% 13% 19% 17% 25% 19% 0%
29 HFP1RCL13 32% 32% 33% 27% 29% 27% 31% 37% 29% 29% 39% 29% 29% 29% 29% 29% 34% 22% 29% 29% 20% 13% 19% 17% 25% 19% 0% 0%
30 MSTM8Min_nat_WP_SA2010 25% 25% 30% 23% 14% 19% 30% 30% 19% 28% 40% 30% 30% 30% 30% 30% 22% 18% 27% 27% 15% 13% 13% 16% 16% 13% 14% 14% 14%
31 GreytonNC3_WP_SA2012 34% 34% 38% 35% 33% 33% 29% 35% 31% 30% 48% 30% 30% 30% 30% 30% 35% 34% 39% 39% 27% 23% 21% 24% 22% 24% 36% 36% 36% 27%
32 GreytonNC_WP_SA2012 34% 34% 38% 35% 33% 33% 29% 35% 31% 30% 48% 30% 30% 30% 30% 30% 35% 34% 39% 39% 27% 23% 21% 24% 22% 24% 36% 36% 36% 27% 0%
33 CDK1_MN1 47% 47% 41% 37% 30% 30% 33% 40% 34% 30% 49% 26% 26% 26% 26% 26% 31% 23% 42% 42% 31% 19% 25% 26% 20% 28% 38% 38% 38% 27% 11% 11%
34 BVL1RCL14 58% 58% 64% 48% 44% 53% 47% 56% 53% 35% 64% 37% 37% 37% 37% 37% 40% 39% 61% 61% 36% 23% 33% 32% 32% 35% 44% 44% 44% 41% 24% 24% 22%
35 HCA1_Hip_caf_SA2013 27% 27% 29% 32% 25% 29% 29% 31% 22% 19% 36% 17% 17% 17% 17% 17% 21% 12% 35% 35% 13% 10% 14% 14% 8% 11% 18% 18% 18% 18% 32% 32% 32% 39%
36 HFP1RCL9 24% 24% 25% 29% 23% 23% 29% 25% 25% 21% 44% 19% 19% 19% 19% 19% 21% 10% 39% 39% 17% 10% 11% 16% 11% 11% 24% 24% 24% 23% 32% 32% 28% 38% 9%
37 Mf4_Min_fra_SA2013 29% 29% 29% 30% 26% 29% 33% 34% 30% 33% 53% 27% 27% 27% 27% 27% 30% 24% 28% 28% 12% 22% 18% 20% 18% 16% 30% 30% 30% 22% 42% 42% 41% 51% 15% 19%
38 SKKRCL8 24% 24% 21% 27% 18% 21% 26% 28% 18% 22% 47% 19% 19% 19% 19% 19% 21% 15% 25% 25% 13% 14% 19% 21% 11% 12% 23% 23% 23% 18% 41% 41% 35% 47% 9% 11% 11%
39 SKKMN1 29% 29% 22% 31% 31% 29% 32% 36% 25% 21% 37% 30% 30% 30% 30% 30% 27% 19% 24% 24% 14% 21% 23% 20% 15% 13% 31% 31% 31% 27% 35% 35% 33% 49% 18% 16% 18% 13%
40 GreytonNC1_WP_SA2012 21% 21% 18% 32% 23% 28% 32% 28% 23% 28% 47% 21% 21% 21% 21% 21% 23% 18% 31% 31% 10% 17% 16% 15% 8% 10% 29% 29% 29% 15% 29% 29% 28% 47% 13% 15% 13% 10% 14%
41 GreytonNC7_WP_SA2012 21% 21% 19% 32% 23% 28% 32% 28% 23% 28% 47% 21% 21% 21% 21% 21% 23% 18% 33% 33% 11% 17% 16% 15% 8% 10% 29% 29% 29% 15% 29% 29% 28% 47% 13% 15% 14% 11% 16% 1%
42 BVL1_RCL1_(B) 34% 34% 28% 41% 34% 39% 40% 41% 26% 29% 47% 16% 16% 16% 16% 16% 23% 25% 47% 47% 29% 27% 25% 22% 14% 21% 32% 32% 32% 30% 37% 37% 41% 57% 19% 23% 27% 23% 23% 18% 18%
43 BVL1RCL12 31% 31% 20% 25% 18% 27% 34% 27% 21% 23% 35% 18% 18% 18% 18% 18% 16% 20% 37% 37% 23% 14% 18% 18% 13% 16% 27% 27% 27% 19% 32% 32% 26% 37% 17% 17% 26% 19% 21% 16% 16% 19%
44 HFPMN3 21% 21% 21% 31% 29% 25% 29% 26% 21% 19% 37% 17% 17% 17% 17% 17% 19% 14% 34% 34% 11% 10% 13% 15% 5% 7% 18% 18% 18% 19% 25% 25% 27% 34% 6% 8% 19% 11% 13% 11% 11% 19% 15%




Appendix H - Abbreviations used in sequence names in Figure 3.2.  
The names of the sequences were as follows: abbreviation of the type of virus (BtAstV)/locality/Species 
abbreviation/province/continent/ year (Sequenced by KB or NI) 
BtAstV- Bat astrovirus  
Species abbreviations used 
South African bat species  
Hip caf: Hipposideros caffer 
Neo cap: Neoromicia capensis 
Pip hesperidus: Pipistrellus hesperidus 
Rhi capensis: Rhinolophus capensis 
Rhi clivosus: Rhinolophus clivosus 
Other bat species abbreviations  
Min pus: Miniopterus pusillus 
Min sch: Miniopterus schreibersii 
Him arm: Hipposideros armiger 
Hip pom: Hipposideros pomona 
Min mag: Miniopterus magnater 
Myo Myo: Myotis myotis 
Myo ric: Myotis ricketti 
Pip abr: Pipistrellus abramus 
Rhi fer: Rhinolophus ferrumequinum 
Rhi pea: Rhinolophus pearsonii 
Rhi sin: Rhinolophus sinicus 
Rou les: Rou les 
Tap mel: Taphozous melanopogon 
Tyl rob: Tylonycteris pachypus 
SA province abbreviations 
WC: Western Cape  






Appendix I - Outline of experimental designs for different subsections of the 
project  
1. General surveillance of AstVs across SAn bat species  
Bats were sampled opportunistically across SA by collaborating Zoologists. A total of 500 individual bat 
samples were used during the current study. The bat faecal material was screened for the presence of AstVs 
using the hemi-nested screening PCR assay designed by Chu et al. (2008).  
Positive and negative controls were used during each step from extraction of RNA as well as during the 
screening PCR and sequencing process.  
If the PCR positive controls did not come up during gel electrophoresis (indicating possible failure of RNA 
extraction or cDNA failure), the entire process was repeated for the batch of samples. If negative PCR controls 
came up as positive during gel electrophoresis (indicating possible contamination), the entire process was 
repeated for the batch of samples in question.  
2. Surveillance of a specific colony of N. capensis bats in the Western Cape of SA for the presence of 
AstVs and CoVs 
Faecal material was collected on a monthly basis over the period of one calendar year (January-December 
2015). These samples were screened for the presence of AstVs and CoVs by means of two qPCR assays. 
Standard curve approach was used to determine relative viral loads for each virus. Negative controls were 
included in each qPCR run to rule out contamination. To further rule out any inconsistencies, samples were 
analysed in triplicate during each run. 
3 Screening of bats (N. nana) at WWTW for the presence of AstVs 
N. nana bats were sampled at WWTW (n=50) and pristine areas 3km away from WWTW (n=47). These 
samples were screened for the presence of AstVs using the hemi-nested screening PCR assay designed by Chu 
et al. (2008), as well as with the AstV qPCR assay designed. Positive and negative controls were utilized during 
each step of the experiment, from extraction of RNA as well as during the screening PCR and sequencing 
process. 
During qPCR runs, samples were run in triplicate to rule out any pipetting inconsistencies. 
4 Bat AstV isolation in vitro  
During isolation attempts of the bat AstV in different cell lines. Negative controls for each experiment (each 




out contamination. A cell culture positive control (HAstV positive faecal sample) was also utilized to establish 
that the isolation protocol was performed correctly.  
To minimize the possibility of contamination between the different cell lines used, cells were not handled at 
the same time in the laminar flow hood. Cleaning was also performed after working with each cell line.  
To further justify positive findings the isolation and propagation attempts were performed in duplicate.  
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